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Definition of terms 
Stats: The term used by the City of Johannesburg Health Services providers to refer to 
statistical data that is collated from facilities on a monthly basis to monitor services, using the 
service point registers and other documents as data sources. 
Service providers: Staff or service providers are used interchangeably in this report in 
reference to health workers providing services in the health facilities 
PLWHAs: All people who test HIV+ and are living with the virus. 
CD4 cell count cut-off point for ART: The criteria used to decide on the CD4 cell count 
level at which an HIV+ person gets initiated on ART. This criterion changed three times 
during this research study from ≤200 cells/μl to ≤350 cells/μl and currently at ≤500 cells/μl. 
Pre-ART individual: An individual who has tested HIV+ and has a CD4 cell count of >350 
without TB (not eligible to start ART). 
 Pre-ART program: A package of care that targets those individuals not yet eligible for 
ART and pre-ART service providers. 
 Timely initiation on ART: When an HIV+ individual has been initiated on ART at the CD4 
count level of ≤350cells/μl or ≤200 cells/μl, depending on the CD4 cell count cut off point for 
ART initiation at the time of data collection. 
Youths: Individuals aged 18 ≤24 years 
 Retention in Pre-ART care: A minimum of one subsequent CD4 cell count check in the 
previous 6 months 
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Youth friendly health services: Services that are based on a comprehensive understanding 
of what the young people in a particular society or community want, rather than being based 
on what service providers believe they need.  It is about creating a service that young people 
trust and feel is there for them and that meet their needs.  
Men friendly health services: Men friendly services are those that are welcoming and 
accessible for men, especially addressing both primary prevention and disease management. 
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Abstract 
Introduction 
South Africa (SA) has more than 6 million people infected with HIV, of whom 2.4 million 
have been initiated on Antiretroviral Treatment (ART). HIV positive non-pregnant women, 
and both women and men without tuberculosis and with a CD4 cell count of >500 cells/μl, 
were not eligible for ART initiation at the time of the study. These were transferred to a 
wellness (pre-ART) program for regular counselling and follow up. However, in SA, as in 
many other countries, previous data reported that there has been poor retention of HIV 
positive individuals prior to initiation on ART. This was particularly the case for youths and 
men. If people do not participate in a pre-ART program and are not regularly followed up, 
they often present for ART only when they are sick. Without an appropriate pre-ART 
program in PHC facilities, patients may end up delaying for ART initiation, leading to poor 
treatment outcome.  
 
Objective  
The objective of the study was to establish the existing gaps in pre-ART care service delivery 
and draw recommendations that would improve the quality of the delivery of pre-ART care 
and retain patients in care. 
 
Methodology 
 This was a mixed method study conducted in the City of Johannesburg (CoJ). Both 
qualitative and quantitative data were collected through interviews, register and file audits 
and the District Health Information System (DHIS). A total of 2,018 participants were 
involved in this study through patient (73) and staff (12) interviews, an HCT register audit 
(1715), ART register and file audits (203), and consultative workshop with health services 
managers (15). In addition, we used records from DHIS data base for NIMART uptake before 
(6957) and after (13578) the NIMART roll-out in the CoJ. STATA version 12.0 was used to 
analyse quantitative data whilst qualitative data was analysed manually. Ethics approval was 
obtained from the University of the Witwatersrand Committee for Research on Human 
Subjects. Prior to each interview session, informed consent was obtained. 
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Results 
The following pre-ART service delivery challenges were identified: long waiting times, 
multiple clinic visits, drug stock-outs, shortage of staff, unplanned disclosure of ones‟ HIV+ 
status, poor staff attitudes to patients, length of time spent on documentation by service 
providers, and cost implications in accessing pre-ART care. Factors contributing to these 
challenges with potential solutions to overcome these were identified. The study also 
established that men (P=0.001) and youths (p=0.05) were less likely than their counterparts to 
collect their first CD4 cell count results. The majority of patients retained in pre-ART care 
did not access the available pre-ART care services and there was no difference in timely ART 
initiation between those who accessed pre-ART before ART initiation and those who did not 
– meaning that the current pre-ART care program was not working. However, being 
knowledgeable of the fact that an HIV+ person can lead a normal life through getting married 
and having an HIV- child was positively associated with retention in pre-ART care 
(p=0.001), i.e. attendance for 6 monthly monitoring. Rolling out NIMART into primary 
health care facilities in the CoJ significantly increased ART uptake, and reduced the 
workload in the referral facilities.  
 
Conclusion and recommendations 
Multiple interrelated pre-ART care service delivery challenges were identified in this study, 
consistent with other studies conducted in SA and elsewhere. This is a cause for concern as 
the provision of effective HIV services is compromised, leading to poor outcomes. In 
contrast, poor access and delayed ART initiation for patients retained in pre-ART care, 
established in this study, have not been reported previously. Therefore there is a need to 
improve access to quality pre-ART care services by those patients retained in pre-ART care. 
This can be attained by reducing pre-ART care access time through established innovations 
like Point of Care (POC) CD4 cell count collection and Central Chronic Medicines 
Dispensing and Distribution Programme (CCMDD), and addressing shortages of staff.  In 
addition, raising patients‟ awareness on available services, addressing poor staff attitudes, and 
strengthening linkages to pre-ART care after patients test HIV positive, would improve the 
uptake of pre-ART care especially among men and youths. 
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Chapter One 
Background Information 
Human Immunodeficiency Virus (HIV) has now been known for about 35 years (CDC, 
1981). Since this time, more than 60 million people have been infected (Merson et al., 2008), 
resulting in about 25 million deaths (UNAIDS, 2015). In addition, about 33 million people 
were estimated to be living with the virus in 2012 (UNAIDS, 2014b), which had increased to 
about 37 million in 2014 (UNAIDS, 2015), the majority in resource poor settings (UNAIDS, 
2014b). At first, as research was being conducted to establish aetiology, diagnosis and 
management of the disease and its transmission, the response to the HIV pandemic was 
prevention. From early 2000, however, care was incorporated into a package. At that time, 
this included psychosocial support, STI and TB screening, management of opportunistic 
infections, and care for the terminally ill through home-based and palliative care. It also 
included care for orphans and vulnerable children due to AIDS morbidity and mortality, 
programs for Prevention of Mother to Child Transition (PMTCT), and Antiretroviral Therapy 
(ART) (Harries, 2002).  
ART was introduced around 1996 (Palella et al., 1998), but at first it could only be afforded 
by high income countries. In 2001, the United Nations General Assembly Special Session 
(UNGASS) convened in New York criticised the inequalities of ART access, leading to a 
global commitment to universal access to ART with other HIV services by 2010 (UNAIDS, 
2001). For example, in 2002 when the first HIV Management Guidelines were published by 
WHO, about 6 million people from resource limited countries were in need of ART, but only 
about 230,000 had access of this, of whom half were from Brazil (WHO, 2002). In order to 
mobilise resources for poor countries, the then UN General Secretary, Kofi Annan, requested 
that a Global AIDS Alliance be established, through which funds could be mobilised to 
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improve access to essential HIV services, including ART, in resource limited countries 
(UNAIDS, 2001). When ART was rolled out in these countries, a CD4 cell count cut off 
point of ≤200 cells/μl was used (WHO, 2003). Globally, there was a backlog of people 
eligible for ART waiting to be initiated. In 2006, Uganda was the first African country to 
initiate more patients than its target of 60,000, as 65,000 patients were initiated on ART 
(WHO, 2006). In addition, the WHO Guidelines recommended the need to prioritise action 
on those who were not yet eligible to start ART to ensure that they were continuously 
monitored and so could be initiated in a timely manner (WHO, 2003). Since then, this priority 
is advocated, although there is little implementation evidence as major implementation gaps 
(to be discussed in detail later in this thesis) exist in pre-ART care. 
South Africa has over 6 million people living with HIV (Shisana et al., 2014), and has the 
largest Antiretroviral Therapy (ART) program in the world (UNAIDS, 2014b). There have 
been challenges around the retention of patients in HIV care programs among those initiated 
on ART (Brinkhof et al., 2008, Fox and Rosen, 2010, Clouse et al., 2013) and major attrition 
among those not yet eligible for ART and at different stages of viral infection (Kranzer et al., 
2012, Losina et al., 2010), and among those eligible but still in the process of being initiated 
on ART (Tayler-Smith et al., 2010, Micek et al., 2009). Poor retention in pre-ART care has 
been shown to delay ART initiation, as patients mostly return for care only when sick 
(Lessells et al., 2011). 
By 2014, over 2.4 million people are on ART in South Africa (UNAIDS, 2014b). This large 
ART program has been possible due to government commitment to increase access to ART in 
line with international recommendations. Varying over time, the CD4 cell count cut off point 
for ART initiation increased from ≤200 cells/μl  in 2010 (SA, 2010a) to ≤350 cells/μl (SA, 
2013d) in 2013, and in 2014, ≤500 cells/μl  (SA, 2014b). In addition, HIV+ patients who are 
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pregnant and have been diagnosed with TB are initiated on ART regardless of their CD4 cell 
count level. As a result, more than 300,000 people are initiated on ART each year, resulting 
in increasing pressure on limited public health resources (Venter and Barker, 2013).  It is 
important that these limited resources are equally disbursed to all HIV service points, 
including pre-ART. 
1.1 Problem statement 
In primary health care facilities in South Africa, in line with WHO recommendations, 
patients who are not yet qualified to start ART are transferred to a pre-ART care program for 
monitoring, and to enable them to access prescribed pre-ART care services, including HIV 
counselling and testing (HCT), INH Prophylaxis Therapy (IPT), Cotrimoxazole Prophylaxis 
Therapy (CPT), PMTCT and psychosocial support (SA, 2013d, WHO, 2013a). However, as 
already indicated, there is overwhelming evidence of patients not retained in pre-ART care 
and lost to follow-up (Boulle et al., 2010, Cornell et al., 2010, Lessells et al., 2011, Rosen and 
Fox, 2011).  Research evidence indicates that the continuing loss of patients in antiretroviral 
treatment programs, among people already on treatment and among those waiting to start 
treatment, is a sign of failure in the health system, not just the fault of patients   (Zachariah et 
al., 2010). 
Various factors related to both patients and health systems contribute to patients not being 
retained in pre-ART care.  Attrition from care programs is more likely to occur among men, 
youths and those with higher CD4 cell counts (Rosen and Fox, 2011, Ahmed et al., 2013), 
while women and those who are married are more likely to remain in care programs (Ahmed 
et al., 2013).  The documented health system factors include poor monitoring, medication 
stock-outs, inadequate pre-ART care, and lack of staff confidentiality leading to unplanned 
HIV+ status disclosure and stigma (Muhamadi et al., 2010). In addition, lack of 
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documentation of next date of visit on their medical chart is associated with attrition and loss 
to follow up (Ahmed et al., 2013). Best practices which increase pre-ART care retention 
include a range of medical and social services. These are: CD4 cell point of care (Faal et al., 
2011, Jani et al., 2010); Cotrimoxazole prophylaxis accompanied by efficient referral (Kohler 
et al., 2011); integration of all services delivered in a facility, the provision of medical and 
food incentives; strengthened counselling and peer support (Kundu et al., 2012, Marson et al., 
2013); and the provision of accurate information on HIV to patients (Smith et al., 2013). 
Boyles and Wilkinson (2011) wrote a position paper highlighting the fact that the WHO and 
RSA Guidelines did not provide clear guidance on the pre-ART care services package and its 
implementation, leading them to emphasise an urgent need to develop pre-ART guidelines, 
based on best practices in pre-ART care services. To date, no collective well-packaged 
interventions have proven to be effective in the pre-ART period to reduce poor retention, and 
further operational research is needed to identify local solutions (Govindasamy et al., 2014). 
In addition, the lack of well-packaged and appropriate pre-ART programs in PHC facilities 
appear to lead to patients using multiple health care modalities, including practitioners in  
private and traditional health sectors; this has also been associated with delays in ART 
initiation (Moshabela et al., 2009).  The assumption is that greater effort and resources are put 
into ART initiations, while patients not yet qualified to start ART receive little attention. In 
the real world, resource limited, high demand environment of health services in contemporary 
SA, there are competing demands on service providers‟ time and conflicting priorities. 
Developing a feasible pre-ART package is a challenge. An intended outcome of this study 
will be to develop recommendations for a feasible and well-structured pre-ART program 
package that will improve the timely referral of patients for ART in South Africa.  
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1.2 Conducting the PhD study 
In the early 2000s, I developed a special interest in factors affecting access to HIV services, 
when I was working as a HIV Program Manager for GOAL, an Irish NGO based in Malawi 
which focused on strengthening the Malawian health system in the roll-out PMTCT. At that 
time, there were no HIV counselling and testing (HCT) centres in primary health facilities in 
Malawi. GOAL started by establishing HCT centres in public health facilities, and through 
these centres, the PMTCT program for HIV+ women was rolled out. Major barriers appeared 
to prevent women from joining PMTCT services; this led me to conduct a study on barriers to 
their uptake of PMTCT (Nyasulu and Nyasulu, 2011a) and the decision making of women to 
join PMTCT (Nyasulu and Nyasulu, 2011b). 
When I moved to South Africa in 2009, I started working for Wits Reproductive Health 
Research Institute (WRHI) as a Regional Quality Improvement Mentor (RQIM), providing 
health systems strengthening support to the City of Johannesburg. In this context, I focused 
on access to quality HIV/TB services. At this time, I realized that unlike in Malawi, where 
women had difficulties in accessing PMTCT, in SA access to PMTCT was not a challenge: 
the uptake in SA was above the 95% WHO target (WHO, 2013b, Goga et al., 2012), 
compared to 38.8% in Malawi at the time (Malawi, 2010). However, I observed that there 
were gaps in proper follow-up systems for patients not yet eligible for ART. Our project 
reports indicated that high numbers of healthy HIV+ individuals and PMTCT mothers who 
were not yet eligible to start ART after delivery dropped out of pre-ART care. This led to 
individuals returning into care late, when they already had a very low CD4 cell count, 
compromising the effectiveness of treatment. This observation ignited my passion to improve 
access to HIV services, and I decided to enroll for a PhD with a focus on exploring pre-ART 
care in Johannesburg. My goal was to develop recommendations that would strengthen pre-
ART care service delivery and improve access to quality services. 
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Initially, according to the approved PhD protocol, I was interested in the impact of a well-
structured and appropriate pre-ART program package at a PHC facility level on the timely 
referral for Antiretroviral Treatment (ART) initiation of HIV+ pre-ART individuals. In line 
with this, I had intended to: 
 Conduct a baseline assessment through interviews with staff and patients and to 
undertake file audits on the pre-ART program, to identify existing gaps to be 
addressed in a program which I would design. I anticipated that patients and staff who 
were to be interviewed would provide possible solutions to the existing gaps; 
 Conduct a consultative workshop with the City of Johannesburg to present and 
validate the baseline assessment findings, discuss the gaps identified, the causes, and 
the possible solutions; and 
 Develop and test the impact of a well-structured and appropriate pre-ART program 
package in PHC facilities, to ensure the timely ART referral of pre-ART individuals. 
During the assessment of the PhD proposal, it was suggested to me that the project was 
beyond the scope of and not feasible for a PhD, and that it would be expensive to implement 
and test the impact of a newly designed pre-ART program. At that time, I was able to defend 
my proposal, as it was possible to implement an intervention in the context of my own role, 
and that of the team I was managing as an RQIM at WRHI. The team was composed of 
medical doctors, nurses and data quality improvement mentors (QIM), who were already 
providing health systems strengthening (HSS) technical support in the City of Johannesburg 
through quality improvement (QI) approaches. Unfortunately, at the end of 2012, a year after 
my PhD registration, there was no further funding for the project, and I and others in the team 
were retrenched. After leaving WRHI, in January 2013, I joined Health Systems Trust (HST), 
working as a quality improvement technical advisor for five provinces of South Africa. This 
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excluded the City of Johannesburg.  By this time, the PhD project baseline assessment data 
had been collected, and I then conducted the second phase of my project, the consultative 
workshop with CoJ health services managers. However, I was not in a position to design and 
initiate a pre-ART program to be implemented by doctors, nurses and data QIMs.  
However, the same training, mentoring and coaching approach proposed to be applied in 
implementing and testing the designed pre-ART program was applied by the same team in 
rolling out Nurses Initiation Management of Antiretroviral Therapy (NIMART), in the same 
study sites of the inner City of Johannesburg.  As a result, I decided to use the data from the 
NIMART roll-out for this research project, and so I describe and analyze it as a potential 
innovation that could be applied more widely to strengthen the implementation of pre-ART 
care service delivery. The NIMART roll-out significantly improved ART uptake, as 
described in the publication provided in Appendix 8.9.1.  
By incorporating the NIMART roll-out innovation, I then reworked the PhD topic, so 
retrospectively changing the study. The revised PHD research involved the following steps: 
 Conduct a baseline assessment through interviews with staff, patients and file audits 
on the pre-ART program to identify gaps to be addressed in a new program. Patients 
and staff were to be interviewed to provide their perceptions of existing gaps and 
possible solutions. 
 Conduct a consultative workshop with the City of Johannesburg to present and 
validate the baseline assessment findings, discuss the gaps identified, the causes and 
the possible solutions.  
 Document the NIMART roll-out innovation in the City of Johannesburg. 
 Identify lessons learnt from piloting the NIMART roll-out and form possible solutions 
from pre-ART care patients and service provider interviews and the consultative 
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workshop, and draw on these to develop recommendations for appropriate pre-ART 
care to improve access to available services and to retain patients in care.  
Currently, working as a mentor and HSS technical advisor on access to quality HIV and TB 
services at HST, I support HST mentors at provincial, district and facility levels in applying 
quality improvement approaches to health systems strengthening. I have learnt that the gaps 
identified in the City of Johannesburg are cross-cutting, occurring in all South African 
provinces. At HST, we also document the best practices and disseminate them. Given the 
incompleteness of pre-ART care records, a finding in my baseline assessment in CoJ, I 
supported a project facility mentor and DoH facility staff to use QI approaches to address the 
gap in their facilities. This improved the completeness of the records, and a paper for one of 
the facilities in Limpopo province was presented at Public Health Association of South 
Africa (PHASA) international conference in September 2014, winning the award of the best 
oral presentation (see Appendix 8.9.4).  It has also been documented as a detailed case study 
by the HST communications and editing team (King, 2015). 
Timeliness was the other challenge I encountered in executing this project. The research 
project needed to be conducted in a timely manner to make a meaningful contribution to the 
fast evolving body of knowledge related to ART. For example, as noted above, when I started 
working on the project proposal in 2012, the CD4 cell count threshold for ART initiation was 
at 200 cells/µL. In March 2012, it had increased to 350 cells/µL, and then later in January 
2015 to 500 cells/µL (Motsoaledi, 23 July 2014, SA, 2014(b)). These changes provided me 
with a better understanding of the SA government‟s allocation of efforts and resources on 
ART compared to pre-ART. This led me to pose the question: “By increasing the cutoff 
point, are we reaching all eligible people or just a specific category of HIV+ individuals?” It 
is importance to mention that the findings, arguments and recommendations drawn from this 
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project are not just applicable to pre-ART care, but embrace issues around linkages to care 
and access to HIV and other services. 
As a Health Systems Strengthening (HSS) Technical Advisor (TA), the experience I have had 
in conducting this PhD research project has enabled me to better understand the complexity 
of strengthening access to HIV services by people living with HIV, the interrelationships of 
the health systems strengthening building blocks, how they complement each other, and the 
importance of tackling them all in addressing access to available services. Most importantly, 
it was important to understand the lived experience of people living with HIV, and the 
attached stigma and discrimination to HIV. In addition, the never-ending process of 
normalizing HIV as any other chronic disease, easily described by service providers, was 
clearly an unending struggle for those living with the virus. Going through their interview 
scripts from my collected data and reviewing literature on their lived experience, I was able 
to appreciate and think about becoming a better TA in HSS on access to HIV services.   
1.3 Thesis organisation 
My PhD thesis begins with a description of the background to the study, which is the problem 
setting section for the thesis. In it, I have provided an overview of the HIV burden globally 
and in South Africa, and the SA government‟s priorities for, commitments to and investment 
in pre-ART and ART service delivery. I have also included a problem statement. The factors 
that motivated and inspired me to conduct a study in pre-ART care, and my lived experience 
in executing the study, are also covered in this section.  
1.3.1 Literature review 
In this chapter, I provide a synthesis of the existing body of scholarly knowledge in the area 
of HIV/AIDS, ART and pre-ART service delivery, globally and within South Africa. I also 
provide more details on how HIV care was rolled out in South Africa, from the time the first 
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person was diagnosed with HIV to date. I describe the theoretical concepts upon which this 
study was based and present a conceptual framework. I conclude this chapter with research 
questions and objectives. 
1.3.2 Methodology 
In this chapter I describe how mixed methods were applied to explore the implementation of 
the existing pre-ART service delivery in South Africa. Since five different sources of data 
were used in this study, I also describe the triangulation of the data in answering the research 
question. The processes involved, as described, sampling of participants, data collection, 
analysis, quality controls and ethical issues.  
1.3.4 Results 
In this chapter I describe findings from all five data sources: pre-ART care staff and patient 
interviews, pre-ART file audits, pre-ART register audit and the District Health Information 
System (DHIS) database for the City of Johannesburg. I established that there is poor 
retention of pre-ART patients in the City of Johannesburg. Poor access to the available pre-
ART services for those retained in care was also established, leading to delays in ART 
initiation even for those retained in care. Interrelated factors, which contributed to poor 
retention and access to pre-ART services, ranged from health systems, staff and patient-
related factors. The NIMART roll-out innovation has shown how the training, mentoring and 
coaching of service providers on a newly rolled out programme improves the uptake of 
services. In order to provide more meaning to these findings, more detailed information is 
given through four case studies from patient interviews, and through describing the NIMART 
roll-out. 
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1.3.5 Discussion  
In this chapter I provide a synthesis and discussion of the study findings in relation to the 
existing body of knowledge. In addition limitations to the study are highlighted. I also 
highlight new findings, illustrating how this thesis contributes to the existing literature. 
Throughout the discussion section, I anticipate recommendations and possible solutions from 
the study findings. Lastly, I describe the predetermined limitations of the study and some 
special situational factors that needed to be acknowledged. 
1.3.6 Conclusion and recommendations 
In this chapter, conclusions are drawn from the findings and I present and discuss the 
recommendations. I also interpret the key study findings in relation to the implications they 
have on the South African ART and pre-ART service delivery agenda. It is critical to mention 
that the findings and recommendations for this study can be applied not only in pre-ART care 
but services delivery across HIV/TB services as well as other services. As a result, even if the 
policy changes to treating all HIV+ people regardless of their CD4 cell count, the project 
findings will still be useful and applicable in different set ups. The recommendations in this 
section mainly focus on how the study findings can be translated or incorporated into the 
existing South African public health policies. Throughout the process of conducting this PhD 
study, more questions were raised, highlighting the need to further supplement the existing 
body of knowledge of pre-ART and ART service delivery. As a result, this section also 
outlines proposed areas for further research. 
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Chapter Two 
Literature Review 
2.1 Introduction 
Globally, about 36.9 million people were estimated to be living with HIV in 2014, a rise from 
preceding years primarily as more people benefited from antiretroviral therapy (ART) 
(UNAIDS, 2015). According to the ART calculator by, stipulating that only about one third 
of all HIV+ individuals are eligible to start ART at a given point in time, about 24 million 
people are HIV+ but are not yet eligible to start ART (Leydon et al., 2010).  The global 
recommendation by WHO is that HIV+ individuals initiate on ART when their CD4 cell 
count is below 500 cells/µl (WHO, 2013a), although different countries use different ART 
initiation CD4 cell count cut-off points depending on available resources and feasibility of 
implementing the policy (WHO, 2013b). A landmark moment has been reached towards 
meeting the 2001 declaration goals (UNAIDS, 2001) as 15 million people have already been 
initiated on ART (UNAIDS, 2015). Even though we have reached ART uptake 2011 target, 
more ambitious 90-90-90 target has already been set -- meaning that 90% are (1) diagnosed, 
(2) on ART and (3) virally suppressed – a goal towards elimination of HIV by 2030 
(UNAIDS, 2014a). 
Reflecting this, UNAIDS has reported a global decline in the incidence of deaths due to 
AIDS by 42% since 2005, representing fewer deaths than the preceding decade due to the 
benefits of the roll-out of ART, and ART is estimated to have prevented 7.8 million AIDS-
related deaths worldwide (UNAIDS, 2015). However, globally, the HIV epidemic continues 
to disproportionally affect sub-Saharan Africa (SSA) as 70% of all new HIV infections occur 
in the region (UNAIDS, 2013), despite a 35% decline in new HIV infections per year from 
2001 to 2014 (UNAIDS, 2015).  The established reasons for the high HIV burden in SSA 
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include poverty, which has been shown to lead to high rates of sexual trade 
(Mbirimtengerenji, 2007). Secondly, cultural practices (Moyo and Müller, 2011) are still 
prevalent in sub-Saharan countries as in Malawi, such as fisi, whereby a man hires another 
man to have sex with his wife if he cannot impregnate the wife (MHRC, 2005), or rites of 
passage to puberty when counsellors hire a male adult to have sex with newly initiated girls 
(MHRC, 2005). Gender inequalities lead to intimate partner violence and unprotected sex 
(Jewkes, 2002, Durevall and Lindskog, 2014), and these are also implicated in the continued 
transmission of HIV (Jewkes, 2002, Barker, 2007). 
In South Africa, an estimated 6.4 million people live with HIV and there was a slight increase 
in HIV prevalence among the SA general population from 10.6% in 2008 to 12.2% in 2012 
(Shisana et al., 2014). There is an addition of about 100,000 new HIV positive cases yearly 
(SA, 2013a). According to the mid-term review on  progress towards achieving HIV/AIDS 
targets and elimination commitments in South Africa, about 2.1 million HIV+ individuals 
were on ART in 2013, making South Africa‟s program the largest ART program globally 
(SA, 2013a). Increased access to ART in South Africa has been possible because in April 
2010, the SA government decentralised ART services, enabling nurses to prescribe and 
dispense ARVs in all PHC facilities (Gordhan, 2010).   Reflecting the numbers of people on 
ART, there has been a significant decline in AIDS related mortality in recent years, with 
about 780,000 deaths averted between 2003 and 2012 (WHO, 2013b).  
Despite these key advances in initiating patients on ART, delays in determining the ART 
eligibility have been well documented (Boulle et al., 2010, Cornell et al., 2010, Rosen and 
Fox, 2011, Lessells et al., 2011). For instance, while encouraging South Africans to test for 
HIV to accelerate diagnosis (Alcorn 2010), the average CD4 count level for patients initiating 
on ART in SA is lower than the CD4 cell count cut-off point now used for ART eligibility 
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(Boulle et al., 2010, Cornell et al., 2010). The main contributing factor is poor retention 
among pre-ART patients, resulting in individuals returning to care later than ideal, so 
negatively affecting the effectiveness of ART (Lessells et al., 2011).   Men also appear to be 
less likely to be retained in care than women (Mugglin et al., 2012). South Africa‟s 
experience is consistent with that of other countries in the region; a systematic review of pre-
ART care retention in sub-Saharan Africa established that patient management before ART 
initiation posed huge challenges, with only approximately 18% remaining continually in care 
until they were eligible to start ART. Again younger individuals and men are most often lost 
to follow-up (Rosen and Fox, 2011). 
2.2 Pre-ART and ART roll-out in South Africa 
 Figure 2.1: HIV care in South Africa 
As we talk about pre-ART care, it is important to understand the history of the type of care 
given to HIV+ individuals prior to accessing ART. This evolved from the time when ART 
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was not available to HIV+ individuals in the public health sector, to when the CD4 count cut-
off point for ART initiation has been increased to 500 cells/µl. A synthesis of how ART has 
evolved in SA is set out in Figure 1 above and discussed in the text that follows. 
2.2.1 1982-2003: First HIV diagnosis and wellness care 
The first person was diagnosed with HIV in South Africa in 1982 (Ras et al., 1983). From 
1996 to December 2003, ART became available in the private sector though not available in 
the public health facilities, and so was mainly accessed by the rich (UNAIDS, 2001, AVERT, 
2015). During this period, in the public health facilities of South Africa, the main focus in 
HIV care was diagnosis and wellness, with HIV+ individuals followed up by nurses and 
doctors to be provided with multivitamins and treated for opportunistic infections; resources 
were directed to the wellness program (SA, 2000a). In 2003, the South African Cabinet 
approved an ART roll-out operational plan – a major government long-term commitment to 
allocate resources to procure ARVs and implement the roll-out (SA, 2003). The actual ART 
roll-out was implemented from 2004, with the eligibility criteria determined by an 
individual‟s CD4 cell count cut-off point of ≤200 cells/μl and WHO clinical staging; this was 
a useful tool to assist clinicians to decide ART initiation eligibility in the absence of CD4 cell 
count laboratory results (WHO, 2007). The WHO clinical staging of HIV is the system of 
grouping HIV+ individuals into 4 stages reflecting the HIV disease progression according to 
the WHO HIV case definition guidelines (WHO, 2007) as follows: 
 Primary stage: Asymptomatic 
 Clinical stage 1: Asymptomatic with persistent generalized swelling of the lymph 
nodes 
 Clinical stage 2: Some unexplained weight loss, repeated respiratory tract and other 
common infections 
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 Clinical stage 3: Conditions where a possible diagnosis can be made on the basis of 
clinical signs like chronic diarrhea, severe weight loss, TB and other infections 
 Clinical stage 4: AIDS defining illness stage, diagnosis can also be made clinically. 
2.2.2 2004-2009: Antiretroviral therapy (ART) roll-out 
In 2004, the ART initiation criteria was introduced in the South African HIV Care Policy; 
according to this, all HIV+ patients with a CD4 cell count of ≤200 cells/μl or WHO Stage 4 
of HIV infection were to be initiated on ART (SA, 2004). Emphasis was placed on ART 
initiation and patient follow-up by doctors through SA referral hospitals (SA, 2004). Those 
who had a CD4 cell count >200 cells/μl and/or were categorised as WHO Stage 3 or lower 
were followed up by nurses in their nearest facilities, mainly PHC facilities, while awaiting 
for ART eligibility and up-referral for  ART initiation by doctors (SA, 2004).  
As described above, at the beginning of ART roll-out, ART was classified as one of complex 
care, and only doctors and not nurses were allowed to initiate patients on ART (SA, 2004). 
Doctors are highly trained health care providers, with training over six years and with SA 
having the highest cost in Sub-Saharan region (about US $59,000 to train one doctor) (Mills 
et al., 2011). On the other hand, professional nurses train for 4 years, covering both general 
nursing and midwifery (SA, 2005a). As a result, the ratio of doctors to population is 
77/100,000, which translates into about 1:1300 (Strachan et al., 2011) compared to a nurse-
population ratio of 1:451 for nurses (Joubert, 2009). Coupled with the HIV burden, the policy 
that doctors only could initiate patients on ART led to the overburdening of doctors (Sanne et 
al., 2010).  
Therefore clinical mentoring and coaching of nurses in ART initiation and management 
(NIMART) was an option, to increase the confidence of nurses and improve professional 
development, so enabling them to manage so called “complex” ART patients (Green et al., 
38 
 
2014). In addition, in 2007, research was conducted in Botswana to establish the possibility 
of nurses initiating patients on ART, with results reflecting that there were no differences in 
patient outcomes whether ART was initiated by a doctor or a nurse (Miles, Clutterbuck, 
Seitio, Sebego, & Riley, 2007). As a result, task shifting of ART initiation and management 
from doctors to nurses proved to be cost-effective with similar patient outcomes (Sanne et al., 
2010). 
2.2.3 2010 - present: Down-referral and the Nurse Initiated Management of ART 
(NIMART) roll-out 
Using the same CD4 ART initiation cut-off point of 200 cells/μl, in SA, by 2009 about 1.2 
million HIV+ individuals were estimated to be eligible for ART, way beyond the capacity of 
the referral facilities where doctors were initiating (Klaussner et al., 2011). The solution to 
reducing the referral site workload was the introduction of decentralised ART services 
through the down-referral of stable patients on ART to their nearest PHC facilities. This 
improved the retention of ART patients and enabled referral sites to focus on problematic 
patients (Klaussner et al., 2011, Zachariah et al., 2007). At the same time, the referral of 
patients to facilities closer to their homes reduced their time and transport costs in accessing 
ART (Mukora et al., 2011). This meant an added task for nurses at PHC facilities to monitor 
these ART initiated stable patients, in addition to providing care to people not yet eligible for 
ART and awaiting up-referral for doctors‟ ART initiation. Even so, in South Africa and 
elsewhere, further research reported that NIMART improved access, was cost-effective, and 
was not inferior to doctor-managed ART (Miles et al., 2007, Sanne et al., 2010).  
In response to this, in April 2010 the South African Government committed to rolling out 
ART initiation in all the 5,500 facilities from primary, secondary and tertiary levels of health 
service delivery – a mandate that led to Nurse–Initiated Management of Antiretroviral 
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Treatment (NIMART) (Motsoaledi, 13 April 2010). This meant ART was no longer a 
doctors‟ only prescription but could be prescribed by nurses- in all SA government PHC 
facilities. This led to the need to train, mentor and coach nurses in NIMART (Motsoaledi, 13 
April 2010). The roll-out of NIMART in the City of Johannesburg significantly increased the 
uptake of services, as demonstrated in a paper published from this research project (Nyasulu 
et al., 2013) (Appendix 8.9.1). Throughout the ART roll-out process, the government was 
responsible for national initiatives aimed at increasing ART access. For example, the national 
HIV Counselling and Testing (HCT) campaign launched in July 2010 targeted testing 15 
million people by the end of June 2011 (Zuma., 2009).  
Whilst NIMART was being rolled-out, the CD4 cut-off point for ART initiation was 
increased from ≤200 to ≤350 cells/μl in 2012 (SA, 2013d), and then to ≤500 cells/μl by 
January 2015 (SA, 2014b), so that many people who were not eligible before were now able 
to be initiated on ART according to the ART calculator (Leydon et al., 2010). However, at 
that time, it was not clear whether the increase in the CD4 count cut-off points for ART 
initiation necessarily translated into increased uptake, since from the time ART was rolled-
out to date, the average CD4 cell count initiation at each point in time has been way below 
the WHO recommended cut-off point (Boulle et al., 2010, Cornell et al., 2010). This is a clear 
indication of gaps in monitoring those not yet eligible to start ART who then end up 
presenting for ART late (Lessells et al., 2011).  Since 2004, greater effort appears to have 
been placed in ART initiation service delivery, while pre-ART, although considered crucial 
in promoting timely referral for initiation on ART and retention after initiation, is neglected 
(Lessells et al., 2011).  This question can best be answered by closely scrutinising the 
investment of resources, including capacity building in human resources in the service 
delivery areas.  
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2.3 Why early ART initiation? 
Globally ART has been shown to assist in reducing the mortality rate of people living with 
HIV from AIDS, and in reducing morbidity and the transmission of tuberculosis and HIV 
(WHO, 2013b). Documented benefits to ART access globally rank from reducing the risk of 
HIV transmission by 96% (Cohen, 2011), reducing Cryptococci meningitis among HIV+ 
individuals (Jongwutiwes et al., 2007), and reducing the incidence of other opportunistic 
infections (Losina et al., 2007). Early ART initiation has also been shown to improve quality 
of life, for example, in Kwazulu Natal, the province with the highest HIV prevalence in RSA 
(Shisana et al., 2014), life expectancy was 11.3 years higher in 2011 than in 2003 when ART 
roll-out commenced (Bor et al., 2013). ART has also been shown to improve quality of life 
and productivity, reflected through an increase of people on ART employed from 27% to 
42% in a cohort initiated on ART over three years (April et al., 2013). Great survival benefits 
are also attributable to ART (April et al., 2013, Vermund, 2013), and if an adult person is 
initiated on ART with a CD4 cell count of above 200 cells/µl, he or she can have an almost 
normal life expectancy (Johnson et al., 2013). 
On the other hand, ART initiation with very low CD4 cell count reduces the likelihood of 
success. For example, data from resource limited countries shows that people who started 
ART at less than 25 cells/mm
3
 faced more than three times the risk of death compared to 
those who started at CD4 cell counts above 50 cells/mm
3
 (Brinkhof et al., 2008). Even those 
who survive after starting ART at a low CD4 cell count have been shown to have higher 
morbidity, and utilize more medical resources than would otherwise be necessary (Leisegang 
et al., 2009). Starting ART at higher CD4 cell counts, or longer pre-ART monitoring and 
care, has been predicted to be more cost effective in running ART programs, due to lower 
rates of sickness, resulting in less hospitalisation for those with higher CD4 cell counts 
(Eaton et al., 2014, Leisegang et al., 2009). 
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2.4 Why pre-ART care? 
Pre-ART care is a service provided to HIV+ individuals from the time they test HIV+ to the 
point at which they need ART: this may be anything from a few months to years, depending 
on an individual‟s CD4 cell count levels at the time of first presentation and enrolment into 
the program (Burtle et al., 2012). Pre-ART care needs to be set up appropriately within 
various facilities that provide HIV testing and care, with the design and functionality 
dependent upon infrastructure and available human resources (WHO, 2013a). This implies 
that people with HIV but without TB, at WHO Clinical Stages 1 and 2, or who have primary 
HIV infection and are not eligible for ART, should be offered a package of care and support 
that includes regular checks of their clinical status and CD4 cell count, the provision of 
Cotrimoxazole Prophylaxis Therapy (CPT) for opportunistic infection prevention as indicated 
(WHO, 2008, WHO, 2013a), the prevention of malaria, malnutrition, and unplanned 
pregnancies (Mermin et al., 2006), and access to regular TB screening services and INH 
Prophylaxis Therapy (IPT) (Sonnenberg et al., 2005).  
According to both the South African and WHO Guidelines, all individuals who are HIV+ and 
not eligible to start ART should be enrolled into a pre-ART program (SA, 2013d, WHO, 
2013a). With proper pre-ART care, patients are expected to undergo adherence counselling to 
prepare for the time when they will be eligible for ART, as adherence counselling has been 
shown to improve ART retention (Etienne et al., 2010, Torpey et al., 2008). Adherence to 
ART is vital in ensuring treatment success, as failure to adhere to treatment regimens allows 
viral replication and the accumulation of resistance mutations; these in turn may lead to 
treatment failure, requiring a switch to more complex drug regimens with lower resistance 
barriers and possibly greater toxicity (Liu et al., 2006). More complex regimens are also more 
expensive; for example, the second-line ART regimen is 2.4-fold higher in price per year than 
first-line treatment (Long et al., 2010). Patients and treatment providers are faced with the 
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prospect of drugs being priced out of reach if a significant proportion of the population 
requires second-line drugs (MSF, 2010). 
As the above discussion indicates, pre-ART care is regarded as critical in ensuring that HIV 
patients are monitored and referred in a timely manner when they are eligible for ART, and 
that they understand the value of ART and so adhere to regimens of care. For example, global 
and national HIV testing and ART guidelines have emphasised the importance of linkage to 
care from the time of HIV+ diagnosis to the time of ART initiation (SA, 2013d, SA, 2013e, 
WHO, 2013a, WHO, 2012 ). Below is a description of the services from which HIV+ 
individuals can benefit if retained in pre-ART care. 
2.4.1 Six monthly CD4 cell count monitoring 
HIV infection leads to the destruction of CD4 cells, with billions of CD4 cells destroyed on a 
daily basis as the body responds by replacing the cells. As a result, the CD4 cell count among 
HIV+ individuals falls over time, at a variable rate, lowering the immunity of an individual to 
fight against infections (Burtle et al., 2012). The global and SA national guidelines stipulate 
that the CD4 cell count for HIV+ ineligible clients must be monitored on a six monthly basis 
to ensure timely ART referral (SA, 2013d, SA, 2013e, WHO, 2013a, WHO, 2012 ) – hence 
the concern that PLWHAs not yet qualified for ART remain in pre-ART care (WHO, 2013a).  
Whilst focusing on CD4 cell count levels as cut-off points for ART initiation, there is need to 
always consider factors that affect CD4 cell count level progression. For instance, gender 
differences in CD4 cell count levels, at each point in time from the time of sero-conversion, 
have been established and debated for two decades, as men have been shown to have a lower 
CD4 cell count than women at any time (Prins et al., 1999, CASCADE-Collaboration, 2003, 
Loupa et al., 2006, Manolescu and Marinescu, 2013). Women reach CD4 cell count level for 
ART initiation 12 months later that their male counterparts (Prins et al., 1999). These CD4 
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cell count level differences continue even after ART initiation (Maskew and McNamara, 
2013), although further research is needed to establish whether or not these differences 
negatively influence the progression of disease  among women after initiation on ART.  
Many other non-HIV factors that effect CD4 cell count levels have been documented, 
including  the use of hormonal pill, implant or injectable contraceptives, menstrual cycles and 
smoking  (Maini et al., 1996), psychological stress (Irwin, 2001) and many others. 
Continuity of care from the point of testing HIV+ to pre-ART, ART and other care and 
support services is critical (WHO, 2012 ). Large cohort studies conducted in South Africa and 
elsewhere have established that low CD4 cell counts are associated with higher rates of 
deaths from all causes, as described above in section 2.3, including hepatitis and non-AIDS 
defining malignancies (Smit et al., 2006, Baker et al., 2008, Monforte et al., 2008). With 
early ART initiation, such deaths can be prevented (WHO 2013). Higher CD4 cell counts at 
ART initiation, which can be achieved through patients accessing pre-ART care (Lessells et 
al., 2011), provide the greatest benefit for patients with significant reductions in opportunistic 
infections like pulmonary tuberculosis and severe bacterial infection, risk of HIV 
transmission, reduced mortality (Emery et al., 2008, Siegfried et al., 2010, Cohen, 2011, 
Lessells et al., 2014, Severe et al., 2010), and reduced defaulting from care (Ford et al., 
2010). Co-occurrence of TB and HIV, to be discussed further below, has been established 
and other studies have shown that early ART initiation has the utmost absolute risk reduction 
of TB (Lawn et al., 2011, Severe et al., 2010). In addition, if HIV+ individuals are monitored 
for a longer period of time before initiation on ART, they are more likely to lessen early costs 
(Leisegang et al., 2009) because opportunistic infections are treated in a timely manner. 
With all the documented benefits of early ART initiation, the International Antiviral Society 
(IAS)-USA Guidelines highlight the importance of initiating all HIV+ individuals regardless 
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of their CD4 count, as affordable and implemented in some developed countries (Thompson 
et al., 2012). At the same time as trying to treat HIV early, the WHO Guidelines for resource-
limited settings have been revised, increasing the CD4 cell count threshold for ART initiation 
in asymptomatic HIV-positive patients from 200 to 350 or 500 cells/mm,
3
 as already noted 
(WHO, 2013a). Since this means increasing resources for the delivery of ART programs, 
decision makers, especially in resource limited countries, have to consider whether to allocate 
more resources to expand ART programs or increase other health programs like pre-ART and 
HIV counselling and testing (HCT). These latter programs may yield greater benefits in the 
long-term but do not address the immediate illness, higher mortality and suffering (Eaton et 
al., 2014). Even so, resource limited countries like South Africa would be unable to afford 
ART for all HIV+ people regardless of CD4 cell count levels, and so pre-ART needs to be 
prioritized to ensure close monitoring and timely ART initiation (Lessells et al., 2011). 
In July 2014, in his budget speech, the SA Health Minister announced that the country had 
taken the challenge of increasing ART initiation to 500 cells/mm
3
 for adults, and for all 
pregnant women to be initiated on ART regardless of CD4 cell count, by January 2015 
(Gordhan, 2014).  Using the ART eligibility calculator, at that time, this implied that about 
two million individuals would be eligible to start ART between 2015-2017 (Leydon et al., 
2010), in addition to the 2.1 million already on ART  (SA, 2013a). This indicated the need for 
greater attention to strengthening health systems to cope with the increased workload, 
ensuring that the limited resources would be available for both ART and pre-ART services 
(WRHI, 2014). 
2.4.2 Patient education about HIV/AIDS 
The relationship between HIV knowledge levels and positive behaviour change has been 
widely debated for more than a decade, as one school of thought stipulates that higher 
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knowledge levels do not necessarily lead to positive behaviour change (Williams et al., 
2003). Others have shown how awareness of services increase uptake (Nyasulu and Nyasulu, 
2011, Tshuma et al., 2014, Chimoyi et al., 2015), while higher HIV/AIDs knowledge levels 
among those who are HIV+ enable them to participate in prevention practices (Shisana et al., 
2014), so stimulating HIV prevention behaviours (Agnew-Blais et al., 2008). Prevention of 
HIV transmission from those who know their HIV+ status is among the objectives for 
positive prevention approaches and provision of HIV information, and education about risk 
reduction methods for PLWHAs is key to preventing HIV (IHA, 2007). In this case, a pre-
ART care program can be used as an entry point to prevent transmission. 
Knowledge levels among the SA general population about the cause of HIV infection, modes 
of transmission, and cure of HIV have been well researched from the 1990s. In the early 
years, knowledge was shown to be low. For example, in 1992, two studies in SA showed that 
only 52% of study participants could identify sexual intercourse as a mode of HIV 
transmission (Blecher et al., 1995, Govender et al., 1992).  The latest South African National 
HIV Prevalence, Incidence and Behaviour Survey still shows low knowledge levels, with 
only 28.6% of individuals aged 15-24 years properly recognizing ways of preventing HIV 
e.g. by the correct and consistent use of condoms, and rejecting incorrect beliefs about HIV 
transmission such as contracting HIV through sharing food with an HIV+ person (Shisana et 
al., 2014). These results suggest almost no change since 2009, when only 28.9% had correct 
knowledge levels (Shisana et al., 2009). Even though the decrease in knowledge levels is not 
significant, there has been decreased condom use in all age groups in their previous sexual 
encounter, dropping from 65% in 2009 (Shisana et al., 2009) to 40% in 2012 (Shisana et al., 
2014). This regression is a great cause of concern, hence the critical need for people to be 
given correct basic information about HIV/AIDS and its prevention.  
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On the other hand, from the mid-2000s when ART was rolled-out in SA public health 
facilities,  knowledge levels among HIV+ individuals receiving ART were shown to be high 
(Nachega et al 2005). However, in South Africa and elsewhere, no research has been 
conducted on the knowledge levels of HIV/AIDS, CD4 cell count, pre-ART and ART care 
among pre-ART program patients. Yet, as stipulated in the latest National Strategic Plan 
(NSP) for HIV/AIDS and TB, this is critical in implementing an appropriate pre-ART care 
(RSA, 2012). Unlike the school of thought that indicates that there is no relationship between 
knowledge levels and behaviour change described above (Williams et al., 2003), high 
knowledge levels about available services were shown to increase access to services, as 
demonstrated in the City of Johannesburg and elsewhere (Nyasulu and Nyasulu, 2011, 
Tshuma et al., 2014, Chimoyi et al., 2015).  
2.4.3 Tuberculosis (TB) Isoniazid Preventive Therapy (IPT) 
TB is the most common cause of death amongst PLWHAs in Africa and elsewhere (Munsuff 
et al 1998, Corbett et al 2003 & WHO 2013). HIV+ individuals on ART have been shown to 
have a ten times higher risk of getting TB than those who are HIV- in the same community 
(McIlleron et al., 2007). In addition to increasing TB incidence, HIV also increases the risk of 
rapid TB progression after an individual is infected or re-infected with TB (Daley et al., 
1992). As a result of this relationship, the HIV epidemic has led to increased TB morbidity 
and mortality. For example, in 2012, PLWHAs accounted for 1.1 million (13%) of 8.7 
million individuals who developed TB worldwide (WHO, 2013b). Even though globally, 
there has been a decline in TB associated deaths since 2003, still about 320,000 deaths from 
TB were associated with HIV in 2012 worldwide (WHO, 2013b). 
Almost three decades ago, IPT was acknowledged as integral in TB and HIV patient 
management to reduce TB incidence among HIV+ individuals (Selwyn et al., 1989). By 
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1998, the WHO and UNAIDS had endorsed the use of targeted IPT for PLHIV, and this is 
still being implemented globally (Wilkinson et al., 1998, WHO/UNAIDS, 1998). Other 
studies have shown that IPT as a prophylaxis is more effective when an individual‟s 
tuberculin skin test (TST) is positive (RR 0.38) than when it is negative (RR 0.89) (Akolo et 
al., 2010, Samandari et al., 2011). These studies have led to debates around using TST as a 
screening test before IPT initiation, and to a change in the South African IPT Guidelines 
whereby IPT is only initiated when the TST is positive (SA, 2014). 
South Africa has a high TB burden, with an estimated one per cent of the population; this 
translates into about half a million people who develop active TB annually, with an increase 
by about 400% over the past 15 years (SA, 2011a). In 2012, SA reported 370,000 PLWHAs 
initiated on IPT, accounting for 71% of the total (WHO, 2013b), but there are challenges 
around the availability of resources, and other constraints in implementing the IPT program at 
all levels, from policy makers to program implementers in health facilities (Getahun et al., 
2010). The use of IPT as a stand-alone intervention has been shown to be challenging, and 
needs to be integrated into other services which HIV+ individuals seek (Getahun et al., 2010, 
Granich et al., 2009). As a result, both international and national guidelines recommend IPT 
services to be provided to ART ineligible PLWHAs during pre-ART care (WHO 2013, RSA 
2013). IPT for pre-ART patients plays a dual role of TB prevention (Selwyn et al., 1989) and 
so delays ART initiation because in SA, since 2012, TB as an opportunistic infection has 
been a criteria for ART initiation, in line with the WHO ART Guidelines (SA, 2014). 
2.4.4 Psychosocial support of patients receiving pre-ART care 
Counselling is an integral part of patient care at all stages in HIV care and service delivery, 
even though limited research has been conducted to establish its effectiveness in retaining 
HIV+ individuals in care (Kranzer et al., 2012). HIV+ individuals require comprehensive 
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counselling and support before ART initiation, to enable them to understand and accept their 
situation and to promote adherence to treatment (Visser et al., 2009). In addition, because 
these individuals experience stigma and discrimination, they need a safe space, as might be 
provided by PLHWA support groups, to discuss matters with others facing similar difficulties 
(Ramlagan et al., 2010). In this case, pre-ART psychosocial support programs can provide a 
safe space for pre-ART patients.   
For many years now there has been consistent advocacy against stigma and discrimination 
against people who are HIV+, and  stigma has been reported to dropped (Simbayi et al., 
2007, Strebel et al., 2006), particularly with close relatives (Thorsen et al., 2008). Even so, it 
is still prevalent (Visser et al., 2009, Ncama et al., 2008). The existence of stigma and 
discrimination in SA has been demonstrated to lead to PLWHAs remaining reluctant to 
disclose their positive status for fear of being rejected, and to resist using condoms; stigma 
therefore leads to lost opportunities for behaviour risk reduction among PLWHAs (Cloete et 
al., 2010). In Tshwane district, Gauteng Province, a high level of apparent community stigma 
was established especially among those with low HIV/AIDs knowledge levels. Further, the 
first ever HIV stigmatisation index study was recently  released, which showed that stigma is 
still in existence; in particular, internal stigma was still at 40% (SA, 2015b). Since low 
HIV/AIDS knowledge levels has been shown to increase stigma in the community, there is a 
need for more efforts to focus on increasing community HIV/AIDS knowledge levels in order 
to change stigmatizing attitudes (Visser et al., 2009).  
Since the roll-out of ART, which has resulted in PLWHA regaining their health, there have 
been talks around normalising HIV as any other chronic condition (Colvin, 2011). 
Normalisation for those living with HIV is defined differently depending on who is defining 
it. For service providers, it means that PLWHAs are adhering to prescribed care, including 
49 
 
ART and pre-ART, nutritional requirements and other recommendations to promote health 
when HIV+ (Whyte et al., 2013); to patients themselves it may mean achieving their day to 
day family responsibilities, and accomplishing life developments or plans that may have been 
interrupted due to HIV+ status (Mattes, 2014). For example, an HIV diagnosis has been  
shown to lead to reduced or no sexual performance with more time needed to develop a 
sexual response for both men and women (Scanavino and Abdo, 2010). This negatively  
affects their sexual and reproductive health rights (Igonya and Moyer, 2013).  When HIV is 
destigmatised, PLWHAs are (in theory) able to live a fully functional life not just in the 
biological context but also in terms of social-economic participation, resumed sexual activity, 
and reconstructed sense of self (Beckmann, 2013, Mattes, 2014, SA, 2015b).  However,  with 
the continued presence of stigmatisation, transitioning to normality for PLWHAs is difficult 
to attain, leading to a permanent transition process (Mattes, 2014). It is even more difficult 
for an HIV+ adolescent to transition into a normal adult (Philbin, 2014). Given that HIV as a 
disease is considered to be exceptional from other chronic diseases, resulting in associated 
stigma (Moyer and Hardon, 2014), we appear to be far from reaching normalisation of HIV 
(Mattes, 2014, Philbin, 2014).  
The South African Department of Health recommends the establishment of PLWHA support 
groups for pre-ART, ART and PMTCT in all public health facilities (NDOH 2009 (FHI, 
2012)). The main aim of support groups is to assist clients to take control of their lives by 
providing them with knowledge and skills, so to assist them to cope and accept their situation 
(Vintges et al., 2007). However, strategies in scaling up PLWHA support groups need  
detailed, participatory planning involving PLWHA themselves (De Barros et al., 2004). 
According to Ramlagan and colleagues (2010), through peer support, participants develop 
advocacy and activist skills to enable them to support themselves and others. HIV education 
also helps them to correctly know about the transmission of the HIV virus, and this may 
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assist the community at large to understand HIV. This in turn may help reduce stigma and 
discrimination against those who are HIV+ (Ramlagan et al., 2010).  
There is need to continuously support pre-ART patients to disclose their HIV+ status as 
recommended in the pre-ART care guidelines (SA, 2013d, WHO, 2008, WHO, 2013a). Rates 
of disclosure are associated with social support (Kalichman et al., 2003). The fact that 
someone has joined a support group means that the individual has disclosed his or her HIV+ 
status, and this is considered to be critical in adherence to services (Unge, Södergård, & 
Marrone, 2010. Although people may be reluctant to disclose to partners and other 
community members because disclosure may lead to negative outcomes including gender-
based violence, stigma and discrimination (Gari et al., 2010, Nyasulu and Nyasulu, 2011), it 
is an important component in pre-ART care in preparation for ART initiation (Worley et al., 
2009).  
Furthermore, access to programs like PLWHA support groups, ART, and nutrition have been 
shown to lead to new ways of disclosure of one‟s HIV+ status other than individual 
intentional or unintentional disclosure (Wilhelm-Solomon, 2013, Mogensen, 2010, Whyte et 
al., 2010). Many PLWHAs have declined to access services for fear of being known to be 
HIV+ because of their concern about stigma and discrimination. For example, in Malawi, at 
the time PMTCT program was being rolled out, HIV+ pregnant mothers declined to join the 
PMTCT program for fear of being known to be HIV+ (Nyasulu and Nyasulu, 2011b, Nyasulu 
and Nyasulu, 2011a). In Northern Uganda in camps for internally displaced people, access to 
a support group and nutritional supplements for those living with HIV led to unplanned 
disclosure, resulting in stigma and discrimination (Wilhelm-Solomon, 2013). Therefore, since 
disclosure of HIV status has to be on voluntary basis, there is need for further discussion and 
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rationalisation around striking a balance between involuntary disclosures versus access to the 
available HIV therapeutic services. 
2.4.5  Prevention of Mother to Child Transmission of HIV (PMTCT) services and 
retention into care 
Prevention of Mother to Child Transmission of HIV (PMTCT) is one of the main strategies 
towards eliminating HIV (WHO, 2013b). Pre-ART care services for HIV+ women of 
reproductive age can assist them to access family planning services and plan for their 
pregnancies, and avoid unplanned pregnancies (Alkema et al., 2013). According to WHO 
PMTCT guidelines (2010) for countries across the globe to adopt, depending on practicality 
to implement the guidelines in each country, pregnant women from gestational age of 14 
weeks are initiated on ART, using different options as described as follows:  
1. Option A – initiation on Zidovudine (AZT) immediately after 14 weeks gestation with 
lamivudine (3TC) and Nevirapine (NVP) during labour then, 3TC /AZT tail for 1 
week. The infant receives NVP throughout the breastfeeding period 
2. Option B - initiation on a triple therapy from 14 weeks throughout labour, delivery 
until the baby stops breastfeeding (WHO, 2010, Mofenson, 2010).  
3. Option B+ -  life-long ART initiation from 14 weeks (Schouten et al., 2013).  
As described above, Options A and B use CD4 cell count level to determine therapy, while 
under Option B+ all HIV+ pregnant women are initiated on life-long ART regardless of their 
CD4 cell count.  Option B+ was an effort to curb the missed opportunities in reaching 
pregnant women with PMTCT without CD4 cell count checking, since CD4 count checking 
was shown to be a barrier to accessing services (Wettstein et al., 2012). Malawi rolled out 
Option B+ about two years ago (UNAIDS, 2013), and a year later it had registered the largest 
decline of 67% in the HIV transmission rate from mother to child (UNAIDS, 2014b). The 
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plausible explanation of this would be women‟s commitment to accepting therapy, as 
determined under Option B+. 
Global consensus was reached by UNAIDS signatories in 2011 when an announcement was 
made advocating for the elimination of new HIV infection among the children and ensuring 
healthy HIV+ mothers and children by 2015 (UNAIDS, 2011).  In response to this, globally 
country-led actions have taken steps towards reaching this goal (WHO, 2013b). According to 
the latest UNAIDS progress report, there has been an increase in access to antiretroviral 
prophylaxis by pregnant women, and this is estimated to have prevented more than 1.4 
million children from acquiring HIV by 2014 (UNAIDS, 2015). On the other hand, a great 
improvement was recorded in ART uptake by HIV+ pregnant women, from 58% in 2012 
(UNAIDS, 2013) to 73% when receiving ART, even though treatment coverage amongst 
children living with HIV still remains lower than the coverage for adults (UNAIDS, 2015). 
WHO has argued that more effort is required to link HIV+ antenatal women and children to 
HIV treatment and care services (WHO, 2013b).  
The prevalence of HIV among ANC clients in SA plateaued at around 30% from 2009 to 
2013 (Shisana et al., 2014). In line with the 2011 UNAIDS  declaration, SA has gone further 
and developed the “count down to zero declaration,” with an action framework which 
declared zero new HIV infections among children by 2015 with better health for the mothers, 
spouses and children (SA, 2012a). Currently RSA has reached the international targets by 
achieving HIV coverage among pregnant women to 100%, with 90% accessing ART (WHO, 
2013b, Goga et al., 2012); however, efforts need to be extended to reach the remaining 10% 
not accessing ART. Since 2009, the mother to child HIV transmission risk has also declined 
from 3.5% to 2% (Dohert et al., 2009, Goga et al., 2012). 
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To ensure an increase in ART uptake among pregnant women, in March 2013, the PMTCT 
Guidelines were updated, recommending Option B, that is immediate initiation of a triple 
therapy ART initiation regimen for all pregnant women, regardless of CD4 cell count during 
pregnancy and breastfeeding (SA, 2013a). In January 2015, a change to Option B+ was 
made, such that all pregnant women were to be initiated on a lifelong ART regardless of their 
CD4 cell count (SA, 2014b). 
Despite positive strides in enabling pregnant women to access PMTCT services, there are still 
challenges in the PMTCT cascade. For example, only 54% of HIV+ babies are initiated on 
ART and HIV testing at 18 months for children born to HIV+ mothers is also low (SA, 
2013a). According to unpublished monthly progress reports for CoJ facilities, PMTCT 
mothers were not keen to continue with ART after delivery; and at the time of Option A and 
B implementation, those with CD4 count >350 did not remain in the wellness program after 
receiving the PMTCT ART course after delivery. Among pregnant women who qualified and 
were initiated on ART (CD4 count <350), many were lost to follow-up after delivery of the 
baby (CoJ unpublished reports 2010-2012). In order to develop a program that promotes the 
retention of women, it is necessary to identify why women drop out. 
Various factors have been identified that contribute to higher rates of loss to follow-up 
(LTFU) among mothers in the PMTCT program (Boyles et al., 2011, Maqutu et al., 2010). 
Firstly, according to WHO Guidelines, an HIV+ pregnant woman has to be fast tracked to 
ensure timely ART initiation (WHO, 2013a). For example, with the current Option B+ 
regimen, mothers should be initiated on ART on the same day of HIV diagnosis (SA, 2014b).  
This speeding up lessens both the time of patients‟ treatment preparation, and their access to 
counselling and support structure sessions, so leading to poor adherence (Boyles et al., 2011). 
Documented practical experience on the implementation of Option B+ in Malawi has 
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established 17% attrition from care within the first six months of their ART. Those initiated 
whilst pregnant with high CD4 cell count were five times more likely to be lost to follow-up 
than those initiated with low (<350) CD4 cell count of WHO clinical stage 3 and 4 (Tenthani 
et al., 2014). Secondly, individuals attending clinics for reasons not related to HIV, like 
antenatal care, although diagnosed to be HIV+, are less likely to adhere compared with those 
who present for HIV testing due to possible exposure to HIV. As a result, it is critical to 
prioritise identification of appropriate strategies to ensure adherence in the PMTCT program 
(Maqutu et al., 2010). Thirdly, depression has been shown to be very high during both the 
prenatal and postnatal period, particularly among women who know they are HIV-infected 
(Chibanda et al., 2010). If this depression is not treated, it may impair adherence to ART 
among the women (Uthman et al., 2014, Ammassari et al., 2004). Lastly, after delivery, 
women may need time to be home to care for the newborn, hence attending the facility post-
delivery may no longer be a priority (Boyles et al., 2011). In addition, decision making on 
feeding options in trying to prevent the risk of transmission to the baby can lead to unplanned 
disclosure. For example, a woman who chooses not to breast feed, or who opts for exclusive 
breastfeeding, may result in inadvertent disclosure in a cultural environment that expects all 
mothers to breastfeed but with some other feeding; this results in women not adhering and 
retaining in PMTCT care (Nyasulu and Nyasulu, 2011, Shongwe and Mkhonta, 2015), To 
ensure women are retained in care, PMTCT programs need to address these challenges.  
Globally, the national reviews submitted to UNAIDS as progress reports on the 
implementation of PMTCT programs have identified several challenges, outlined below 
(UNAIDS, 2013). These include firstly, operational issues around how the services are 
delivered, for example poor service awareness; loss to follow-up of mothers and HIV 
exposed babies; poor involvement of spouses; and challenges around implementing infant 
feeding polices and others. Secondly, there are issues of programmatic reach such as delays 
55 
 
in diagnosing HIV status among pregnant women, as many countries have a high rate of 
deliveries in homes rather than in health facilities, leading to unsafe delivery and difficulties 
in following up the mother-baby pairs after delivery. Finally, policy issues exist around the 
effects of stigma and discrimination against those who are HIV+ (UNAIDS, 2013). 
2.4.6 Cervical cancer screening 
Notwithstanding the effectiveness of pap smears for early diagnosis and treatment, cancer of 
the cervix is the seventh most common cancer worldwide, with 528,000 new cases and 
266,000 deaths reported in 2012 (WHO-GLOBCAN, 2012, Ferlay et al., 2015). In Sub-
Saharan Africa, women have shown to be disproportionately affected with cervical cancer, 
accounting for one out of every eight of all female cancers (Mbulaiteye et al., 2011). In South 
Africa, about 2.5% of women develop cervical cancer (SA, 2000b).  
HIV+ individuals have a higher occurrence of various kinds of non–AIDS-defining cancers, 
compared to the overall population (Patel et al., 2008), and HIV+ women have a far greater 
risk of cervical cancer than do those who are HIV- (Batra et al., 2010, Serraino et al., 1999, 
Snyman, 2013), and develop cancer ten years earlier than the women who are HIV- (Snyman 
et al., 2006). In most cases, the diagnosis is made when the cancer is advanced, with 
treatment effectiveness complications resulting in a higher risk of dying for HIV+ women 
(Maiman 1998).  Given this, it is important to actively prevent cervical cancer among HIV+ 
women (Franceschi and Jaffe, 2007). The SA Cervical Cancer Screening Guidelines currently 
under review stipulate that women above 30 years of age without symptoms of cervical 
cancer should be screened for every five to ten years (SA, 2000b). The latest pre-ART care 
guidelines which are part of the ART guidelines recommend yearly cervical cancer screening 
for all HIV+ women; this is a great opportunity to reach all HIV+ women (SA, 2014(b)). 
However, the implementation of the cancer screening program to reach eligible women in SA 
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is still a challenge (Snyman, 2013, Batra et al., 2010). According to a recent WHO report, in 
South Africa, the screening coverage is still only 13%. An estimated eight women die every 
day and this is projected to increase to twelve deaths per day by 2025 (WHO/ICO, 2014). In 
an effort to curb the cervical cancer rate, in 2014, the SA government launched an HPV 
vaccination program targeting girls from the age of nine years in public schools, with the goal 
of reaching almost half a million of girls (Richter et al., 2014).  
2.5 Youth Friendly Health Services (YFHS) 
Youth Friendly Health Services (YFHS) are those services that consider all aspects of young 
people‟s well-being, with particular attention to sexual and reproductive health (SRH) 
(Baloyi, 2006). According to the Declaration of the 2001 United Nations General Assembly 
Special Session (UNGASS), the main purpose of establishing YFHS is to improve access by 
young people to information, reducing their susceptibility to being infected by HIV 
(UNAIDS, 2001).  In 2004, UNESCO developed characteristics of YFHS to be adopted 
globally for use in different settings, and these are still being used (UNESCO, 2004). These 
characteristics were categorised into service provider, health facility and program design. I 
summarise these as follows: 
Service Provider Characteristics: (1) Service providers are to be trained to be knowledgeable 
of Sexual Reproductive Health (SRH) issues that affect youths, e.g. contraceptives and to 
have special interpersonal skills to work with the youths, to encourage younger people to feel 
at ease to talk to service providers. (2) Service providers need to have respect for young 
people and be able to relate with the youths with respect, without judging adolescents‟ sexual 
activity. (3) Privacy and confidentiality observed whereby young people are to be counselled 
and examined in private, and to be reassured that their information will not be shared with 
anyone not working in the health service. (4) There is a need for sufficient consultation and 
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interaction time with service providers, since young people need more time than the older 
people with the service provider, as they may be frightened and anxious about presenting to 
the health facility. There is a need for more time to reassure them to open up and to explain 
things that may be well understood by adults, depending on age and knowledge levels. More 
time is also needed to address all their questions. (5) Peer counsellors should be available 
because young people prefer conversing with their peers on sensitive issues; hence it is 
critical that youth peer counsellors are recruited, trained and involved in provision of youth 
services 
Health Facility Characteristics (1) There is a need for allocated time and space for youths 
since convenient times and special spaces, or both, are important in delivering YFHS, as 
youths may not feel free to mix with adults and may not be able to take time off from school 
to present to a clinic. (2) There needs to be enough space and privacy when providing 
services to the youths to ensure that services are offered out of sight and sound of other 
people, as also argued above. (3) Generally young people like a comfortable environment that 
matches their taste and interests, with posters and décor that encourage them and ensure a 
welcoming environment. 
Program Design Characteristics: (1) There is need to involve youths themselves in 
identifying what they need and ways of addressing the needs to be incorporated in the design 
of the facility services. For example before designing YFHS, program designers need to 
engage with youths for their input on the package and design of services. (2) Long waiting 
times including fear of exposure discourage clinic attendance and return by youths and 
introducing ways of reducing waiting times would attract more young people to the service. 
(3) The services should be affordable as young people may not have their own source of 
income. (4) Encouraging the male or female partner or friend of the young person attending 
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the clinic to join in, where appropriate, without judgement if no regular is accompanying the 
youth would make young people feel comfortable. (5) The facility should have a wide range 
of services including the above described SRH services and others like minor and major 
ailments delivered as a one stop shop, as young people will rarely go if referred to access 
services at another service point  (UNESCO, 2004 page 1-7). 
Unfortunately, the setup of reproductive health services in many countries limits access by 
youths. For instance, in the USA, male adolescents described how stressful it was to obtain 
sexual health services, due to personal psychological barriers like embarrassment, and 
external service barriers including lack of respect from providers, poor confidentiality, and 
difficulties negotiating the healthcare system (Lindberg et al., 2006, Langhaug et al., 2003).   
In South Africa, although the occurrence of HIV among young individuals aged 15-24 years 
dropped from 8.7 in 2008 to 7.1 in 2012 (p<0.001) (Shisana et al., 2014), there are 
knowledge gaps in HIV/AIDS among youths, and a need to address these gaps (Shisana et al., 
2014). Many South African youths have difficulties in accessing health services due to 
negative attitudes of service providers, poor timing of services, lack of privacy, feelings of 
shame by young people if they are seen by others to be waiting for the services, lack of 
YFHS training for service providers, and lack of information given to young people about 
their diagnosis, to enable them understand their condition (Seekoe, 2006, Ehlers, 2003, Geary 
et al., 2014). In Eastern Cape (EC), this poor access has been associated with the high 
pregnancy rates among primary, secondary and tertiary school learners (Department of Basic 
Education 2013: 25, unpublished data). 
Currently, the government and other implementing partners have acknowledged the poor 
access to HIV services by young people and are working towards addressing the gap (SA, 
2013c). A quality improvement initiative in youth friendly services in public primary health 
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facilities, supported by the Reproductive Health Research Unit (RHRU), established some 
lessons learnt which were used to develop the National Adolescent-Friendly Clinic Initiative 
(NAFCI) in South Africa (WHO, 2009). Some of these documented lessons in implementing 
YFHS were: need for facility clinic support, capacity building of service providers, resource 
limitations, and most importantly, the involvement of the youths themselves in planning and 
implementing the YFHS (WHO, 2009).  
In pre-ART care services, there is similar emerging evidence on poor access by youths. For 
example, less than 50% of patients diagnosed with HIV in SA who are not yet qualified for 
ART have been reported to remain in clinical care, and youths, along with men and 
individuals with higher CD4 cell counts, are most likely to be lost to care (Rosen and Fox, 
2011, Lessells et al., 2011). Ensuring that the pre-ART services are youth-friendly would 
assist in improving access and their retention in care to these critical services by the youths.  
2.6 Medical pluralism among HIV+ individuals  
Pre-ART care patients frequently drop out of regular care and are lost to follow up, as 
explained above, returning to health services only when they are already ill. One important 
question is what they do until they are symptomatic and sick. Do they take no action to 
maintain their health or do they seek care outside of biomedicine, taking advantage of 
medical pluralism as available in South Africa? Pluralism in accessing health care refers to 
the use of more than one health or medical modality, which might be alternative or 
complementary to (conventional) biomedicine (Shih et al., 2009). An individual using 
biomedicine through private and public facilities, or self-medication concurrently or 
subsequently, can also be regarded as practicing medical pluralism (Moshabela et al., 2009), 
to the extent that they are engaging with multiple providers and may be receiving varying 
advices.  
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Complementary and alternative medicine (CAM) includes knowledge-based theories and 
practices used in the prevention or treatment of illness or promotion of health and wellbeing, 
which are not part of biomedicine (WHO, 2013c). These can include Chinese medical 
therapy, or aspects of it such as acupuncture and moxibustion (Manheimer et al., 2009). It 
also includes herbal therapy, naturopathy or homeopathy, and in South Africa, this also 
includes advice and treatment from sangomas and spiritual healers (Cook, 2009). Sangomas 
are lawfully known in South Africa as "traditional health practitioners", and may include 
diviners, herbalists, traditional birth attendants, and traditional surgeons (SA, 2005b). About 
80% of South African black patients are reported to use traditional healers before consulting 
with modern medicine (Cook, 2009). Although traditional and complementary medicine 
plays a big role in influencing people‟s health seeking behaviours and access to care, it is 
however an underestimated part of health service delivery (WHO, 2013c). As a result, it is 
important to collaborate with these alternative practitioners to better understand how patients 
under their care can access and adhere to medication such as ART (WHO, 2013c, Wreford 
and Esser, 2008, Pantelic et al., 2015). In 2005, a Traditional Healer‟s Act was adopted in 
South Africa which legally recognised the role of Traditional Medicine (TM) in delivering 
care and in potentially supporting people to access conventional healthcare. Under this act, 
traditional healers included diviners, herbalists, prophets, traditional surgeons, and traditional 
birth attendants (SA, 2005b).   
Patients seek complementary and alternative medicine for many reasons. These include: in 
relation to HIV, confirmation of diagnosis or seeking an alternative diagnosis, especially 
when the person is still in denial of the diagnosis (Wringe et al., 2009) and when it is known 
that biomedicine cannot heal the disease (Schatz et al., 2013). The main challenge is when 
these ideas contradict each other, so requiring action to ensure that there is a consensus 
between them (Schatz et al., 2013), to avoid a person abandoning and defaulting from 
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prescribed medication like pre-ART or ART when they opt for alternative healing (Daniel et 
al., 2008, Wanyama et al., 2007, Akusoba, 2013). 
Medical pluralism is common among HIV+ individuals in South Africa (Moshabela et al., 
2009, Cleary et al., 2013, Pantelic et al., 2015, Moshabela, 2012) and users of traditional 
healers such as sangomas have reported that these healers are holistic in their approach to 
managing sickness, treating both the physical and spiritual well-being of their patient, and 
that they are also much more affordable (Ritcher, 2003, Tais and Zoberg, 2013). Nonetheless, 
there is evidence across SA of compromised care of HIV+ people by traditional healers due 
to failure to conform to WHO minimum standards like: HIV training received, systematic 
evaluation of their products, quality control measures, record keeping and others (WHO, 
2004). This makes it difficult to integrate traditional healer practitioners and biomedical 
sectors (Walwyn and Maitshotlo, 2010). 
Alternative medicine can be cheaper than biomedicine (Ritcher, 2003, Tais and Zoberg, 
2013), but these expenses may increase where people combine treatments from different 
modalities. In one study in SA among ART clinic attendees in a workplace, 84% of the ART 
patients reported ever using traditional medicine with a monthly expenditure of around £4 – 
£27 (an equivalence of R80- R540) per month (Babba et al., 2007). Those practicing medical 
pluralism were shown to be more likely to borrow money and pay for healthcare out of their 
pocket, with a higher level of expenditure than non-plural users (Moshabela et al., 2009). In 
addition, medical pluralism has shown to be a barrier to timely ART initiation in South Africa 
(Pantelic et al., 2015, Moshabela et al., 2009).  
HIV+ individuals are reported to practice higher medical pluralism before ART initiation 
than after initiating on ART, with greater levels of expenditure (Moshabela et al., 2009). 
Therefore defaulting from care for a pre-ART patient may mean that the patient is seeking 
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alternative health solutions, with greater expenditure, but without effective treatment and 
poor, delayed or no cross-referral to the modern medicine system.  
2.7 Reasons for poor retention in pre-ART care 
Many studies within SA and elsewhere have documented factors contributing to retention in 
care by pre-ART patients and this section outlines a summary of these factors. As noted 
above, being male and young, but also, having a higher baseline CD4 cell count, unmarried 
patients, low socio-economic status, patients whose next visit date was not documented on 
their medical chart, and those with lower educational level, are all factors associated with 
attrition in pre-ART care (Ahmed et al., 2013, Lessells et al., 2011, Marson et al., 2013, 
Mugglin et al., 2012, Rosen and Fox, 2011). The costs, mainly on the patients‟ side, have also 
been shown to negatively affect patient retention in pre-ART care (Rosen et al., 2007).  
In addition, stock outs of ART and related medication, insufficient or poor pre-antiretroviral 
care, and lack of privacy lead to poor retention (Diabate et al., 2007, Muhamadi et al., 2010). 
The other point is the lack of availability of packaged comprehensive pre-ART care services 
(Boyles et al., 2011, Govindasamy et al., 2014). Furthermore, motivation is important in 
enabling an individual to access care, and non-existence of motivation or incentives for HIV+ 
individuals not yet sick to come back for follow-up sessions is implicated in poor retention 
(Lessells et al., 2011, Boyles et al., 2011). Lack of recognition of the importance of a specific 
health services by patients or clients can lead to poor uptake and retention. For example, a 
position paper highlighted the fact that an understanding amongst HIV+ individuals that ART 
is only necessary as a last option when one gets sick, in spite of other efforts to stay well 
though living with HIV, reduces their retention in pre-ART care whilst healthy (Boyles et al., 
2011).  
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2.8 Good practices on pre-ART care service delivery 
Despite the challenges documented around poor retention and high LTFU in pre-ART service 
delivery, the introduction and maintenance of best practices in South Africa and elsewhere 
have shown ways to retain patients, as described in summary in this section. Immediate 
receipt of  CD4 cell count results at the time of HIV testing care (Faal et al., 2011, Jani et al., 
2010, Larson et al., 2013, Wynberg et al., 2014) and issuing of Cotrimoxazole for 
prophylaxis, accompanied with efficient referral and integration of pre-ART care into 
existing PHC services, have proven effective especially in retaining patients in pre-ART care 
(Kohler et al., 2011). 
In addition, according to Smith and others (2013), retention is higher where there is the 
integration of services, provision of medical and food incentives, and strengthened 
counselling and patient education which provide pre-ART care patients with accurate 
information on immune function, HIV disease progress and treatment. This supports pre-
ART patients to appreciate the significance of pre-ART care and so retain them in care 
(Smith et al., 2013). In addition, peer support (Lambdin et al., 2013, Kranzer et al., 2012) and 
decreasing operational and resource draining demands of HIV care (Smith et al., 2013) may 
support retention in pre-ART care.  
Furthermore, in urban clinics in Africa, putting in place interventions targeting men and 
accounting for patients‟ mobility due to employment may improve uptake and retention 
(Marson et al., 2013). The other documented best practice is the provision of food incentives 
to pre-ART care patients (Kundu et al., 2012), although nutritional supplements can lead to 
unintentional disclosure of one‟s HIV+ status and so stigma and discrimination (Wilhelm-
Solomon, 2013, Mogensen, 2010). This unplanned disclosure when accessing HIV 
therapeutic programs like nutrition, support groups and provision of ART is even worse in 
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displacement camps, as shown in Uganda (Wilhelm-Solomon, 2013), because populations are 
under closer surveillance than would be the case in urban settings. 
2.10 Conceptual framework 
In general, conceptual frameworks systematically characterise ideas about a phenomenon in a 
meaningful way (Meleis, 1997, Tiffany and Johnson-Lutjens, 1997). The conceptual 
framework employed in this thesis draws on some basic principles from the rational models 
of organisational theories (Shortell and Kaluzny, 1988), Rogers‟ diffusion of innovation 
classical theory of change (Rogers, 1995), and quality improvement processes.  
2.10.1 Rational models of organisational change 
According to Shortell and Kaluzny (1988), rational models focus on four stages in the 
organisational change process which are: (1) identification of the gap; (2) identification of a 
possible intervention to address the gap; (3) the actual implementation of the intervention; 
and lastly (4) institutionalisation, where the change is accepted and intervention adopted. 
These four stages are similar to a simple quality improvement cycle that can be applied when 
addressing gaps in health care. A typical example used for more than a decade is the Plan-
Do-Study-Adopt cycle (PDSA) cycle, one of the quality improvement approaches used to 
develop solutions to address an identified gap (SA, 2012b, Hughes, 2008). The four stages of 
rational models organisational change process, mentioned above, take a similar approach of 
quality improvement cycle (Shortell and Kaluzny, 1988). This is commonly used by the 
health care quality improvement NGO, the Institute for Healthcare Improvement (IHI), for 
rapid cycle improvement (Berwick, 1998, Hughes, 2008). In addition, quality improvement 
approaches have shown to greatly improve quality of care and compliance with standards in 
low and middle income countries (Franco and Marquez, 2011). The PDSA as a quality 
improvement process was first used in Japan in car manufacturing (Walton, 1986) and later in 
65 
 
the health sector (Best and Neuhauser, 2005). The quality improvement process is further 
discussed below. 
In order to improve the quality of services in South Africa, the Department of Health 
established the National Core Standards (NCS) for all levels of health service delivery (SA, 
2011b). The NCS assessment tools (discussed further in section 2.10.3 below) and many 
other different DoH existing tools are used to identify gaps to be addressed through quality 
improvement projects. For example, the NIMART readiness tool was used in this study to 
identify gaps that would hamper NIMART implementation. The diagram below describes a 
quality improvement process: 
 
 
Figure 2.2: Quality Improvement Process 
 
As shown in the above diagram, quality improvement starts with the identification of gaps 
and causes, using the available tools. If the QIP addresses a specific gap, the tested idea can 
be adopted; if there is no outcome or a negative outcome, the tested idea or action can even 
Identification of gaps through interviews, 
observations and document reviews 
Identify root causes and possible solutions 
Develop and implement a quality 
improvement plan  
Monitor whether the QIP has addressed 
the gap or not 
Monitor outcome, adopt or abandon the 
tested solutions/ideas 
Document and share results 
Gap identification 
Addressing the gap  
Outcome dissemination 
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be abandoned. Both the adoption and abandonment of ideas can be documented and 
disseminated in different forums.  
2.10.2 Rogers’ diffusion of innovation classical theory of change 
This classical theory of change is concerned with the importance of being aware of 
innovation, and persuasion towards making a decision to adopt a change, as critical stages 
towards adoption of any form of change (Rogers, 1995). For instance, I managed the process 
of rolling out the NIMART in the PHC facilities of the City of Johannesburg, following a 
systematic 10 step process, which later on significantly increased the uptake of ART, 
documented as an innovation (Nyasulu et al., 2013). The implementation of the NIMART 
roll-out was conducted in the same CoJ facilities as the pre-ART care assessment.  As a 
result, in this study, the lessons learnt from implementation of the NIMART roll-out 
innovation were further examined to establish how they can be applied to address the 
identified pre-ART care gaps.  
2.10.3 Addressing the quality of health services gaps in the SA health systems 
The South African Government has shown commitment in ensuring universal access to good 
quality health services including HIV and pre-ART services. The government has been 
documented to be taking a lead in Africa in its commitment to financing and driving the 
response towards the HIV/TB epidemic, with a five-fold increase in its budget for ART 
service delivery from the time ART was being rolled out in 2003 to 2010 (UNAIDS, 2015).  
Currently, to ensure access to services including ART and pre-ART in all facilities across the 
country, there are plans to implement National Health Insurance (NHI) in South Africa. This 
is currently being piloted in ten of 52 districts across the provinces (Matsoso and Fryatt, 
2012). To date, the government has allocated resources to multiple initiatives which all aim at 
improving the quality of health, focusing on health systems strengthening through 
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compliance to standards, with measures which are used to identify the gaps and to address 
these through QIP. The government‟s vision is that if all facilities meet the minimum 
standards in providing health care services, then NHI can be fully implemented (SA, 2011b).  
In addition, in 2014, an ideal clinic initiative was also launched which enables facilities to 
meet the National Core Standards (NCS). The ideal clinic focuses on eight workstreams as 
outlined by the president at the launching ceremony as follows: Service Delivery, Waiting 
Times, Human Resources, Infrastructure, Financial Management, Supply Chain 
Management, Scaling up and Sustainability, and Institutional Arrangements (Zuma, 2014). 
The underpinning principles for ideal clinic, NCS and all other initiatives to improve the 
quality of care at facility level, are the six ministerial priority areas outlined below: 
1. Health service providers respect the service users and have a caring attitude 
2. The facilities should be clean 
3. Service users must access care fast and there should be shorter waiting times 
4. There should be a better expected outcome of patient care with fewer mistakes and 
errors. 
5. There is a reduction in facility-based infection through infection control approaches 
6. Medicines to be accessed by service users and are available when needed without 
stock outs (SA, 2011b pages 21-41). 
In this study, I incorporated ideas from Rogers‟ diffusion of innovation classical theory with 
a focus on use of an innovation for quality improvement and access to services, the rational 
models of organisational change theory, and general quality improvement principles. In 
Figure 2.3, I set out a conceptual framework diagram which shows how the gaps and causes 
identified in pre-ART services were planned to be incorporated with lessons learnt from 
implementing the NIMART roll-out, to develop recommendations for improvements in the 
quality of pre-ART services. These principles enabled me to better understand what is 
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involved in delivering pre-ART and ART care, with the baseline assessment helping me to 
identify gaps and causes and solutions. According to an analysis of organisational theories by 
Shojania and others (2004), it is important also to note that the rational model empowers 
organisational management, in this instance the pre-ART service providers, while reflecting 
on the needs of the clients, to implement change according to the interests of the organisation 
(Shojania et al., 2004). In addition to identifying pre-ART service delivery gaps, it is critical 
to develop recommendations on the appropriate pre-ART reflecting the documented 
innovations and best practices. I return to this in the conclusion of the thesis. 
The research has three target areas: patients, health workers and health systems. The baseline 
assessment of pre-ART care identified gaps in and the causes affecting the efficacy of pre-
ART service delivery. As shown in Figure 2.3 below 
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Figure 2.3 Conceptual framework for the study 
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2.11 Research question 
 What should be done to improve access to and retention in pre-ART care? 
To answer the research question, five sub-problems were developed: 
 Problem 1: What are the gaps in the existing pre-ART program? 
 Problem 2: What are the causes of these existing pre-ART care gaps? 
 Problem 3: What possible interventions might address the existing gaps in the delivery of 
pre-ART care?  
 Problem 4: What lessons can be learnt from the NIMART roll-out implementation  
 Problem 5: What are the documented best practices that can be adopted to improve the 
quality of pre-ART care?  
2.12 Aim and objectives  
2.12.1 Goal 
To establish the existing gaps in pre-ART care service delivery and draw recommendations that 
would improve the quality of the delivery of pre-ART care and retain patients in care. 
2.12.2 Objectives 
1. To identify gaps in the delivery of pre-ART services 
2.  To identify, describe and analyse the causes of pre-ART service delivery gaps, drawing 
on interventions already underway 
3.  To explore possible interventions to address pre-ART service delivery gaps 
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4. To establish lessons learnt in implementation of an effective NIMART roll-out to be 
adopted in pre-ART service delivery, and 
5. To develop recommendations that would improve the quality in delivery of pre-ART care 
services and retain patients in care 
Each objective answered each of the five research questions stated above. Different data sources 
and methods were used to answer the research question, and to meet the objectives, as shown in 
Table 2.1 below: 
Table 2.1 Research questions and objectives 
 Research Questions Objectives 
1 What gaps exist in the pre-ART 
program 
To identify gaps and causes in the delivery of the 
pre-ART services 
2 What are the causes of existing pre-
ART care gaps? 
To establish causes to the pre-ART service delivery 
gaps 
3 What possible interventions can 
address the existing gaps in the 
delivery of pre-ART care? 
To identify possible interventions to address the pre-
ART service delivery gaps 
 
4 What lessons can be learnt from the 
NIMART roll-out implementation  
To establish lessons learnt in implementation of an 
effective NIMART roll-out to be adopted in pre-ART 
service delivery, and 
5 What are the documented best 
practices that can be adopted to 
improve the quality of pre-ART care?  
To develop recommendations that would improve the 
quality in delivery of pre-ART care services and 
retain patients in care 
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Chapter Three 
 Methodology 
3.1 Study setting 
3.1.1 Study site 
The study was conducted at two facilities in Region F of the City of Johannesburg (CoJ) 
(Figure 2.1). The CoJ municipality is situated in Gauteng Province, South Africa, and has 7 
regions (A-F), with a total population of approximately 4.4 million. This accounts for 36% of 
the Gauteng population and four percent of the national population (SA, 2015a).  
 
Figure 3.1: Map of South Africa and City of Johannesburg indicating Region F 
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Region F is the inner city of Johannesburg, with an estimated population of 478,000 (DHIS 
data base 2012), including migrants from other SA provinces and other African nationalities 
(SA, 2015a). The latest statistics indicate that in CoJ, only 24.8% of the population is 
employed, and about 17% live in informal settlements (SSA, 2012).  The 2011 census 
showed that 84.6% of the population in CoJ were born in SA while the rest had migrated to 
SA from other countries - a drop from 97.1% in 2001 (COJ, 2013a). This migration to CoJ 
reflects the fact that city continues to draw people from other countries looking for better 
economic prospects and quality of life (COJ, 2013a, SA, 2015a). In addition to registered 
immigrants, the inner city is a hub of illegal immigrants not registered officially and hence, 
the population estimate of total numbers and numbers of immigrants is probably much lower 
than the true figures (SA, 2015a).  
 
 
As shown in the above Figures, the inner city has extremely varied regions, which range from 
severely degraded residential areas, to the rather stable commercial and educational 
institutional area of Braamfontein. In most cases, the migrants who cannot afford 
http://commons.wikimedia.org/wiki/File:Johannesburg.jpg http://victordlamini.com/news/joburgs-inner-city-
blues/ 
Figure 3.2a Marshalltown, inner COJ Figure 3.2b A degraded building, Joubert 
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accommodation use abandoned buildings, and many live without access to water and 
sanitation facilities. 
3.1.2 Health services in Johannesburg and referral system 
In Region F of Johannesburg, services are delivered at different levels namely: tertiary, 
secondary, community and primary levels (CoJ, April, 2015). Reflecting this, the region has 
one tertiary level hospital, one secondary level hospital, one Community Health Care (CHC) 
facility and 17 Primary Health Care (PHC) facilities. I describe these below. 
Charlotte Maxeke Academic Hospital, formerly known as Johannesburg General Hospital, 
is an academic hospital and a tertiary level referral hospital for the city. This hospital has an 
HIV clinic and at this level of care, all diagnosis, treatment and plans of care are prescribed 
by specialist doctors; nurses provide nursing support care. South Rand Hospital is a 
secondary hospital located in the southern part of CoJ.  All diagnosis, treatment and plans of 
patient care are undertaken by specialists and general practitioner doctors, while nurses 
provide nursing support, mainly guided by doctors. Community Health Centres (CHC) 
were developed to serve a population of up to 300,000, and act as first level referral sites for 
Primary Health Clinics (PHCs). Services provided by CHCs include curative care, maternal 
and child health (including maternity care), immunisation, health promotion activities, 
community outreach and minor surgical theatre. All CHCs provide 24-hour services. 
Hillbrow is the only CHC in Region F of CoJ. Lastly, Primary Health Clinics (PHCs) are 
intended to serve a population of about 100 000 people and provide the following services: 
curative care, maternal and child health, health promotion activities, community outreach and 
daily medical services of eight to 10 hours. The PHC facilities are mainly headed by a nurse 
and PHC nurses are trained in clinical diagnosis and prescription. They take the lead in the 
diagnosis, treatment and planning of patient care at PHC facilities. In complicated cases, 
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there are clear guidelines on referral of patients to the different levels of care described above 
(CoJ, April, 2015).3.1.3 Referral system 
The referral system is an important component of health service delivery. The CoJ health 
service has referral systems in place in line with the WHO referral system, as illustrated 
below: 
 
 
 
 
 
 
 
 
 
Figure 3.3 Referral system flow diagram (WHO, 2015) 
As shown in the above figure adapted from WHO referral notes, in the CoJ referral system, 
constant communication between the different levels of the referral system is required. In 
CoJ, using an outward referral form, complicated cases are referred from PHCs to CHC, 
secondary or tertiary levels depending on the complexity of the case. All stable cases at 
receiving sites are expected to be back referred to PHC or CHC levels, depending of the case, 
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by completing the back referral form (Appendix 8.8). In addition, outward and back referrals 
are used as supervision and capacity building opportunities for both the initiating and 
receiving facilities. The underpinning principle is that patients access care at the nearest 
facility whenever possible. 
Predominantly, patients who are not yet eligible to start ART are managed at their PHC 
facilities unless they have complications needing referral to CHC, secondary or tertiary health 
facilities. As a result, this study focussed on the PHC facilities in Region F, CoJ. At the time 
of data collection, the Department of Health (DoH) had designed systems to ensure that all 
foreigners had translators based in the facilities and provided access to services for those 
without legal identity documents. All PHC facilities provide HIV testing services and CD4 
cell counts to determine patients‟ eligibility to start ART. Patients with CD4 count >500, with 
no TB, are expected to be enrolled into a pre-ART care program for monitoring and other 
pre-ART care services.  
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3.1.4 Study period 
Data for this study were collected through interviews with pre-ART care patients and service 
providers, consultative workshops with health services managers, ART and HCT register 
audit as well as DHIS data on ART uptake in CoJ. Below is a table showing the time period 
applied for each data source: 
Table 3.1 Data sources and time periods 
Data source Time period 
Interviews with pre-ART care patients and service providers July 2012 
Consultative workshops with health services managers March 2013 
ART  register audit  February 2012-July 2012 
HCT register audit  May 2011-April 2012 
 DHIS data on ART uptake in CoJ Oct 2009-Feb 2012 
 
3.2 Study design 
This study used a mixed methods design (Tashakkori and Teddlie, 2003), with both 
quantitative and qualitative data used at various stages to understand the research problem as 
completely as possible (Creswell, 2009). In this study, I used an embedded model of mixed 
methods, whereby a quantitative design had a nested qualitative component, enabling me to 
collect both quantitative and qualitative data within a traditional quantitative design (Creswell 
and Plano Clark, 2011).  
The purpose for using mixed methods was to collect complementary data, as neither 
qualitative nor quantitative were sufficient by themselves to capture the trends and details of 
the situation, either in relation to pre-ART care and NIMART roll-out (Green et al., 1989, 
Tashakkori and Teddlie, 1998). Mixed methods provided an in-depth understanding of the 
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pre-ART care service delivery and questions around access (Blaxter et al., 2010, Creswell, 
2009). This approach helped to validate findings from different data sources (stated in Table 
3.2), so achieving triangulation (Barnes 2012), and they ensured that the weaknesses of one 
method were offset by the strengths of another (Tashakkori and Teddlie, 1998).  Lastly, the 
pre-ART care research study had both qualitative and quantitative questions requiring both 
numerical and textual data, hence again the applicability of mixed methods (Williams, 2007). 
Data were collected from qualitative and quantitative methods, as shown in the table below: 
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Table 3.2 Qualitative and quantitative study questions  
Question Methods Study population 
What are the demographic characteristics of 
pre-ART care patients?  
Quantitative Pre- ART care patients  
What are the pre-ART care patients‟ 
knowledge levels in relation to HIV/AIDS, 
CD4 cell count, pre-ART and ART services 
rendered in their facilities?  
Quantitative Pre- ART care patients 
Are the facilities youth and male friendly? Quantitative 
and 
quantitative 
Pre- ART care patients 
How was NIMART rolled-out in the CoJ and 
what was its effect on ART uptake? 
Quantitative 
and 
qualitative 
NIMART project 
information and DHIS 
database 
What were the differences between rolling 
out NIMART and pre-ART services? 
Quantitative 
and 
qualitative 
NIMART project 
information and pre-ART 
service providers 
What was the pre-ART patients‟ pathway of 
care from their first encounter at a facility to 
the date of interviews? 
Qualitative Pre- ART care patients and 
service providers 
What are the common gaps and underlying 
causes in delivering pre-ART care services at 
the facility? 
Qualitative Pre- ART care Patients and 
service providers 
What are the possible recommendations to 
address existing facility gaps? 
Qualitative Pre- ART care Patients and 
service providers 
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3.3 Study sampling  
3.3.1 Sampling methodology of participants for interviews: 
When selecting participants (pre-ART care patients and staff) for interviews for this study, 
multistage sampling was employed (Kirkwood and Sterne, 2009), with three stages as 
described below; 
1st Stage:  Selection of facilities 
At the time of the study, pre-ART care patients were managed by nurses at their nearest PHC 
facilities. As a result, in order to access pre-ART care patients and service providers, all PHC 
facilities in CoJ were included for sampling. Due to time and financial constraints as a self-
funded PhD student, only two facilities were randomly selected out of the 17 PHC facilities. 
This was done by writing names on small pieces of papers, which were mixed; then a 
volunteer was asked to pick out two pieces of paper.  
2nd Stage: selection of pre-ART patients still in care:  
It is important to determine the appropriate sample size in order to make inferences to the 
study population based on our findings from the sample (Kirkwood 2009). A number of 
variables were of interest in this study. These included process variables such as cervical 
screening, IPT, CPT, CD4 cell count checks ups and family planning being offered to pre-
ART patients. There was one outcome variable - timely referral for ART initiation. In order 
to estimate sample size, I focused on the proportion of patients who were referred for ART on 
time. To estimate this, a pilot study was undertaken. A file audit was undertaken of all 
patients who were initiated on ART over the preceding six months, between January and 
August 2012, at the clinics, in order to estimate the proportion of pre-ART patients referred 
for ART initiation in a timely manner. A total of 203 files were audited, of which 30 were 
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referred from pre-ART care. Only three of these patients (10%) from the pre-ART program 
had timely ART initiation. The flow diagram below shows the results: 
 
Figure 3.4 Pre-ART patient file audit selection process flow diagram  
The initial plan was to conduct a baseline or pre-test assessment, and then later, after piloting 
a designed intervention, a post-test assessment would be conducted. As a result, comparison 
of two proportions was applied (at baseline assessment and project evaluation) (Kirkwood 
and Sterne, 2009).  Individuals sampled at baseline assessment were unexposed to the 
appropriate pre-ART care program intervention, whilst the sample at the project evaluations 
was considered exposed to the intervention. The timely ART referral at baseline was at 10%, 
and it was expected to increase to 30% after the pre-ART intervention.  
Using the 80% power and 95% two sided significance level, the sample size was calculated 
using the formula below: 
                
                     
         
 
Total number of patients initiated from Jan-Aug 2012 (203) 
Patients who went through pre-ART 
care before initiation (30) 
Those referred for ART timely 
(CD4  cell count >300) (3) 
=10% 
Those with delayed ART referral 
(CD4 count <300) (27)  = (90%) 
Patients who did not go through 
pre-ART care program before 
initiation (173) 
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Where: n1 = Sample size at baseline, n2 = Sample size at project evaluation,   =5%, 
  80%,         and      30%. Using this formula adapted from Kirkwood and 
Sterne (2009), sample size was calculated with STATA as shown in the output below: 
Table 3.3 STATA sample size calculation output 
 
Two-sided significance level(1-alpha): 95% 
Ratio of sample size, Unexposed (baseline)/Exposed (evaluation): 1 
Percentage of those referred for ART timely before intervention: 10% 
Power 80% 
Percentage of those referred for ART timely after intervention. 30% 
Risk/Prevalence Ratio: 3% 
Risk/Prevalence difference: 20 
Sample size exposed 72 
Sample size not exposed 72 
Total sample size 144 
 
As shown above, 72 pre-ART program patients were to be selected for interviews at baseline 
(non-exposed) and evaluation (exposed) phases; in total 144 patients were to be interviewed. 
All patients attending pre-ART care services in the week 6 – 10 July 2012 were selected for 
interviews, until the sample size of 72 was reached. These patients were not expected to be 
homogeneous, since patients are scheduled for either monthly or three monthly appointments, 
depending on the type of services to be given or their clinical condition. In addition, during 
the same week, all health service providers involved in the pre-ART care program were 
selected for interviews. The above register and file audits pilot study processes involved in 
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sample size calculation yielded some key preliminary results which will be elaborated further 
in the chapters four and five that follow. 
3rd Stage: selection of pre-ART care patients who dropped out from care 
People who dropped out from the program were systematically selected and telephoned to 
come for interviews. To identify non-attending but registered patients, I manually reviewed 
clinic records. Paper files for people who were registered for and/or attended pre-ART 
services were organized alphabetically on shelves, as shown in the photograph below (Figure 
3.6). 
 
Figure 3.5 The pre-ART filing system cabinets and shelves 
This filing system allowed me to identify patients who had not presented at the facility for the 
past 12 months.  The first file on each drawer, of a patient who had not attended, and for 
whom a telephone contact number was available, was invited to participate in the study. A 
total of 15 files were selected and patients were phoned to schedule an interview. The phone 
numbers for six patients were not working; five of the nine patients who were called accepted 
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to participate and were scheduled for interviews. Four did not come after the phone call; of 
these, two had moved out of the City of Johannesburg whilst the other two just refused, 
indicating that they no longer wanted to do anything with pre-ART care for unspecified 
reasons.  
All pre-ART care service providers in the two facilities were included in the study. Using the 
above selection criteria, the baseline assessment included a total of 73 patients (30 male and 
42 female) and 12 service providers (4 male and 8 female) for interviews.  
Table 3.5 Sampling methodologies for register and file audits 
 Category Inclusion criteria # included 
1 HCT register audit All patients who tested HIV+ over a 12 months 
(May 2011 – April 2012) period were included 
for auditing  
1715 
2 ART register  audit All patients who were initiated on ART 
between February- July 2012 
203 
3 Pre-ART care file 
audit: 
This is a subset of (2) patients who were 
initiated on ART between February- July 2012 
after attending pre-ART before their CD4 count 
levels dropped to a level when they become 
eligible for ART  
30 
Total 1918 
 
3.3.2 Inclusion criteria for patients in NIMART roll-out  
All from Region F, initiated on ART from October 2009 to March 2012,   were included. All 
patients who had transferred to Region F facilities from other regions or districts were 
excluded. A total of 20535 iinitiated on ART were included, of whom 6,957 patients (both 
adults and children) were initiated before the NIMART intervention (October 2009-
September 2010) and 13,578 after NIMART (October 2010-February 2012). 
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3.3.3 Sampling methodology of participants for the consultative workshop 
Choosing the appropriate participants is particularly important in the research process as it 
directly affects the quality of the study outcomes (Jacobs, 1996). However, adopted from the 
Delphi technique, the workshop participants were recruited based on their expert knowledge 
on the pre-ART service delivery gaps, causes and possible solutions, and willingness to 
participate (Hsu and Sandford, 2007, Lofmark and Thorell-Ekstrand, 2005, Powell, 2003).  
The participants were health services managers in the City of Johannesburg from a health 
background. Fifteen participants were involved in a consultative workshop (Delbecq et al., 
1975). These managers were decision makers who would utilise the recommendations drawn 
from the study. 
3.4 Data collection 
3.4.1 Data collection tools 
3.4.1.1 Questionnaires for patient and staff interviews 
I used the South African National Clinical Guidelines for ART and WHO Guidelines on 
Standard pre-ART Care and Information to be offered to pre-ART program patients (SA, 
2013d, WHO, 2008) to develop the data collection tools for pre-ART care patients and staff  
(see Appendix 8.5). Some questions from the Wits Reproductive Health Institute (WRHI) 
questionnaires, used in studies among HIV+ individuals in the same population (in 
Johannesburg), were also adopted. In order to establish factors contributing to men and 
youths being most often lost to follow-up in pre-ART care, a component of measures to 
assess youth and male friendliness of the facilities was also included. These tools were used 
to collect data from participants on the following areas: 
 Demographic characteristics. 
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 Pre-ART patients‟ pathway of care from first encounter at a facility to the date of 
interviews 
 Participants‟ knowledge levels on HIV/AIDS, CD4 cell count, pre-ART and ART 
services rendered in their facilities. 
 Participants‟ perceptions of male and youth friendliness of the facility, which included 
asking the participants the definition of youth and male friendliness, whether they felt 
that facilities were friendly to youths and men, and the gaps and possible solutions to 
making the facilities youth or male friendly. 
 Participants‟ perceptions of the common gaps in delivering pre-ART care services at 
the facility, and 
 Participants‟ perceptions of possible recommendations to address the existing facility 
gaps. 
These interview tools had both closed and open-ended questions, enabling the collection of 
both quantitative and qualitative data through interviews with pre-ART care service providers 
and patients.  
3.4.1.2 Checklist for pre-ART care register audit: The pre-ART care register checklist 
covered the following areas: Age, gender, TB screening, the CD4 cell count value, CD4 
testing, collected their CD4 cell counts results (see Appendix 8.5.4).  
3.4.1.3 Checklist for ART patients’ file audit:  The file audit checklist covered the following 
areas: gender, initiation date and the CD4 cell count level at the time of initiation (see 
Appendix 8.5.5).  
3.4.1.4 NIMART readiness assessment tool: This was a Department of Health tool used to 
assess facility readiness to start implementing NIMART. The tool covered the following 
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areas: General information around recording and reporting of facility, basic HIV/AIDS 
Services delivered by the facility, availability of policies and National Treatment Guidelines, 
availability of laboratory and pharmacy services and capacity and lastly, HIV/AIDS Service 
Point Access to care, treatment and support. 
3.4.2 Pretesting of data collection tools 
The tools were pre-tested to ensure feasibility of the study, and to identify questions that were 
poorly understood, ambiguous or inconsistent (Armstrong et al., 2001). Pretesting of tools 
was conducted in one of the CoJ facilities which was not part of the study. Comments from 
the participants during the pilot study enabled me to finalise the questions through the 
modification of questions, adding and removing other questions, as described in Table 3.5 
below: 
Table 3.5 Changes made to data collection tools after pretesting 
Before pre-testing After pretesting 
What are the possible 
solutions to address 
the gaps in pre-ART 
care in this facility? 
This question did not elicit much information from respondents. As 
a result we included the list of pre-ART care services in a table as 
follows: 
What do you think should be done to improve the services below? 
HIV counselling and testing  (HCT), disclosure and prevention, on-
going counselling, PLWHA support groups, TB IPT – client 
education, screening and administration of IPT, social grant 
acquisition support, nutrition  (food parcels and infant feeds), and 
adherence support 
Do you think the 
facility is youth 
friendly? 
Do you think the 
facility is male 
friendly? 
We realised that not all respondents understood what youth and 
male friendliness of the facilities meant. As a result the questions 
changed as follows: 
What is a youth friendly facility? (if the respondent does not know, 
the interviewer should define it to him/her) 
Do you think this facility is youth friendly? Why? 
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Before pre-testing After pretesting 
What is a male friendly facility? (if the respondent does not know 
the interviewer to define it to him/her) 
Do you think this facility is male friendly? Why? 
Initially we had a 
separate additional 
page for PMTCT 
patients 
Because there was some repetition of questions, later we 
incorporated the question into the pre-ART patient questionnaire 
and removed the repetitive questions. 
The flow of questions 
was inconsistent as 
some questions did 
not make sense when 
asked in the initial 
flow 
The flow of questions was revised and numbering was changed. 
 
3.4.3 Data collectors 
Data through interviews for this research were collected in July 2012 by seven people 
including me, the project coordinator, and five others (three males and two females) recruited 
to conduct patient interviews. The project coordinator, who had a Master‟s degree in Public 
Health (MPH), was recruited with support from Foundation Professional Development (FPD) 
on a full time basis, as a project fellow, for 6 months (March – August 2012). The fellow was 
responsible for register and file audits under my direct mentorship and supervision.  She also 
co-managed the greater part of the staff and patient interview data collection week through 
facilitating the logistics, co-facilitating the training for the data collectors, and she conducted 
some of the staff interviews.  Five data collectors were recruited. The criteria for recruitment 
was matric level (a qualification on completion of high school) and previous experience in 
collecting qualitative and quantitative data. These data collectors were mainly sourced from 
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the Wits Reproductive Health Research Institute (WRHI), which as a research organisation 
had a database of data collectors.  
These five data collectors were also trained and experienced HIV/AIDS peer-educators 
attached to WRHI project on part time basis. As a result, the team was well conversant on the 
basic principles when talking to people who were living with HIV. In addition, because of 
their role with WRHI, these data collectors were scheduled for bi-monthly psychological 
debriefing sessions with a qualified clinical psychologist. Before the actual data collection 
through interviews with staff and pre-ART patients, the data collectors were trained, covering 
the following areas: introduction to pre-ART and research study, overview of the patients‟ 
and service provider‟s interview questionnaires, conducting interviews, data quality checks, 
debriefing sessions, a practical session on conducting interviews, feedback sessions and a 
plan for the data collection week. Further information on this is provided in Appendix 8.6. 
3.4.4 Data collection process 
Data collection for pre-ART care patients and service providers‟ registers and files for 
auditing and ART naïve patients for NIMART roll-out innovation was carried out as shown 
in the table below: 
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Table 3.6 Description of data collection processes 
Category Process 
Pre-ART care 
patients and 
service providers 
interviews 
First round: Five data collectors with experience in conducting 
interviews were trained and oriented by me on how to use the 
questionnaires, for them to familiarise themselves with the tools. At 
the end of each data collection day, as a principal investigator, I 
facilitated a debriefing session whereby the data collectors 
presented on how the data collection process went on the day and 
the highlights on findings from each interview conducted. 
Particularly focus was placed on the open ended (qualitative) 
questions. This enabled me to capture the qualitative data highlights 
from the interviews conducted on the day, and to identify emergent 
issues to guide later interviews and establish when saturation was 
reached.  
Second round: This phase focused on validating the findings from 
the baseline assessments, establishing the possible causes of the 
identified pre-ART care service delivery gaps and developing 
possible recommendations. This was done through a consultative 
workshop with the health service managers, whereby the findings 
on identified gaps in the pilot facilities, with proposed 
recommendations from the baseline assessments, were presented to 
the team of health services managers. The presentation was 
followed by further discussions on the causes and possible 
recommendations.  In order to avoid the risk of domination by 
specific individuals, forcing other participants conforming to their 
view point (Oh, 1974, Adams, 2001), I facilitated this in such a way 
that the dominant participants were controlled while quieter ones 
were encouraged to contribute.  
HIV+ HCT 
register audit 
The following parameters were used to audit the registers: Age, 
gender, whether they were screened for TB, whether their CD4 cell 
count was checked, the CD4 cell count level, whether they collected 
their CD4 cell count results. 
ART and pre-ART 
file audit. 
The ART register for patients initiated between February and July 
2012 was audited to establish their gender, initiation date and the 
CD4 cell count level at the time of initiation. The files for the same 
list of ART patients were traced and audited to establish whether 
they attended pre-ART care before becoming eligible for ART. The 
ART file audit checklist covered the following areas: Gender, the 
date a decision was made to initiate the patient, date the patient was 
initiated on ART and whether they accessed the following pre-ART 
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care services: TB screening, cervical cancer screening, IPT, CPT 
and multivitamin tablets. 
ART care patients 
initiated through 
NIMAMRT 
We documented the 10 step process of rolling out NIMART and 
compared uptake of ART in the CoJ before and after NIMART roll-
out, to establish the effect of NIMART on ART uptake. 
3.5 Data processing and analysis 
3.5.1 Quantitative data 
3.5.1.1  Quantitative data from patient and staff interviews 
Quantitative data were entered into Epi Info 2003 (US Centres for Disease Control, Atlanta, 
GA, USA) and analysed using Statistical Package STATA software version 12 (STATA 
Corporation, College Station, TX, USA). HIV/AIDS knowledge levels of the participants 
were established through HIV/AIDS knowledge questions, using both unipolar and bipolar 
Likert scales (Strener and Norman, 2003). During data analysis, the HIV/AIDS knowledge 
levels and socio-demographic characteristics were compared to whether the respondent had 
his/her CD4+ cell count checked within the past six months according to WHO/SA pre-ART 
care guidelines. Chi-square or Fisher‟s exact test were used for categorical variables. In 
addition, CD4 cell count levels at the time of the interviews, access to pre-ART care services, 
disclosure on HIV+ status, and sources of HIV/AIDS information were analysed and 
presented in tables or graphs. 
3.5.1.2  Quantitative data from patient register and file audits 
Patient register and file audit data were captured in Excel and imported into STATA for 
analysis. Age (whether a youth aged 18-24 or not) and gender were the two main variables 
for the file and register audits. We performed a chi-square test to compare differences in 
proportions between the two groups. A chi-square P value of ≤0.05 was considered 
significant. The mean CD4 cell count, return visit for collection of CD$ cell count results, 
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and access to pre-ART services i.e. TB screening, IPT and CPT were compared by gender 
and age groups.  
3.5.1.3  Statistical analysis for data from NIMART roll-out implementation 
Continuous data were expressed as means (standard deviation [SD]), medians or interquartile 
range [IQR]. Categorical data were presented as frequencies and percentages. The Durbin-
Watson statistic was used to test for auto-correlation between NIMART roll-out and ART 
uptake. The time series data were modelled using segmented regression analysis of 
interrupted time series which, as suggested by Wagner and others (2002), has the advantage 
of controlling for baseline level and trend. The time series patterns before and after the 
intervention to assess differences were compared. The trends before and after the intervention 
were analysed to assess whether passage of time was associated with increased ART 
initiation. The change in average numbers of those initiating ART immediately after 
intervention was estimated and tested for significance. The specific model used was: 
YT = β0 + β1 * time + β2 * intervention t + β3 * time after intervention t + et, 
where Yt is the total number of new ART initiations in a month in Region F, which is the 
response variable in this model; time is a continuous variable indicating time in months at 
time t from the start of the observation period; intervention is an indicator for time t occurring 
before (intervention = 0) or after (intervention = 1) NIMART rollout, which was 
implemented at month 13 in the series; and time after intervention is a continuous variable 
counting the number of months after the intervention at time t, coded 0 before NIMART and 
1 - 18 after NIMART. In this model, β0 is the estimate of baseline level of outcome, being the 
mean number of patients initiated on ART at time zero; β1 estimates the mean change in total 
number of ART initiations that occurred in each month before NIMART rollout, β2 estimates 
the level change in the mean number of initiations after NIMART; and β3 estimates the 
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change in the trend in the mean monthly number of ART initiations after NIMART compared 
with the monthly trend before NIMART intervention. The error term et at time t represents 
the random variability not accounted for by the model. Throughout a two-tailed t-test at a 5% 
level of significance was used.  
3.5.2 Qualitative data 
The last part of the questions from the patient and staff interviews, looking at the existing 
gaps in pre-ART care, and possible solutions to address them, was open ended, and the 
verbatim text provided qualitative data. On each day after data collection, a debriefing 
session was conducted whereby each interviewer narrated data generated from each 
participant.  During the debriefing sessions, relevant individual quotations were identified. 
Qualitative data were then manually analysed to construct themes and matrices. Later, all 
qualitative data were transcribed as individual scripts for each participant. Word processing 
was used to develop themes manually, based on the interpretation of the fundamental 
importance on a higher analytical level as compared to more descriptive categories.   
3.6 Triangulation of data 
Triangulation of data has been shown to establish validity and credibility of research findings 
(Guion et al., 2011). In order to establish trustworthiness and validity of results, different 
sources of data were chosen, including clinic monthly statistics, pre-ART patients‟ and 
service providers‟ interviews, and patients‟ file and register audits. Throughout the data 
collection and analysis processes, consistencies and inconsistences in the findings from the 
different data sources were observed and analysed, as described in the table below: 
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Table 3.7 Triangulation of different sources of data  
Consistency observation Data source 
The type of services indicated to be offered at the facility by the 
staff and actual services accessed by the patients and what was 
documented in the files and HCT registers of patients who 
accessed pre-ART care in the facilities 
PIs, staff interviews, 
register and file audits 
Clinic ART and pre-ART statistics Staff interviews and 
clinic statistics 
The pathway in which patients access care, i.e from HIV pre-test 
counselling to initiation on ART? 
Staff and PIs 
Pre-ART care staff availability Staff and PIs 
HIV/AIDS knowledge levels Staff and PIs 
3.7 Quality control 
In this study, quality control measures were taken to ensure that the data generated were of 
good quality. Firstly, the research data collectors were trained prior to conducting data 
collection. In addition, at the end of each data collection day, a detailed debriefing session 
was conducted. In this session, the data collectors made brief presentations on the interviews 
conducted in the day, highlighting the key findings; this gave us all a sense of new issues 
emerging from the interviews and those which required more probing. Data were double 
entered by myself and the pre-ART project research fellow, and cleaned to take care of all 
inconsistencies. Missing values were checked and data were corrected. Lastly, verification of 
data with the original questionnaires was done throughout the process, even at the time of 
writing up the research report, to ensure that the analysis and report were reflections of the 
study findings.   
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3.8 Ethics considerations 
The study was approved by the University of the Witwatersrand Committee for Research on 
Human Subjects (see Appendix 8.2), with supporting approval from the City of Johannesburg 
(see Appendix 8.4). All interviews were conducted in privacy, consent was sought and the 
signed consent forms did not have the participants‟ name. No incentives were given to study 
participants. However, transport money was provided to patients to attend interviews if they 
had not come for pre-ART services for 12 months and were phoned to come for interviews. 
The amount of transport money reimbursed ranged from R30-R50 ($3-$5), depending on 
where the participant lived.  
With the realisation of the fact that asking people about their lived experience of HIV can 
sometimes lead to psychological trauma for the interviewer as well as the respondent, a 
debriefing support structure was established to deal with such issues. Throughout the data 
collection process, no psychological trauma case was identified during the debriefing 
sessions. In addition the data collectors attended scheduled WRHI bimonthly debriefing 
sessions as a support structure for them as HIV/AIDS peer-educators, as described earlier in 
this chapter. 
Initially, the facilities were named and facility managers had different questionnaires from 
the other pre-ART service providers. The ethics committee recommended that facilities not 
be named and that I merge the questionnaires for facility managers and the rest of the staff to 
ensure privacy and confidentiality of the responses, as there were only two facilities and 
managers participating in the study. For this purpose, throughout this thesis, where there is a 
risk of breech of confidentially, I neither refer to a facility name nor link staff respondents to 
their roles to pre-ART care. 
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3.9 Dissemination of results 
The first phase on dissemination of the results was after baseline assessments. The baseline 
results, highlighting the identified gaps and possible recommendations, were presented to the 
facility and regional health managers of CoJ. At this time, ideas were sought from the CoJ 
partners to be included in developing recommendations for pre-ART services. In addition, 
findings for the study were published or written up as abstracts for international conferences 
(see Appendix 8.9). 
3.10 Limitations and special factors considered in the study 
One of the most important responsibilities of researchers is to report on the limitations and 
challenges in their study. It is important to be aware of the problems or limitations before 
commencing the study. Many are unavoidable, hence the need to acknowledge them at the 
report writing phase (Fisher et al., 2002). Below I elucidate the limitations in this study. 
3.10.1 Selection bias 
In both quantitative and qualitative research, the selection of study participants and 
methodology used is crucial in drawing broader inferences from the findings (Kirkwood and 
Sterne, 2009, Polit and Beck, 2010, Kirkwood and Price, 2013). This study was conducted at 
primary health care facilities in the City of Johannesburg, which may be different to those in 
other provinces of SA and elsewhere. However, as discussed in Chapter 1, drawing on my 
knowledge acquired in my role as a QA technical advisor in five provinces across South 
Africa (not including CoJ), I believe that the identified gaps in these clinics are similar to 
those that exist across South Africa. As a result, the recommendations in the study can be 
generalized at PHC level across South Africa, although with caution, as the study site was 
urban, and its population mainly migrants, in contrast to other South African provinces which 
are rural with a large population of local residents. In addition, since most people were 
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migrants, they travel to their homes over Christmas and on other similar occasions, to be with 
their families, leading to a low uptake of services at different times of the year. Selecting 
clinic attenders during these periods may lead to selection bias. However, to be more 
inclusive in this study, data were collected five months before the festive season.   
Some patients lost to follow were not traced for interviews. However, efforts were made by 
phoning to get hold of the patients and to schedule interviews at an appropriate time and 
place. This was not always successful as described above (3.3.1). Given the possibility that 
the characteristics and lived experiences were different from those people who were 
interviewed, it is difficult to generalise the findings to a wider population (Campbell and 
Machin, 1999, Kirkwood and Sterne, 2009).   
3.10.2 Information bias 
All registers were in place for the pre-ART and ART programs; however, as described in this 
thesis, there was poor data recording especially with pre-ART registers. At the time of the 
study, most ART registers were well completed, whilst the pre-ART and HCT registers were 
mostly incomplete. Every possible effort was made to compare the registers with the source 
documents, such as patients‟ files or cards, to ensure completeness of data. In addition, the 
triangulation of data, using the interviews with 73 patients and service providers and 
workshop with health services managers, was used to validate and verify findings.  
Even though all patients still in pre-ART care and selected for interviews voluntarily 
accepted to be interviewed, it is important to acknowledge that some of the information 
required them to recall what happened (for example, narration of their care pathway from the 
time they were diagnosed). People tell particular stories emphasising one area not others, 
leading to recall bias (Campbell and Machin, 1999, Kirkwood and Sterne, 2009). However, 
since the patients were interviewed after collecting their files, the interviewers assisted in 
98 
 
validating the information by checking what was documented in the patients‟ files when 
necessary.  
3.10.3 Situational Factors 
It is important to take an account of all other factors and processes taking place in the health 
systems that may affect the results of the study. Below I set out these factors: 
6.2.3.1 Population mobility 
Region F of the City of Johannesburg, where the study was conducted, is comprised of a 
highly mobile population, as discussed above. The recommendations developed from this 
study have been critically reviewed as to whether they are applicable for both mobile and 
stable populations.  
6.2.3.3.2 CD4 cell count cut-off point 
HIV service delivery is one of the areas with a fast evolving body of knowledge due to 
ongoing research in the area. For example, the CD4 cell count at the time of initiation of the 
research project in 2011 was at ≤200 cells/μl which increased to ≤350 in 2012 with a further 
increase to ≤500 cells/μl in January 2015. These changes may have affected the number of 
patients on pre-ART care, and may affect the applicability of the results in South African 
context. 
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Chapter Four 
 Results 
In this section, I present both qualitative and quantitative findings from data collected in the 
study. In addition, outcomes from a consultative workshop with health services managers in 
the City of Johannesburg, and documentation of the NIMART roll-out processes, are 
presented. A total of 2018 participants were included in this study, as shown in the table 
below: 
Table 4.1 Study participants 
 Category Number 
1 Patient interviews 73 
2 Staff interviews 12 
3 Consultative workshop with CoJ health services managers 15 
4 HCT register audit 1715 
5 ART register audit and pre-ART file audit 203 
Total participants in the study 2018 
 
In addition, 6957 and 13578 people from the DHIS ART initiation data base were included in 
the before and after NIMART roll out time series analysis respectively.  
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4.1 Interviews with pre-ART care patients      
 4.1.1 Socio-demographic characteristics and 6 monthly CD4 count check ups  
In this study, I established the socio-demographic characteristics of the participants in order 
to better understand their association with access, adherence and retention in pre-ART care. 
In this case, CD4 cell count testing within the past 6 months, at the time of the interviews, 
was used to approximate adherence. In Table 4.2, I present the participants‟ socio-
demographic characteristics and their CD4 cell count 6 monthly check-ups. 
Table 4.2 Socio-demographic characteristics and 6 monthly CD4 cell count monitoring  
Socio-demographic 
variables 
No (%) CD4 count, 
6 monthly 
No CD4 count 6 
monthly 
P value 
All respondents (73)  73 (100) 50 (68.5%) 23 (31.5%)  
Gender 
Male  30 (41) 21 (70) 9 (30) 0.82 
Female 43 (59) 29 (67) 14 (33) 
Employment 
Employed 13 (18) 9 (69) 4 (31) 0.95 
Unemployed 60 (82) 41 (68) 19 (32) 
Age 
<24yrs  23 (32) 19(83) 4 (17) 0.68 
>24yrs 50 (68) 41(82) 9 (18) 
Educational level* 
≤ Grade 4  64 (87) 44 (69) 20 (31)  
0.9 ≥Grade 5 9 (13) 6 (67) 3 (33) 
Marital status 
Married 25 (34) 19 (76) 6 (24) 0.32 
Not married 48 (66) 31 (66) 17 (34) 
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As illustrated in the table above, most patients interviewed were unemployed (82%), illiterate 
(87%), aged >24yrs (68%) and not married (66%). Consistent with WHO and SA Guidelines 
that each pre-ART patient should to be tested for CD4 cell count every six months (SA, 
2014(b), WHO, 2013a), the majority (68%) adhered to six monthly CD4 cell count check-up. 
There were no significant differences in the uptake of the six monthly CD4 cell count check-
ups according to different demographic characteristics. 
4.1.2 CD4+ count levels for the interviewed pre-ART care patients 
At the time of the interviews, I established the current CD4 cell count levels for participants. 
Almost all (99%) mentioned that they had their CD4+ count checked at least once since they 
had tested HIV+. Further, two thirds had their CD4+ cell count checked within the six 
months period prior to the interview. Below is a summary of the exact CD4 count levels for 
the patients at the time of the interviews: 
 
Figure 4.1 CD4 cell count levels for interviewed patients 
As illustrated above, the CD4+ cell count levels for participants who knew their CD4 cell 
count levels, mostly documented also in their files, ranged from 3 to 1000 cells/mm
3 
with an 
>350-1000 
cells/μl  
65% 
>200-350 
cells/μl  
17% 
3-≤200 cells/μl  
9% 
Do not know 
9% 
Average : 419 cells/μl   
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average of 419 cells/μl. Only 64% had a CD4+ cell count of > 350 cells/μl and (27%) had 
≤350 cells/μl, such as 3-200 cells/μl (9%), and >200-350 cells/μl (17%), qualifying these 
patients to be on ART and not in the pre-ART program at the time of the study. The majority 
of those with CD4 cell count <350 were attending recommended ART preparedness 
counselling sessions for ART initiation, while nine percent did not know their CD4 cell count 
levels; when this was checked, I established that their CD4 cell count was not documented in 
their pre-ART files. The one person with a CD4+ cell count of 3cells/mm
3
 had not yet been 
booked for initiation counselling sessions at the time of the interview, and he was referred to 
the service provider for urgent attention as described in the section below. I discuss this 
further below, including in relation to the ethical issues associated with this low cell count. 
In summary, even though the majority (two thirds) of interviewed patients had their CD4 cell 
count checked within the recommended previous 6 months, delays in ART initiation among 
patients retained in pre-ART program was established. 
4.1.3 Patient pathways in accessing pre-ART care services 
In order to understand the patient care pathways, patients were asked to narrate their 
experience of accessing pre-ART care.  The majority (56%) of patients interviewed did not 
test HIV+ at the facility where they were accessing pre-ART care. Due to mobility to and 
within CoJ  (COJ, 2013a, SA, 2015a), some patients tested positive in a facility nearer to 
where they used to stay, and they received a formal transfer letter to the current facility after 
they moved. In addition, SA had a large HIV Counselling and Testing (HCT) campaign, 
launched in December 2009 by the president and encouraging all to be tested and know their 
HIV status (Zuma, 2009). Since then, some non-governmental organisations have started 
mobile HIV testing in busy spots in the city, such as at taxi ranks and markets. As a result, 
some patients interviewed had tested positive at a mobile clinic and were then referred to the 
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facility for CD4 cell count checking and follow-up. None of the study sites at the time of 
interview provided patients with immediate CD4 cell results; rather, people were asked to 
come back to collect their CD4 count results after 2 weeks. In this section, I present three 
diagrams on patient‟s experience, reflecting two patients who had defaulted from care and 
another who had not defaulted, despite considerable challenges.  
4.1.3.1 “Committed to accessing pre-ART care regardless of access challenges”: The story of 
Lusungu 
Lusungu (pseudonym) was a 33 year old man.  He was single.  He had continued his 
education to secondary school, and was working for a construction company at the time of 
interview. On the day of interview, he came to the clinic for a CD4 cell count check. Lusungu 
had tested HIV+ at a taxi rank mobile clinic run by WRHI in May 2009, and he had been 
referred to the study site clinic to check for CD4 cell count levels and for referral to care. 
Two months after testing positive, in July 2009, Lusungu reported at the clinic, his CD4 cell 
blood sample was taken and he was asked to come back in two weeks for the results. After 
two months, in September 2009, Lusungu came back to collect the results. These were 
missing, and as a result, he had to give another sample of blood for a CD4 cell count, and to 
come back again in two weeks for results. 
Lusungu went back to the clinic after four weeks in October 2009 to get the CD4 cell count 
results, which was at 900 cells/μl. On that day, he was registered for pre-ART care, screened 
for TB (which he did not have), was put on IPT to prevent TB infection, and was provided 
with a supply of multivitamins. In December 2009, he returned for multivitamins and was 
told that they were out of stock; he would have to come back the following week when the 
tablets would be available. Lusungu did not return until July 2010, when his CD4 cell count 
was redone. He was then supplied with multivitamins, and advised to return in two weeks for 
the CD4 cell count results. 
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When Lusungu came back for the CD4 cell count results after four weeks in August 2010, he 
was advised that he had a CD4 cell count of 950 cells/μl. Lusungu reported that he was 
delighted by this improvement – “When I learnt that my CD4 cell count was higher than 
before, I was very happy!” Lusungu returned again after about nine months when his CD4 
cell count was rechecked and more multivitamin tablets distributed. The CD4 cell count at 
this time was not known as Lusungu did not mention it and it was not documented in the file. 
Lusungu then did not come back for CD4 cell count results for 17 months, until the day of 
interview.  His March 2011 results indicated that his CD4 count had dropped to 450 cells/μl 
from 950 cells/μl; he was due for another CD4 cell count check on the interview day. 
Lusungu was worried because his CD4 cell results 16 months earlier (in March 2011) had 
dropped by 500 cells/μl from those of July 2010: “I am very scared, maybe my CD4 cell 
count has dropped further by now. Maybe I need to start taking the serious HIV medication!” 
Lusungu regarded multivitamins and IPT as “not serious” medications, but he considered 
ARVs as serious HIV medication.  
Lusungu‟s pathway captures how patients are asked to come back for blood results, 
especially CD4 cell counts, and how loss of blood results and drug stock-outs result in 
patients having to make multiple visits. Even though Lusungu did not return precisely at 6 
monthly intervals for CD4 cell count visits, he was still retained in care three years after 
diagnosis. Lusungu‟s care to pathway is summarised in the figure below. 
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Figure 4.2 Lusungu’s pre-ART care pathway 
Lusungu explained to the interviewer that he had disclosed his HIV+ status to his partner but 
not to parents, family and friends. He was very knowledgeable of the difference between HIV 
and AIDS. Even though he was not able to explain the meaning of the CD4 cell count, later 
this was explained to him by the interviewer, Lusungu knew that a CD4 cell count of ≤350 
cells/μl meant that a person would need to start ART. He reported that his main source of 
information was the facility counsellors. 
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Lusungu‟s knowledge levels around HIV and ART were good. Lusungu knew that he needed 
to use condoms even if both he and his partner were HIV+. As noted above, he knew that if 
his CD4 cell count reached < 350 cells/μl, he would have to start ARVs, and that this would 
help him feel better and live longer. He was not aware of which room to go to for ART 
Initiation but he did understand the implications of treatment:  “My friend told me that if time 
comes for me to start real treatment, I will go to one of the rooms on that side but am not sure 
of the exact one.” What I know is that after I start taking ARVs, I am not supposed to stop 
even if I feel better.” However, he was not aware of the services available for HIV+ 
individuals not yet eligible for ART, despite accessing some of these services. He explained 
that no one had told him about such services. 
Lusungu was able to describe what male and youth friendly services were supposed to be, 
and stated that the facility was not friendly to youths or to men. The main reason for this 
perception of unfriendliness was that there were no fast queues for youths, which would cater 
for young people going to school, or for men who were working. Lusungu also referred to 
drug stock-outs and long waiting times: “Tablets are always out of stock and delays of 
services lead to waiting for much longer time.”  
Lusungu had ideas about possible solutions to the above gaps: use of a patient appointment 
booking system so that a patient only needed to come in at the booked time, the facility to 
have youths serving youths and men serving male patients, and fast queues for youths and 
working men especially in the morning. Lusungu believed that men need to be scared to force 
them come to access care as reflected in this quote: “Give HIV pamphlets to men to scare 
them so that they come to take their treatment.” 
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4.1.3.2 “I was still in denial”: Nabanda 
Nabanda was a 37 year old woman, married and living with her partner. She had remained in 
school until Grade 5 (upper primary school) and was working as a domestic worker. In 2008, 
Nabanda fell pregnant. In July 2008, when she went to the clinic for Antenatal Care (ANC), 
she was offered an HIV test as an entry point to PMTCT and she tested HIV+. If she were not 
pregnant, Nabanda would not have had an HIV test. She disclosed her HIV+ status to her 
partner and he also tested positive for HIV. 
Nabanda had defaulted from pre-ART care, and was traced to be interviewed during the data 
collection period. When Nabanda‟s knowledge levels around HIV/AIDS were assessed, she 
was able to differentiate HIV and AIDS, and she knew that one could get married and have 
an HIV- baby even when the person was HIV+. She was also able to explain what a CD4 cell 
count meant, and that one needed to start ART if the CD4 cell count was at <350 cells/μl. She 
also gave a good definition of ART, although she was not sure where she had to go if she was 
to start ART. “I was not aware of all the available pre-ART care services even though I 
accessed the PMTCT program and multivitamins.” She had limited knowledge of the youth 
and male friendliness of the health facility.  Even though the source of information for her 
HIV/AIDS knowledge was the counsellor in the clinic, she proposed that the best way to 
sensitise people about pre-ART care services was through community sensitisation and clinic 
health talks.  
Even though she went through counselling sessions, Nabanda claimed that she was “still in 
denial.” On the first visit, she was asked to join a PMTCT program. At that time, according to 
the PMTCT guidelines, Nabanda received AZT and her blood was taken for a CD4 cell count 
and she was asked to come back after 2 weeks for the results; if the CD4 cell count was ≤350 
cells/μl , she was advised that she would start the lifelong ART.  
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Nabanda reported that even though she was “in denial‟ about being HIV+, she still joined the 
PMTCT program for the sake of her unborn child. When she came back for the CD4 cell 
count results, Nabanda reported that her CD4 cell count was very high, although she could 
not remember the exact count level and this information was not recorded in her file. At that 
time, according to the current PMTCT guidelines, she continued on AZT and was advised 
that if she chose to breastfeed after delivery, she would continue to remain on AZT until the 
child stopped breastfeeding. Nabanda commenced treatment on the PMTCT program and 
delivered her baby in November 2008. During the period of pregnancy and delivery, she 
came to all scheduled visits, including the visit held six weeks after delivery, when the baby 
was tested for HIV through a PCR test. When she came after two weeks for the PCR test 
results, she was told that her baby was HIV negative.  
That same day, Nabanda registered for pre-ART care and was given six months‟ supply of 
multivitamins. Since that day, she had never returned to the clinic and she decided to stop 
breastfeeding her baby. Nabanda went back to work, and her mother assisted her by taking 
the baby to the clinic until all immunisations were complete.  
Nabanda stopped receiving care because, she said, she was “in denial” that she was HIV+: 
she explained that “I was not ready to be tested and I did not believe I could be HIV+!” In 
addition, she felt the quality of counselling given to her did not provide all the information 
that she needed, and the attitude of the service provider was not that good: “The nurse who 
assisted me was also not very nice to me.” She did not provide examples of why she thought 
this.  
Nabanda said she tested to protect her baby from becoming HIV+ and since the baby was 
HIV-, she felt that she had no reason to continue with pre-ART care. Below is a graphic 
presentation of the pathway of access to the care for Nabanda: 
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Figure 4.3 Nabandas’s pre-ART care pathway 
From the time Nabanda defaulted from care, until the time she was traced and asked to come 
to the clinic for an interview to share her experience, she had not been followed up by a 
service provider. After data collection, she was followed up and after further counselling, she 
returned to care for regular monitoring.  
4.1.3.3 “But I tested HIV+ on time”: Chisomo 
Pre-ART care is aimed at people who test HIV+ and have high CD4 cell counts, and care 
includes monitoring their CD4 cell levels so that ART can be initiated on time. However, 
many patients are lost to pre-ART care, or return to care when they are already ill (Lessells et 
al., 2011). In addition, as already noted, patients seek care from different sources, and this has 
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been shown to delay access to ART (Moshabela et al., 2009, Pantelic et al., 2015). The 
participant with the lowest CD4 cell count is described in the case study below, to highlight 
factors leading to his delay in ART initiation. 
Chisomo (pseudonym) had been enrolled into pre-ART care, and when he was interviewed, 
he had an exceptionally low CD4 cell count level of 3 cells/μl. Chisomo was 38 years old, 
and married. He had attained a secondary level of education and had a full time job as an 
accounts clerk at the time of interview. He said he had learnt about the HIV services provided 
at the facility through a friend, in 2008, and he came to the facility to be tested. He tested 
HIV+.  At that time his CD4 cell count was 950 cells/μl. He was told that he was not eligible 
to start ART, but that he should come regularly for multivitamins and CD4 cell count 
monitoring. 
Because he was employed full time, Chisomo found it difficult to come to the clinic, and so 
sought care from private general practitioners whose clinics were open at weekends when he 
was off work. As a result, he was able to find time to access care: “I had a full time job. As a 
result I was not able to come to this clinic; as you know, they only open during the week from 
8-4pm. To save my job, I had to seek care from private clinics.”  
Chisomo did not go to one specific clinic, but changed clinics from time to time, leading to a 
lack of continuity of care. Although asked, he could not give any reason for switching 
doctors. At the private clinics, he mentioned that he was prescribed multivitamins, but could 
not always afford to purchase these. Because of the costs involved in having his CD4 cell 
count checked at a private laboratory, he did not monitor his CD4 cell count levels between 
the initial count in 2008 and when we met in June 2012. 
Early June 2012, the private practitioner emphasised to Chisomo the importance of checking 
his CD4 cell count, as clinically his health was deteriorating and the doctor felt that he might 
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need to start ART. Chisomo decided to look for money, and tested for the CD4 cell count 
level which was 03 cells/μl. Chisomo was immediately referred back to the public health 
clinic to be initiated on ART as he could not afford ART in private facilities.  
To be able to attend the public health facility clinic, Chisomo had to take time off from work. 
According the SA ART guidelines at the time of the interviews, before ART initiation, 
patients were supposed to receive three ART readiness counselling sessions, and to have 
routine baseline blood samples done before ART initiation (SA, 2013d). On the day of the 
interview, Chisomo reported that he had been coming to this facility for the past three days, 
but the ART baseline bloods had not been drawn. He also reported negative staff attitudes: “I 
have been here since Monday, but not yet initiated on ART. The staff attitude is bad, I 
approached one of the nurses and he said he cannot help.”   
When questions were asked about his knowledge around the meaning of HIV/AIDS, and 
prevention when a person was HIV+, Chisomo could not identify the difference between HIV 
and AIDS, nor did he understand the need to use a condom if both partners were HIV+, 
although he had disclosed his HIV+ status to his partner. In addition, he could not define or 
explain the meaning of CD4 cell count, although he knew what ART meant and he knew the 
room where he was supposed to go to be initiated on ART. He thought that ART would cure 
him of HIV, and that he could stop taking ART if he felt better. At the end of the HIV/AIDS 
knowledge and pre-ART and ART service awareness section of the interview, after 
identifying major knowledge gaps, the interviewer, a trained HIV/AIDS adherence 
counsellor, conducted a counselling session with Chisomo in order to address the identified 
gaps. 
Chisomo also had little awareness of available pre-ART care services. He considered the 
main gaps in pre-ART service delivery to be long clinic waiting time, negative staff attitude 
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and poor integration of services, and he recommended that the facility reduce the waiting 
time and integrate pre-ART services; although there were no longer relevant to him, they 
could be relevant to his partner and others accessing pre-ART services. For example, he 
argued for integrating adherence counselling and bloods in the same day: “Reduce waiting 
time. Do everything to the patient in one day not making patient come back and forth for 
different services taking for ever; for example, combine adherence counselling with blood 
checking.” Even though he was aware of HIV counselling, testing, CD4 count tests, and ART 
services delivered at the clinic, he was not aware that the facility also had PLWHA support 
groups, IPT, adherence and disclosure counselling, and PMTCT services, nor that it provided 
nutritional and social grant support, even though his main source of information on available 
pre-ART services was from clinic counsellors. Chisomo proposed counselling, IEC materials, 
community sensitisation, and health talks as ways to sensitise people to the available pre-
ART services. 
I had joined the interview in the course of the discussion around challenges in accessing care, 
and, as indicated above, Chisomo‟s CD4 cell count was 3 cells/μl – an unimaginably low 
level. Chisomo looked very sick, and had a severe skin rash; skin was flaking from his body 
and there was some discolouration on his face.  I intervened, asking one of the service 
providers to attend to him as a matter of urgency.  I negotiated with the PHC nurse to assist 
so that blood was drawn. Whilst we were not yet through the questionnaire, Chisomo was 
called in to give bloods for ART initiation preparation, and we could not continue with the 
interview. Below is a figure showing Chisomo‟s pathway to accessing care 
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Figure 4.4 Chisomo’s pathway to care 
The above figure summarises Chisomo‟s story as described, reflecting the fact that he tested 
HIV+ on time with a high CD4 cell count, he then defaulted from public health clinic care 
and instead accessed care through different private clinics, and only returned back into care 
when he was extremely ill. 
4.1.3.4 Analysis of pre-ART patients’ pathway to care 
None of the 73 interviewed patients gave an account of a pathway to care that fitted directly 
with the WHO/SA Guidelines of pre-ART care, that is, no one gave an account of care that 
included all elements: 6 monthly CD4 cell count check, access to IPT if they had no 
symptoms of TB, and accessing the prescribed pre-ART care services as outlined in chapter 3 
above.  Major challenges to accessing pre-ART care have been identified in this study. These 
challenges were related to patients themselves, service providers and health systems 
consistent with the conceptual framework illustrated in figure 2.3. These challenges will be 
discussed further in chapter five. 
In 2008 Chisomo tested HIV+ at 
the clinic,  
CD4 cell count at 950 cells/μl to 
joint pre-ART for regular 
monitoring 
2008-2012  - different private 
clinics  
In June 2012 CD4 cell count check 
prescribed  at private clinic 
End June CD4 cell count checked 
at private clinic and was 03 
cells/μl. Chisomo refffred back to 
the puclic clinic for ART initiation  
First week of July 2012 - 
Chisomo reporting to study site 
for 4 days trying to access ART 
(Patient interviewed on his 4th 
day visiting the clinic) 
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The timelines of the processes involved in accessing care were compromised in this study, as 
many patients could not remember the exact months each step took place. However, 
interviewers tried to verify the narratives with what documentation was on file. Not all of 
what was said by patients during interviews was documented in their files, and this made it 
difficult, especially when other care was accessed outside the current facility.  
4.1.4 HIV/AIDS knowledge  among pre-ART care patients 
Basic HIV/AIDS knowledge levels were established among pre-ART patients participating in 
this study. In order to establish the association of knowledge levels and retention 6 monthly 
CD4 cell check-up was used as a proxy for retention, as shown in the table below: 
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Table 4.3 Basic HIV/AIDS knowledge and six monthly CD4 cell count check-ups 
Variables No (%) 6 monthly 
CD4  
No  6 
monthly 
CD4 
P 
value 
All respondents 73 (100) 50 (68.5%) 23 (31.5%)  
Patients’ knowledge about HIV/AIDS (Meaning and prevention when HIV+) 
HIV is the same as AIDS (False) 20 (27) 17 (85%) 3 (15%) 0.062 
Do you have to use a condom use when both of 
you are HIV+? (yes) 
28 (36) 8 (35%) 15 (65%) 0.67 
Having a normal life after being HIV+ 
Can one still get married whilst HIV+? (yes) 23 (38) 15 (87) 15(13) 0.03 
Can one have a baby whilst HIV+? (yes) 51 (70) 41 (82) 10 (18) 0.001 
Patients knowledge about CD4+ count  
What is the CD4+ count cut-off point for one 
to start ART (< 350) 
41 (56) 13 (26) 28 (58) 0.79 
Knowledge/awareness of Pre-ART services  
Which of the following services are provided in this facility? 
PLWHA support groups (yes)  15 (21) 10 (67) 5 (33) 0.86 
CD4 cell count monitoring (yes)   69 (95) 50 (72) 19 (28) 0.6 
IPT (21/73) 21 (29) 14 (67) 7 (33) 0.83 
Nutritional supplements (food items)  12 (16) 10 (83) 2 (17) 0.23 
Multivitamin supplements  69 (95) 52 (75) 17(25) 0.71 
HIV counselling services  52 (72) 36 (69) 16 (31) 0.73 
ART Knowledge 
If you had to start ARVs, do you know which 
room to go to be initiated on ART? (yes)  
48 (66) 12 (25) 36 (75) 0.097 
ART will cure me of HIV (False) 19 (26) 13 (68) 6 (32) 0.99 
I can stop the ARV drugs once I am feeling 
better (False) 
18 (25) 11 (61) 7 (39) 0.44 
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As shown in the above table, HIV/AIDS knowledge gaps among pre-ART patients were 
established and compared to the CD4 cell count checked within the last 6 months. I describe 
these further below. 
4.1.4.1 Patients’ knowledge about HIV/AIDS  
The knowledge levels of the pre-ART care patients on the meaning of HIV/AIDS, prevention 
when HIV+, and disease progression from HIV to AIDS were assessed.  Less than half (36%) 
of the patients knew that there was a need to use a condom when both partners were HIV+.  
There were no differences in 6 monthly CD4 count check between those knowledgeable or 
not knowledgeable about the meaning of HIV/AIDs and prevention. 
4.1.4.2 The fact that one may have normal life after being HIV+:  
Patients were asked about their perception that one could lead a normal life after being 
diagnosed HIV+, through getting married and having an HIV- baby. Patients‟ perceptions of 
leading a normal life after being diagnosed HIV+ were analysed to establish its association 
with pre-ART care adherence, retention and access to 6 monthly CD4 cell count check-ups. 
Less than half (38%) of the respondents thought one could get married, but over two thirds 
believed that a person who was HIV+ could have a baby who was HIV-. Those who reported 
that one could live a normal live through getting married (P=0.03) and having a baby 
(P=0.001) were more likely to have had their CD4 cell count checked within the last 6 
months.  
4.1.4.3 Patients’ awareness of the available pre-ART services 
In my earlier study on access to PMTCT services among pregnant women in Malawi, I 
established that awareness on the available services affects access to and utilisation of 
services (Nyasulu and Nyasulu, 2011). In this study, I sought to establish whether pre-ART 
care patients were aware of the available services. In both study sites, the facilities provided 
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all pre-ART care services as prescribed by the SA Guidelines (see chapter one) However, 
lack of awareness of available pre-ART care services was established as only a few knew 
about the available PLWHA support groups (21%), IPT (29%), or knew about nutritional 
supplements (16%). The majority (95%) were aware that multivitamin tablet supplements 
were provided and that CD4 cell count monitoring took place in the facility. 
4.1.4.4 ART Knowledge  
Knowledge gaps among patients around ARVs were also established. Patients who are 
initiated on ART are expected not to stop treatment when they feel better, as ARVs do not 
cure HIV/AIDS. In this study, only 26% of interviewed patients knew that ART would not 
cure HIV, and 25% thought they could stop taking ARVs if they felt better. In addition, 
patients need to know which room to go to be initiated on ART when eligible, but only 68% 
of the pre-ART patients interviewed knew which room they would go to, for this purpose. 
4.1.5 Services accessed by participants 
  
Figure 4.5 Pre-ART services accessed by interviewed patients 
Patients were also asked about the services they accessed during the period they were 
attending pre-ART services, as shown in the figure above. Even though pre-ART care 
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services are supposed to be provided as a comprehensive package of care, interviewed 
patients retained in care did not receive all prescribed services. Multivitamin tablets and CD4 
cell count monitoring were the minimum package of care given to patients. As a result, 
almost all interviewed patients received multivitamin tablets and had been checked for CD4 
cell count at least once, the majority (68%) had received HIV counselling, and about a third 
each (35% and 33%) had received IPT and adherence counselling services. The South 
African Government has a social grant system aimed at improving the living conditions of the 
disabled and poor, which includes PLWHA (Mitra, 2010). In addition, health facilities 
distribute nutritional food items to PLWHAs who are in need. At times they also refer the 
PLWHAs to community based organisations and structures that provide PLWHA support. 
However, very few had accessed care to receive a social grant (5%), community referral 
(7%), or nutritional services (17%) and only 10% had attended a support group. 
4.1.6 Patients’ awareness and access to available services 
  
Figure 4.6 Access and awareness of the services among pre-ART patients 
In order to establish patients‟ awareness and access to the available pre-ART care services, I 
compared the relationship between awareness and uptake of the specific pre-ART care 
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Awareness
Access
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services graphically, as shown above. As illustrated, access to services is slightly higher than 
awareness except with HIV counselling services, where access is slightly lower than 
awareness. Generally, the uptake of services was directly related to awareness of the 
available services.  
4.1.7 Sources of HIV/AIDS information  
Participants were asked about the sources of information in relation to HIV/AIDS, CD4+ cell 
count, pre-ART and ART care. Their main sources of information in the facility are set out 
below: 
  
 
The majority (80%) mentioned counsellors as the main source of information in the facility 
and nurses were mentioned least often (14%). Information, education and communication 
(IEC) materials accessed in the facility, and friends and/or fellow patients, were mentioned 
by 54% and 47% respectively.  
14% 
80% 
47% 
54% 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Nurse Counsellor IEC materials Friends or fellow
patients
Note: Total>100% due to multiple responses 
Figure 4.7 Distribution of sources of information 
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4.1.8 Disclosure of participants’ HIV status 
Understanding factors that affect disclosure among pre-ART patients is critical in planning 
for interventions that would promote disclosure to ensure adherence. In this study, I 
established the number of patients who disclosed their HIV+ status and analysed this 
response to establish the association between disclosure of one‟s HIV+ status and their socio-
demographic characteristics.   
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Table 4.4 Disclosure of participants’ HIV+ status among interviewed pre-ART patients 
Disclo
sure of 
HIV 
status 
to: 
N=73 
N (%) 
Demographic characteristics 
Gender Employment Age Marital status Educational level 
Male 
(30) 
Female 
(43) 
Yes 
(13) 
No  
(60) 
Youths 
(23) 
Adult 
(50) 
Married 
(25) 
Not Married 
(48) 
Illiterate 
(9) 
Literate 
(64) 
Partner  54(75) 23(77) 31(72) 10(78) 39(53) 17(74) 37(74) 18 (72) 36 (75) 6(66) 48(75) 
PValue N/A 0.8 0.05 0.99 0.8 0.6 
Friend 24(33) 13(43) 11(25) 7(53) 17(28) 10(43) 14(28) 7(28) 17(35) 1(11) 23(35) 
PValue N/A 0.1 0.04 0.2 0.5 0.1 
Family 40(55) 17(57) 23(53) 6(46) 34(57) 10(43) 30(60) 18(72) 36(75) 4(44) 36(56) 
PValue N/A 0.8 0.5 0.2 0.8 0.5 
 
Pre-ART patients were asked whether they had disclosed their HIV+ status to someone, and 
the following was established: the majority of patients (74%) had disclosed their HIV+ status 
to their partners, 55% to family and 33% to friends. Those who were employed were more 
likely to disclose their HIV+ status to their partners (p=0.04) and friends (p=0.05) than were 
people who were unemployed.  
4.1.9 Identified gaps 
Participants were asked to identify gaps with possible solutions in the existing pre-ART 
program, which might be relevant to developing recommendations for an appropriate pre-
ART care program to promote timely ART referral and retain patients in the program. The 
questions to elicit information on these gaps were open-ended, and as a result, qualitative data 
were generated. These gaps were classified into three categories: patient, staff and health 
systems related gaps.  
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4.1.9.1  Patient related gaps 
Time spent to attend clinic  
At the study sites, PHC facilities operate between 7.30 am to 4.30 pm, as illustrated below. 
 
Figure 4.8: Clinic signage for the clinic opening hours 
These hours were reported to be the normal working hours for those participants who were 
employed, as for those undertaking piece work or casual employment, and this was also the 
time when those who were not employed sought jobs. The majority of patients reported 
having difficulty in finding time to visit the clinic, as it was difficult to get time off from 
work or to interrupt job seeking: 
Taking time off from work on monthly basis is a challenge (PI, M, # 32);  
The truth is that I stopped coming here because most of the time I look for jobs (PI, F, 
# 49). 
Time spent on attending pre-ART services also translated into costs, for example time spent 
travelling to and from the clinic and waiting for services is costly for those who had to pay 
for public transport and whose salaries were deducted if they took time off work. 
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Tablets are always out of stock! As a result we have to come here many times. To find 
time off to come here is a salary deduction and even the transport money is expensive 
(P1 #05). 
We do appreciate that these services are free but truly speaking, we still need money 
for our transport and when we spend time here instead of working we also lose money 
(PI, M, # 42). 
When patients were asked about the possible solutions to address the identified gaps in pre-
ART services, many mentioned having flexi-hours with services provided outside of normal 
working hours. Others thought of innovations whereby pre-ART care patients could receive 
their multivitamins outside the facility, or just collect them quickly without spending much 
time at the clinic: 
To tell the truth, if these services were provided outside our working hours, many of us 
would not be missing our appointments (PI, M, # 19). 
We are not sick people. Why can‟t they make it fast when we come to collect 
medication, just come to the clinic, pick-up medication and off we go without waiting? 
(PI, F, and # 26). 
The staff must schedule medication collection accommodating client‟s time table for 
example those who are working or self-employed staff to be seen either first thing in 
the morning or last thing in the evening (PI, M, # 42). 
I wish we would just collect these medications from somewhere. For example, a certain 
place without coming to the clinic, that would reduce our clinic visits and maybe we 
need to only come here once a year for blood check-ups (PI, M, # 61). 
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Privacy and Confidentiality 
Patients felt that pre-ART care clinic visits had the potential to compromise privacy and 
confidentiality related to their HIV+ status. This breach of confidentiality was mainly a 
concern among men, as women were able to access clinics easily while healthy for services 
like family planning, bringing children to under-five clinics, and accessing other children‟s 
services. Men‟s clinic visits are mainly associated with sickness. Most patients in the pre-
ART care program were healthy, and patients who were interviewed believed that clinic 
attendance especially among men created a suspicion among others that the person was 
HIV+. 
Women have many reasons to come to the facility, like family planning injections and 
tablets; they can bring children whilst we men mainly come here when we are sick (PI, 
M, #20). 
If I keep coming to the clinic every month, people will know that there is something 
wrong like HIV. You know people are always suspicious! (PI, M, #38). 
The other point is the fact that; who wants people to see him/her at the clinic now and 
again? They will make their conclusion that we have AIDS and yet we are not sick! (PI, 
M, #53 – youth). 
The possible solutions to address breaches of privacy indicated by participants mainly 
focused on ways to reduce the number of facility visits, as well as reducing the time spent in 
the facilities. Patients proposed some innovative ideas to address this: 
The best is to look at ways that would reduce the number of visits we come to the clinic 
or making us not come to the clinic at all- like collect the vitamins from somewhere 
outside the clinic and only come once a year for blood check-ups (PI, M, #40). 
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Just pack our medication so that when we come to the clinic, we can just pick-up then 
pack and go without waiting at all (PI, M, #10). 
Not ready to test for HIV 
In all CoJ PHC facilities, people are tested for HIV either after voluntarily coming to the 
facility to be tested or through provider-initiated counselling and testing (PICT), whereby the 
service providers initiate the HIV testing conversation and offer services to the patients. For 
example, all pregnant women accessing ANC services are offered HIV testing on their first 
and consecutive ANC visits to ensure that they access PMTCT services in the event that they 
are HIV+. If they test positive for HIV, service providers are expected to provide them with 
post-test counselling, which includes the meaning of HIV/AIDS, modes of transmission, and 
how it can be prevented. Referral options are also offered to patients, for example, if a patient 
is positive, he or she can be referred for a CD4 cell count check, TB screening, clinical 
staging or pre-ART care, according to the SA Guidelines (SA, 2010b). In this study, some 
participants who tested positive through Provider Initiated Counselling and Testing (PICT) 
felt they were not ready to test:   
I tested because I was pregnant and I had to use PMTCT for the sake of my baby. I was 
not well counselled and given all the needed information from clinic staff. I was not 
ready to be tested and I did not believe I could be HIV+. I then stopped coming to the 
clinic because I was still in denial. (PI, F, #60). 
Other non-PMTCT patients whose HIV testing conversation was initiated by service 
providers also reported that they were not prepared to test on the day they tested. Some 
participants looked at this as being “taken by surprise,” as shown in the quotation below: 
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You know what, my brother (referring to the interviewer), it is very difficult to make a 
decision to come here and test for HIV especially when you doubt that you may have it. 
Like me I was just taken by surprise to be asked to test for HIV while I came here for 
another illness! Unfortunately, I tested positive (PI, M, #6). 
4.1.9.2 Staff related gaps   
Shortage of staff 
Patients mentioned shortages of staff as a major gap in delivery of pre-ART care influencing 
access to care with long queues of people waiting to be seen by one clinician. We established 
that in these clinics, each professional nurse (PN) was consulting an average of about 50 
patients per day, significantly above the 40/PN/day recommended by the Department of 
Health (DoH) as the maximum. The average waiting time was three hours at the time of the 
study, again higher than the DoH recommended two hours.  
 
 
As shown above (Figures 4.9a and 4.9b), there were long queues of patients waiting to be 
seen by the service providers.   
Figure 4.9a Patients in a queue outside the clinic Figure 4.9b Patients waiting for services inside the clinic 
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There is too little staff and too many clients. As a result, we wait for too long in the 
queues. There is need to hire more staff (PI, M, # 19). 
There is too long waiting time. Imagine, people waiting for three hours without 
someone in the consultation room. (PI, M, #12). 
The services are too slow and the facility looks short staffed (PI, F, #7). 
Increasing the number of staff was the most common proposed solution to address their 
perceived shortage. In addition, some innovative solutions on enabling patients to collect 
their medication outside the facility were seen as reducing the workload on the service 
providers.  
Staff attitude 
Staff attitude is a ministerial priority area of the South African Government in the delivery of 
all health services  (SA, 2011b). In this study, negative staff attitudes and rudeness towards 
pre-ART care patients were reported by some of the interviewed patients. A number of 
patients narrated how negative staff attitude made them feel stigmatised and discouraged 
them from coming to access pre-ART care services, as shown in the quotes below, including 
from one woman who dropped out of care and had to be traced back for an interview: 
When I came back for my CD4 count check-up, the nurse became rude to me, and I felt 
stigmatised, hurt and disappointed. The clinic staffs are not welcoming and as a result, I 
decided not to come back. After all, I am not sick, my CD4 count is still high (PI, F, # 
62). 
Staff attitude to us as patients is not good. There is need for staff to love and have 
positive attitude towards HIV+ patients. Staff must be friendly to patients (P1, M, #14). 
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Customer care is poor and patients are being shouted at (P1, M, and #18). 
Quality of counselling 
According to the SA HIV Counselling and Testing Guidelines, during each HIV pre- and 
post-test counselling session, the service provider is expected to provide the patient with all 
the information on HIV/AIDS, including its definition, modes of transmission and how it can 
be prevented. Referral options are also offered to patients. For example, if a patient is 
positive, he or she is post counselled and then referred for a CD4 cell count check, TB 
screening, clinical staging or pre-ART care (SA, 2010b). Patients are given a chance to ask 
questions for clarity of the information given and any other HIV/AIDS related knowledge 
areas. For successful pre- and post-test counselling sessions, service providers are expected to 
be knowledgeable and well conversant about HIV/AIDS knowledge area. In this study, 
participants felt service providers, especially counsellors, showed major HIV/AIDS 
knowledge gaps during counselling sessions, even though they reported the counsellors to be 
the main source of HIV/AIDS information. Below is a quote from a patient interview, in 
response to questions on the difference between HIV and AIDS and whether ART could cure 
HIV or not; after the interview, the interviewer addressed all the questions from the 
participant: 
The fact is that a lot of information is not given to us as patients during counselling 
sessions. Some of the counsellors seem not to know what they are telling us. For 
example I never knew most of the information you have just briefed me … counsellors 
should have more workshops on updated HIV/AIDS information (PI, M, # 16). 
Emphasis was also placed on the need for service providers to prioritise those who have not 
had formal education with HIV/AIDS information, as shown in the quote below: 
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The staffs do not teach us and give us enough information especially for those of us 
who have not done much school (PI, F, # 15). 
In addition, another patient reported that she never received any counselling in the process of 
being tested for HIV and accessing care after testing HIV+.  
I never received any kind of counselling. They took my blood for CD4 count, but I 
never received any kind of counselling to explain what it was. The counsellors told 
me to go home. You have just met me here by chance but I had stopped coming for 
more than a year. (PI, F, #66). 
4.1.9.3 Systems-related gaps 
Loss of CD4 cell count results 
The patients also reported loss of CD4 cell count results.   As described above, after their 
blood was taken for CD4 cell count, patients were asked to come back and collect results 
after two weeks. When they returned to the facility for results, some patients would find their 
results missing and they were asked to either come another time or give another blood sample 
to be resent to the laboratory. As a result, at the time of the interviews, there were patients 
who did not know their CD4 cell count results.  
I don‟t know my CD4 count results. The results are missing and I am here today 
looking for my results (PI, M, # 03). 
Each time I come here, my blood results go missing now my file is missing (PI, F, 
#30). 
For example, a 20 year old girl indicated that after being in the program for 18 months, she 
has never had her CD4 cell count results:  
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I was checked for CD4 count 18 months ago but up to now I don‟t know the results 
because they got lost. I never wanted to check again because the hand from which the 
blood was drawn is still sore. After all I do not want to start ARVs now (PI, F, # 13). 
Youth unfriendliness 
In this study, youth friendly services (YFHS) were defined in ways consistent with that 
provided by  Baloyi and colleagues (2006), as those services that incorporate all areas of 
young (<24yrs) people‟s well-being, with particular attention to sexual and reproductive 
health (SRH). The majority (56%) of patients and staff interviewed knew the meaning of 
YFHS. For those who did not know, the interviewer defined it to them so that they were able 
to respond to subsequent questions. Seventy percent of interviewed patients reported that the 
facilities were not youth friendly and when asked to elaborate, they stated that youths were 
not put on fast queues, there were no youth peer educators, and youths were consulted 
together with adults. This was embarrassing and delaying.  
There is need for separate youth counselling rooms from adults and recruit youth peer 
educators. It is not nice when they mix us adults with youths. They can‟t feel 
comfortable and may stop coming to the clinic (PI, M, # 20). 
As youths, we wait with everybody in the queue and this is at times embarrassing for 
us, the young ones (PI, M, Youth, # 59). 
There is need to provide peer educators for youths (PI, F, # 52). 
There was also a realisation among respondents that most youths are sexually active, and if 
HIV+ they can easily spread the disease. As a result, they felt that it was important to priotise 
providing HIV+ youths with HIV prevention strategies: 
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More and special attention must be given to us youths, ourselves as youths we must 
also find ways of preventing HIV. As you know us youths, we are young and still 
very active sexually and can easily spread the HIV disease very fast (PI, M, # 53 - 
youth). 
Drug stock outs 
At each clinic visit, pre-ART care patients are provided with multivitamins to be taken 
throughout the pre-ART care period, and those eligible for TB prophylaxis are given 
Isoniazid Preventive Therapy (IPT) for a period of six months. Patients mentioned stock-outs 
of pre-ART medications including IPT and multivitamins, so that they received either small 
quantities or no medication, and were asked to come back at a later time for the medication. 
This led to multiple visits to the facilities, with an increase in the costs of transport and other 
opportunity costs. At times, patients were asked to buy the multivitamins themselves. 
Vitamins are sometimes out of stock and we have to go and come back (PI, F, and # 
38).  
I stopped coming to the facility because each time I came, I would be told that there is 
no medications after standing in the queue for a long time. Then I just gave up (PI, F, 
and # 63). 
When I came again to get vitamins, I was told that there were no vitamins and was 
told to buy from the chemist. It is very expensive to be buying the vitamin on my own 
and I felt I would rather sit back and not come to the facility again. (PI, M, # 61). 
Patients frequently explained the drug stock outs in terms of government system failure and 
the most commonly mentioned solution to address the gap was for the government to take 
action:  
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The government must make sure that all required medications are always available 
(PI, M, # 40). 
Multiple clinic visits 
Pre-ART care involves patients getting multivitamins, CD4 count 6 monthly check ups, IPT 
if they have no TB symptoms, psychosocial support, cervical cancer screening and family 
planning for women, and other services in accordance with the SA pre-ART Care Guidelines 
(SA, 2013d). In this study, it was established that these services were not well integrated, 
leading to patients being given different appointments for different services. This led to 
multiple visits. As a result, pre-ART patients ended up presenting at the facility almost every 
month. Patients found this frustrating and saw this as a particular challenge: 
 Frequency of facility visits must be reduced; they are too many. They give us 
different dates for similar services we can get in one day! Look at me: I am not sick, 
so why should I always be at the facility every month? Something has to be done! (PI, 
F, # 21). 
It would be better if they could give medication every three months as opposed to 
monthly since taking time off from work on monthly basis is a challenge (PI, F, # 32). 
Pre-ART services not prioritized 
The study site facilities provide under-five children wellness services, treat minor and chronic 
diseases, and provide Sexual and Reproductive Health (SRH), TB and HIV/AIDS services 
(CoJ, 2013b). Pre-ART care is rendered as a part of HIV services for individuals who are still 
healthy. Some patient participants felt that because pre-ART patients are usually not sick, the 
service providers pay relatively less attention to them compared with those who are sick. 
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Below is a quotation from a female patient who thought that the service providers gave them 
relatively little attention: 
As you know this facility is very busy. Those of us with high CD4 cell counts are not 
sick and we are healthy. The staffs do not take us seriously so that we remain healthy! 
It is high time that the staff also prioritise us, even though (we are) healthy! (PI, F, # 
21). 
4.2 Pre-ART service providers’ interview results 
4.2.1 Demographic information 
A total of 12 pre-ART care service providers (4 males and 8 females) participated in the 
study, which included facility managers (2), professional nurses (4), administration assistants 
(2), counsellors (2) and one health promoter. Their age ranged from 23 – 46 years, although  
only one service provider was aged < 24years. Three out of nine service providers indicated 
that they were not trained in filling out the pre-ART care register. Almost all service 
providers were aware of the available pre-ART care services in the facilities. 
4.2 Awareness and recording 
Even though the majority of pre-ART care patients were unaware of the available pre-ART 
services at the facility, almost all service providers (11/12) were able to mention all the pre-
ART services rendered in the facilities. Providers were able to describe their involvement in 
the delivery of pre-ART services, and most of them (10/12) reported that the pre-ART care 
patients were aware of all available pre-ART care services. 
In the study sites, the facilities had nurses, counsellors, health promoters and administration 
clerks working in pre-ART care on a day-to-day basis, whilst the other staff categories like 
doctors, social workers, psychologists and dieticians could be accessed by patients on request 
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upon referral. All staff respondents reported that the facilities did not have enough staff to 
deliver pre-ART services.  
4.2.3 Patient access to care pathway 
When the pre-ART service providers were asked to describe the pathway by which patients 
with >350 CD4 cell count could access care in the facility, they were able to describe the 
process as below:
 
Figure 4.10 Pre-ART patient care pathways as reported by service providers 
The challenges in patients accessing these services, mentioned by the services providers, 
were shortage of staff, with an example of having no nurse to see pre-ART care patients at 
times (a similar example given by patients in the section above), and stock outs of 
medication, whereby patients are requested to buy their own multivitamins or were asked to 
come back when stocks were available. No staff members mentioned loss of blood results to 
be a major challenge, although this was reported by patients themselves. 
4.2.4 Referral systems 
The main referral points for complicated pre-ART care patients mentioned by service 
providers were Hillbrow Community Health Clinic (CHC) and Charlotte Maxeke Academic 
Hospital. Although the study sites had contact persons for their referral sites, the service 
Testing HIV+ 
CD4 cell count 
check 
To come back 
after 2 wks 
If CD4 cell count 
>350 referreal to 
pre-ART care 
Monitoring and accessing 
pre-ART services 
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providers reported that they do not get feedback on what happened to patients.   One of the 
respondents reported that this was a lost learning opportunity: 
When we refer patients to these facilities there is poor feedback system. There is need 
to give us feedback on what happened to the patients, because we can learn on how 
patients are managed at that level (SI, # 1). 
The interviewed staff reported that the Department of Health provides transport for patients 
to go to referral sites. However, they also reported that at times patients would wait for 
transport for the whole day to go to the referral sites. By the time they arrived at the referral 
sites, the outpatient departments would already be closed. 
4.2.5 Pre-ART services information systems 
All pre-ART service providers mentioned that they were involved in the collection and 
collation of pre-ART related data at different levels, for example, the data clerk was 
responsible for the registration of patients, the counsellors and nurses recorded data on their 
daily service registers as they consult with patients in the consultation rooms. The facility 
managers indicated that they were responsible for the collation of data on a weekly and 
monthly basis, for monthly submission to DHIS by the seventh of each month. The main 
concern raised by the majority was the fact that there was too much documentation, and that 
this took up a lot of health service providers‟ time: 
Each one of us knows our roles in pre-ART, for example, I as a professional nurse, I am 
responsible for clinically assessing the patient and depending on my judgement, make a 
plan of care like supply patient with multivitamins, IPT or check CD4 cell count. I am 
supposed to record everything in the registers, bloods file, patients‟ file tally sheet, 
there is just too much recording, taking away much time we can use to see more 
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patients, but I have to do it as at the end the facility manager will need stats from me 
(SI # 2). 
There is too much work mainly due to too much administrative work involved in ART 
services (staff interview # 10). 
4.2.6 Comparison of pre-ART and NIMART services roll-out  
Some of the service providers we interviewed were already working in the CoJ facilities at 
the time ART and pre-ART were rolled out in the facilities and so were able to compare the 
two. Service providers who had been employed at the time of ART and pre-ART roll-out in 
2004 felt that not much focus had been placed on decentralizing pre-ART services to PHC 
facility nurses, as there were no clear cut guidelines and the nurses themselves were not well 
trained in pre-ART care: 
 We as nurses, from the beginning, we were not well oriented and capacitated for pre-
ART services. I felt like they left us to swim from the deep end on our own (SI, # 10).  
In contrast, nurses felt that NIMART was better when rolled-out since they were well trained, 
mentored and coached by doctor and nurse mentors from WRHI, which was supporting the 
NIMART roll-out process. By this time, there were clear ART guidelines. The NIMART roll-
out also had clear indicators to monitor progress. As a result, nurses were able to report the 
numbers initiated and retained on ART, as I discuss further below. This was not the case for 
pre-ART services, however, as there were no clear indicators for progress monitoring at the 
time of the interviews. 
What I can say is that pre-ART was just allocated to us nurses as just one of an 
additional task without much capacitation of nurses and ways of monitoring progress - 
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very different with NIMART where nurses are well trained to do the job with 
guidelines (SI, # 09). 
4.2.7 Inability to monitor pre-ART care uptake and progress 
Poor record keeping tracking retention 
In order to monitor the progress of service delivery, all facilities are supposed to report on 
uptake and retention in care. South Africa, as a signatory to the global Millennium 
Development Goals (MDGs), monitors progress towards achieving the goals (SA, 2013b), 
and had set national targets to reach them (RSA, 2012). These targets were decentralised to 
provincial, district and then facility levels. In the study sites, it was reported that facility 
managers on a monthly basis, in their monthly meetings, update the facility staff on ART 
uptake progress towards their facility target. As a result, the majority of the staff interviewed 
had an idea of the patients enrolled and retained on ART in their facilities.  
At the time of the study, the reporting was done either through the District Health 
Information System (DHIS) if the indicators for the data element were included in the DHIS, 
or at facility level only if the indicator was not part of DHIS. For example, the data element 
to monitor uptake of pre-ART care services was the number of patients registered and 
retained in pre-ART care.  At the time of the study, pre-ART care uptake and retention data 
elements were not part of DHIS and were monitored at facility level, while ART uptake and 
retention indicators were monitored through the DHIS monthly reporting system. The 
facilities kept records on HIV Counselling and Testing, pre-ART care and CD4+ cell count, 
but most of these were incomplete. The ART registers, in contrast, were mostly complete and 
way better recorded, as shown in the figure below: 
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F 
Figure 4.11 Completeness of pre-ART and ART patient registers 
The incompleteness of these pre-ART services registers made it difficult to track the linkage 
to care from HIV testing to CD4 cell count check, and later on to track whether these people 
were registered and retained in pre-ART care. In contrast, it was much easier to monitor ART 
uptake and retention as the registers were complete:  
I am not sure of how many we have for pre-ART, but the facility manager updates us 
on monthly basis on how many we have on ART because we are supposed to report 
daily to the facility manager and we have a target to meet (SI, # 06). 
Though not sure of the exact numbers, but I know that patients not yet eligible for ART 
mostly do not come back. As long as they are still healthy (SI, # 12). 
Lack of monitoring of uptake of services and retention in pre-ART care may lead to inability 
of the service providers to identify the gaps in the delivery of the pre-ART services. 
Complete ART register Incomplete pre-ART register 
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4.3 NIMART roll-out 
4.3.1 NIMART roll out process 
At the time ART was rolled out, initiation of eligible clients was undertaken only by doctors, 
as described in Chapter 3. Primary Health Care nurses would prescribe other medications but 
not ART. Around 2010, several studies in South Africa and other countries established that 
there were no differences in patient outcomes between nurses‟ and doctors‟ ART initiation, 
and nurses ART initiation proved to be more cost effective (Miles et al., 2007, Sanne et al., 
2010). This led to the SA presidential mandate that all facilities start initiating patients on 
ART, and consequently a call was made to roll out ART to all facilities through NIMART, 
with support from non-governmental partners (Motsoaledi, 13 April 2010). 
At that time WRHI was a PEPFAR funded partner for the City of Johannesburg. From 
October 2010, it took up the role of providing technical support to the CoJ in the 
decentralisation of ART, from referral hospitals where the ART initiation had been conducted 
by doctors to PHC facilities where ART was to be initiated by nurses. During this process, I 
managed a team of clinical quality mentors (nurses and doctors) and data quality mentors, 
who trained, mentored and coached nurses at PHC facilities to initiate patients on ART, 
following a ten staged process described below.  
This was accomplished by applying quality improvement approaches through training, 
mentoring and coaching health service providers. WRHI supported NIMART roll-out in the 
CoJ by designing a ten step approach. The steps followed in rolling out NIMART were 
intended to ensure buy-in and sustainability, as shown below: 
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Figure 4.12 Ten steps in rolling out NIMART 
Throughout the process the WRHI engaged with the DoH/CoJ partners in order for them to 
share a common vision and acquire ownership of the program, in the hope that this would 
lead to sustainability. 
Using the above assessment process, the facilities were grouped into green if they had all the 
minimum standards, amber if they had minor gaps, and red if they had major gaps. The 
assessment results were then presented to the City of Johannesburg health services 
management team in a consultative workshop in November 2010. The main purpose of the 
workshop was to discuss and classify facilities into green, amber and red. CoJ Region F 
health management team and facility managers also discussed around which gaps could be 
fixed quickly to ensure the facilities were green. As a result, facilities which met the 
minimum standards were the first to implement NIMART and were put in batches according 
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to their readiness to start NIMART as follows: green as first batch, the second batch labelled 
amber while red was the last batch.  
Of interest was the commitment shown by the facility manager for Clinic A, as described in 
the following case study. The clinic was one of the two clinics that were labelled red, and so 
one of the last to implement NIMART. 
 
4.3.2 “Where there’s a will, there’s a way” 
Using the above assessment tool, Clinic A attained the following results: 
Table 4.5 Clinic (A) NIMART readiness assessment result 
Assessment area Colour 
Score 
Description  
General  No counselling rooms 
Basic HIV/AIDS 
Services 
 All listed services provided 
Policies and 
National 
Treatment 
Guidelines 
 Did not have National Nutritional Guidelines for PLWA 
and TB 
Laboratory 
Capacity 
 No lab in the facility was supported by National Health 
Laboratory Services (NHLS) 
Pharmacy 
Capacity 
 Very limited storage space which could not 
accommodate ARVs if NIMART rolls out 
HIV/AIDS 
Service Point 
 The clinic had no trained nurse to initiate patients on 
NIMART, and there was no dedicated person to manage 
the ART section of the clinic services. 
Clinic A was one of the facilities in the southern part of the City of Johannesburg, with an 
annual headcount (an annual average number of all patients accessing the clinic each month) 
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of 2268 from 2009-2010, of whom about one third (650) were children under 5 years. A 
monthly average of 75 individuals was tested for HIV; of these an average of 28 was HIV+. 
Of the 28 positive individuals, seven had a CD4 cell count of <200 and were referred to a 
nearest secondary facility described in section 3.1.2 for ART initiation. 
The above findings for Clinic A were presented during the health services managers‟ 
consultative workshop. The Clinic A facility manager also participated in the workshop, and 
a decision was made that this clinic and another one were to be scored red, so indicating that 
these would be the last two facilities to roll-out NIMART. This was because CoJ had to 
procure park homes (demountable buildings) as temporary office structures to create more 
space to accommodate counsellors and provide storage space for the medicines.  
Regardless of the identified major challenges to implement NIMART in this facility, the 
facility manager was motivated and committed to using the available resources to meet the 
minimum standards to implement NIMART. Below were some of the efforts she made to 
reverse the decision about delayed implementation of NIMART; 
Within a month after the readiness assessments, WRHI scheduled NIMART training for 
nurses from CoJ. The Clinic A facility manager made an effort to ensure that she and one of 
the professional nurses went through this training progam, which provided them with 
technical capacity to implement NIMART in their clinic. She created space in one of the 
consultation rooms to store the additional ART medication, so resolving the problem of 
storage. Instead of waiting for CoJ to procure a park home for extra space, she partitioned a 
very large consultation room into two rooms, and turned the second room into a counselling 
room. In addition, when she worked in the clinic, she asked the counsellors to use her office 
as an HIV counselling room.  At the same time, she acquired the National Nutritional 
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Guidelines for PLWA and TB from WRHI, which was missing at the time of the assessment. 
After these efforts, the clinic assessment changed, as reflected below: 
Table 4.6 Clinic (A) clinic assessment results after addressing the identified gaps 
Assessment area Colour 
Score 
Description  
General  1-2 counselling rooms 
Basic HIV/AIDS 
Services 
 All listed services provided 
Policies and National 
Treatment Guidelines 
 Acquired the National Nutritional Guidelines for 
PLWA and TB from WRHI 
Laboratory Capacity  No PHC facilities have a laboratory;  the facility 
was supported by National Health Laboratory 
Services (NHLS) 
Pharmacy Capacity  Created space in one of the consultation rooms for 
storage of medicines hence had enough space for 
ARVs 
HIV Service Point  Two nurses trained in NIMART 
 
Within three months, this facility manager had turned her clinic from red to green, so 
allowing the facility to be ready to implement NIMART. As a result, the clinic started 
initiating patients on ART by nurses at the same time as those facilities which had been rated 
green on the initial assessment. 
4.3.3   NIMART training, mentoring and coaching of CoJ nurses by WRHI 
From October 2010 to July 2011, the WRHI mentoring team of doctors and nurses trained 
and mentored professional nurses in NIMART from the 17 CoJ PHC facilities. This involved 
a five day training session (three days covered adult ART initiation and two days ART 
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initiation in children) held at WRHI offices. The DoH NIMART training manual was used, 
covering the following areas, as described in Appendix 8.7: HIV basic science refresher, 
Staging and opportunistic infections, PMTCT refresher including infant feeding, Case 
finding/diagnosis cases, HIV Staging and Opportunistic Infection (OI) cases, adult/children 
ARV initiation and management, ARV regimens, when to start, how to start, monitoring and 
side effects, adherence, TB/HIV co-infection, TB infection control and quality improvement. 
All nurses wrote pre- and post-tests during the course. The nurses were then supported and 
mentored in their PHCs by WRHI mentors to begin initiating patients on ART.  
A total of 46 nurses from CoJ were trained in NIMART.  The first phase of mentoring was 
done by those trained in NIMART filling in a self-assessment questionnaire on their skills for 
mentors to identify the skills gaps on which to focus during the mentoring sessions.  This was 
followed by onsite and telephonic mentoring and coaching them to initiate patients on ART. 
In addition the WRHI mentors would observe the nurses initiating a patient on ART or 
conduct file audits to monitor progress of the mentees towards ART initiation skill. 
4.3.4 Acceptability of the NIMART rollout  
The WRHI NIMART mentoring team engaged with the CoJ and DoH partners to establish 
the NIMART rollout and associated processes. This led to buy-in on the part of the CoJ to 
roll-out NIMART, and CoJ health services management and service providers consequently 
took the lead in rolling out the program by ensuring that the nurses are relieved from day-to-
day clinic duties to attend the NIMART training. In addition CoJ supported the facilities to 
address the identified gaps, including the procurement of lockable cupboards for storage of 
ARVs, to ensure they meet the minimum standards to implement NIMART.  This approach 
strengthened the sustainability of the program. Before NIMART rollout, only one of the 17 
PHCs was able to initiate patients on ART, with all initiations undertaken by doctors. By 
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October 2011, all 17 CoJ facilities were initiating patients on ART by nurses. In addition, 
there was a sense of ownership with an understanding that NIMART was not a WRHI 
program but their own, and was supposed to continue even after WRHI withdrew from 
supporting CoJ. 
4.3.5 ART initiations and decrease in patients load 
In the 12 months before the NIMART commenced, the referral Community Health Centre 
(CHC) facility was initiating a monthly average of 389 patients (SD 82.27). After NIMART a 
growing number of patients were initiated by nurses in the PHC facilities leading to a 
monthly average decrease to 238 12 months after NIMART, as shown below:  
Figure 4.13 Trends in ART initiations at a PHC referral 
4.3.6 Total ART initiations in Region F  
In the 12 months before the NIMART rollout, the mean number of patients initiated monthly 
on ART in Region F was 580 (SD 80.48). In the 12 months following NIMART, initiations 
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increased significantly to a monthly mean of 732 (±SD 71.29) illustrated in the figure below:
 
Figure 4.14 Trends in total ART initiations in Region F 
The above figure visually displays the number of ART initiations in Region F. The trend was 
stable before intervention and decreased steadily after NIMART rollout. ART initiations are 
shown to steadily increase, even though there is a visible interruption after initiation of 
NIMART. There was a brief decline in August 2010 when the civil servants, including nurses 
and doctors, were on strike demanding salary increments and better working conditions. To 
assess chance and control for other effects, a time-segmented regression analysis was fitted. 
Results are set out in Table 4.7 below: 
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Table 4.7 Segmented regression model and most parsimonious model 
  ART Initiations at referral hospitals  Total ART Initiations in 
Region F 
  Coefficient*  Standard 
error 
p-value Coefficie
nt 
Standard 
error 
p-value 
a.  Full Segmented regression model 
 Intercept     391 42.19  548.95 40.44  
 Baseline trend    -0.30 5.73 0.958 4.73 5.49 0.396 
 Level Change after 
NiMART    
-10.65 52.53 0.853 73.03 48.14 0.141 
 Trend change after 
NiMART    
-17.39 7.02 0.027 3.20 6.25 0.612 
b.  Most parsimonious segmented regression model 
 Intercept    389 19.35  579.75 18.87   
 Level change after 
NiMART    
-12.34 46.08 0.791 99.09 37.29 0.013 
 Trend after NiMART 
   
-17.69 4.44 0.01 7.94 2.97 0.013 
* Month 13 was excluded as this was when NiMART was introduced 
Results from the segmented time series model, presented in Table 4.7, show that initiation at 
referral facilities gradually decreased after introduction of NIMART, while the total 
initiations in Region F increased. Model (a) presents a full segmented model, which shows 
that the month-to-month decrease in number of initiations in the Region F referral hospital 
before NIMART was non-significant (p=0.958). After NIMART, the number of initiations 
dropped by 11, with a month-to-month decrease of 17 (p=0.027). For the total initiations in 
Region F, no model term was significant; the non-significant terms were eliminated by 
stepwise elimination and the most parsimonious model introduced. Model (b) is the most 
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parsimonious model, and shows that initiations at the referral hospital had an average month-
to-month decrease of 18 (p=0.01). The total initiations decreased by 12 (p=0.791) 
immediately after NIMART introduction, a result that was not statistically significant. In 
addition to a decreasing trend in referral hospital initiations, the total number of ART 
initiations in Region F PHCs increased by 99 (p=0.013) immediately after NIMART, the 
trend afterwards showing an average increase of 8 (p=0.013) every month.  
4.4 ART register audit results 
The ART register audit included patients who were initiated on ART within six months at the 
time of the study from the two facilities, and included a total of 203 patients (77 males and 
126 females). The ART register audit provided preliminary results for this research project 
because they were part of the processes involved in sample size calculation described above 
in chapter three. Below is a description of the preliminary results yielded at this stage. 
4.4.1 Demographic characteristics, CD4 cell count and access to pre-ART care from ART 
Register audits  
Table 4.8 Pre-ART patients’ demographic characteristics and access to care 
Demographic 
characteristics N (%) 
CD4 count ≤350 P value Pre-
ART 
P 
value 
All respondents 203 (100) 15 (7)  30 (15)  
Gender 
  
Male 77 (38) 2 (3) 0.04 7(9) 0.07 
Female 126 (62) 13 (10) 23(18) 
Pre-
ART  
  
Accessed 30  3(10) 0.6   
No access 
 
173 
 
12(7%)  
The CD4 count levels at the time of initiation and access to pre-ART care, before becoming 
eligible for ART, were established in this study as shown in the table above. During the 
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period selected for file audits, the CD4 cell count cut-off point for ART initiation was ≤350 
cells/μl. Out of the 203 (77 males, 126 females) people initiated on ART within six months,  
only 15 (7%) patients had been initiated on ART when their  CD4 cell count was ≤350 
cells/μl, of whom 2/77 (3%) were men and 13/126 (10%) were women. This suggests that 
women were more likely than their male counterparts (p 0.04) to be initiated on ART in a 
timely manner. 
Only 30 (15%) of those initiated on ART were recorded to be in the pre-ART care program 
before they became eligible to start ART. The odds of being in the pre-ART program before 
ART initiation was twice as much for women (18%) as for men (9%), though the p value was 
almost significant (0.07). The audit also established that even those who were in the pre-ART 
program before ART initiation did not initiate on time. Only three (10%) out of 30 accessed 
ART on time, whilst 12 (7%) of the 176 who did not access pre-ART care before ART 
initiation had timely ART initiation. There were no significant differences in timely ART 
initiation between those who accessed and did not access pre-ART care before ART initiation 
(p = 0.6).  
4.5 Services accessed by patients in pre-ART care program 
Files for those patients who accessed the pre-ART care program before being initiated on 
ART (30/203) were further audited to determine the type of pre-ART services they accessed. 
As recommended by WHO and SA Guidelines and discussed in section 2.4, this should 
include: TB screening, IPT, CPT, multivitamins, family planning, cervical cancer screening 
and CD4 cell count monitoring. Below are the details of the accessed services:  
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Table 4.9 Services accessed by pre-ART patients 
List of services All (N=30) Gender  P value 
  M (7/30 = 23%) F (23/30 =77%)  
TB Screening 14(47) 2(29) 12 (52) 0.3 
IPT 9(30) 1 (4) 9(30) 0.3 
CPT 16(53) 3(43) 13(57) 0.5 
2
nd
 CD4 cell count 21(70) 6(86) 15(65) 0.3 
Multivitamin 30 (100) 7(100) 23(100) N/A 
Family planning 0(0) N/A 0(0) N/A 
Cervical cancer screening 0(0) N/A 0(0) N/A 
Support group 0(0) N/A 0(0) N/A 
 
This file audit established that being in the pre-ART care program did not necessarily result 
in access to all available pre-ART care services in the facility and in fact, the majority of 
patients accessed limited pre-ART care services (Table 4.8). Being male or female did not 
result in significant differences in the uptake of pre-ART care services (p=0.3 – p=0.5). 
4.6 HCT register audit results 
All patients who tested HIV+ at the study sites were recorded in a pre-ART register of all 
care received in the facility before ART initiation. We conducted a register audit for the 
period of May 2011 to April 2012 in the facilities to gain an understanding of the pre-ART 
care given to a pre-ART patient in the first 12 months. The data elements which were 
supposed to be recorded in this register were: Date file was opened; Patient name; Telephone 
number; Age; Gender; TB screening done; CD4 testing; CD4 cell count value (1
st
, 2
nd
, 3
rd
 and 
4
th
 CD4 cell count values); Collected their first CD4 cell counts results; Eligible for IPT/INH; 
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IPT Commenced; Eligible for CPT; CPT commenced; Referred to Wellness clinic; Patient 
attended Wellness clinic; Patient still at Wellness clinic, and whether Patient was initiated on 
ART. These records were documented in the registers either with dates or ticks. The CD4 cell 
count cut-off point for ART initiation during the period of the register audit (May 2011-April 
2012) was at ≤200 cells/μl and as a result the file audit excluded those with CD4 cell count of 
≤200 cells/μl. There were major gaps established in the completeness of the register and only 
the most completed variables were included for analysis for this research project. The 
valuables dropped off from the study due to incompleteness of the records were: 2
nd
, 3
rd
 and 
4
th
 CD4 cell count  levels, Eligible for IPT/INH, IPT Commenced, Eligible for CPT, CPT 
commenced, Referred to Wellness clinic, Patient attended wellness clinic, Patient still at 
wellness and if patient was initiated on ART. Below (Figure 4.13) are details of number of 
patients included in the audit. 
 
Figure 4.15 Number of patients included in the pre-ART care register. 
A total of 2824 patients tested HIV+ in the facilities and the mobile HIV testing sites 
surrounding the facilities‟ catchment areas. Of these, 1705 were included in this study, as 
shown in the above flow chart. 
2824 tested HIV+ (May 2011-
April 2012) 
2238 CD4  cell count recorded 
1705 with CD4 cell count 
≤200cells/μl eligible for pre-
ART 
(included in the register audit) 
533 with CD4 cell count <200 
cells/μl eligible for ART 
(excluded from audit) 
586 CD4 cell not recorded 
(excluded from the audit) 
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The CD4 cell count cut-off point for ART initiation during the period of the register audit 
(May 2011-April 2012) was at ≤200 cells/μl and as a result, the file audit excluded those with 
CD4 cell count of ≤200 cells/μl as they were ineligible to join pre-ART care. There were 
major gaps established in the completeness of the register and only the most completed 
variables were included for analysis for this research project. The variables dropped off from 
the study to incompleteness of the records were: 2
nd
, 3
rd
 and 4
th
 CD4 cell count  levels, 
Eligible for IPT/INH, IPT Commenced, Eligible for CPT, CPT commenced, Referred to pre-
ART clinic, Patient attended pre-ART clinic, Patient still at pre-ART and if patient had been 
initiated on ART.  
4.6.1 CD4 count levels at first HIV test 
The protocol during the audited period was that if an individual tested HIV+, blood for a CD4 
cell count check was drawn, and he or she was asked to come back in two weeks‟ time to 
collect their CD4 count results. Data were analysed to determine the average CD4 count 
levels for pre-ART patients at the time of testing HIV+. There were 1,713 patients who tested 
HIV+ and had a recorded CD4 cell count level of >200 cells/μl. These people were eligible 
for pre-ART care program according to the then SA ART guidelines (SA, 2013d). The mean 
for their CD4 cell count was 464 cells/μl.   
In order to better understand the data, this mean was further tested as to whether there was a 
normal distribution using a kernel density estimate (KDE). The KDE is a non-parametric way 
to approximate the likelihood concentration function of a random variable, and it smothes 
inferences about the population (Janert, 2009). Below is a normal distribution graph for the 
register audit CD4 cell count: 
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Figure 4.16 Kernel density estimate for CD4 cell count distribution 
As shown in the above figure, the CD4 cell count distribution appears to be normal with a 
Standard Deviation (SD) of 191 cells/μl.   
4.6.2 Gender, age and CD4 count levels at the time of the first HIV test 
 A total of 1713 of the 2238 patients were eligible for enrollment into the pre-ART care. 
Their average CD4 count levels were further compared to the patients‟ gender and age.  As 
indicated in the table below; the first CD4 cell counts mean for women was significantly 
(p=0.000) higher than men. Even though the mean CD4 cell count for those >24 year olds 
were higher than their counterparts, the differences were not significant.  
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Table 4.10 CD4 count levels according to respondents’ characteristics  
Characteristics  Observations  Mean(cells/μl,) SD (cells/μl) P value 
All respondents 1713 464   
Gender Female 1220 479 200 0.000 
 Male 493 426 162 
Age  <24 179 462 202 0.9 
 >24 1534 479 190 
 
4.6.3 Collection of CD4 cell count results after the first HIV test. 
 All patients recorded in the register, who tested HIV+ during the period of the register audit, 
gave blood for a CD4 count check and were asked to come back after a minimum of two 
weeks. The register audit established that not all patients came back to collect their CD4 cell 
count results as in table below; 
Table 4.11 Collection of CD4 cell count results after the first HIV test 
Demographic characteristics N (%) CD4 results collection P Value 
All respondents 1705 (100) 1230 (72) N/A 
Phone 
Contact 
Yes  1545 1112 (73) 0.021 
No  160 103 (64) 
Gender 
  
Male 485 320 (66) 0.001 
Female 1216 904 (74) 
Age 
  
<24 179 118 (66) 0.05 
>24 1526 1112 (73) 
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As shown, 72% of patients testing positive for the first time came back to collect for their 
CD4 cell count results. Comparing those with and without phone numbers, 73% of those who 
had phone contacts in the register collected their CD4 cell count results; this was significantly 
(p=0.02) higher than those who did not have phone numbers. The main plausible reason for 
this is that the counsellors were able to follow them up telephonically. In addition, women 
(74%) were more likely (p=0.001) to come back for CD4 cell count results than men (66%). 
The other finding is that those who were <24yrs (66%) were less likely (p=0.05) to come 
back for their CD4 cell count results compared with those who were aged >24yrs (73%). 
4.7 Findings from the consultative workshop 
Once data collection through interviews with patients and staff, and file and register audits, 
was completed, the findings related to the identified gaps in pre-ART care service delivery 
were summarised and presented to health service managers for the City of Johannesburg in a 
consultative workshop held on 30 March 2013, at CoJ Health Services Eureka House, located 
in the inner city of Johannesburg. In line with the quality improvement processes described in 
section Chapter two, the workshop had three main objectives: 
 To verify if the findings were a true reflection according to the managers‟ 
experiences.  
 To discuss the causes of the identified gaps, and  
 To come up with possible and appropriate solutions to address the identified gaps. 
In this section, I outline the identified gaps through interviews with patients and staff, and the 
possible causes and solutions established through the interviews and the consultative 
workshop with the health services managers.  
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Table 4.12 Identified gaps and causes by pre-ART patients and services providers 
Identified gap Causes 
1.  Service delivery 
Pre-ART services not youth and 
male friendly 
Staff not oriented or trained in youth and male friendly services 
Long queues and waiting times  Lack of triage of patients upon arrival 
Multiple clinic visits Drug stocks not enough for longer period 
Lack of proper packaging and integration of pre-ART 
Loss of CD4 and other blood 
results 
Poor record keeping for lab results, sometimes blood did not go to 
lab 
And no feedback on results from the lab 
2. Health workforce 
Shortage of staff High staff turn over 
Insufficient funds to recruit new or additional staff 
Lack of HIV knowledge among 
facility HIV counsellors 
Poor support and mentoring of counsellors 
3. Health information systems 
Facility staff not familiar with 
facility stats on Pre-ART and ART 
timely referral 
Lack of awareness and usage of pre-ART statistics 
Little and poor documentation of pre-ART statistics 
4. Access to essential medicines, 
Drug stock outs Insufficient funds to procure and stock sufficient pre-ART 
medication 
Delays in reordering stocks  
5. Financing 
Shortage of staff Insufficient funds to recruit staff 
Drug stock outs Insufficient funds to procure and stock sufficient pre-ART 
medication 
6. Leadership/governance 
Shortage of staff Demotivated staff leading to resignations 
Lack of funds to recruit additional staff 
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During the consultative workshop, these gaps were further grouped according to the WHO 
Health System framework/Health Systems Strengthening (HSS) as it relates to pre-ART 
service delivery, as described above in table 4.12. As reflected below, depending on the 
causes, some of those gaps are applicable on more than one HSS building block. 
4.7.1 Service Delivery 
Good health services are those which provide good quality health care which can be easily 
accessed by those who need them, regardless of their socio-economic status, whilst 
maximising available resources (WHO 2007). Gaps related to pre-ART service delivery 
established in this study were: (1) youth and male unfriendliness of the services, (2) long and 
queues and waiting times, (3) multiple clinic visits, (4) loss of CD4 cell count and other 
laboratory results, (5) shortage of staff, and (6) lack of HIV knowledge among facility HIV 
counsellors.  
4.7.2 Health workforce 
A health workforce that is performing well is one which responds to the needs of the service 
users in an efficient and effective way to achieve the best possible health outcomes while 
ensuring the fair distribution of staff (WHO 2007). This study established a shortage of staff 
to provide pre-ART care services, and knowledge gaps among HIV counsellors who were 
reported to be the main source of HIV counselling information to pre-ART patients. In 
addition, when the shortage of staff reported during the assessments was further discussed 
during the consultative workshop it was established that there were no funds to hire staff. The 
other factor identified and related to shortage of staff was staff turnover, whereby staff resign 
from the public health services due to demotivation as a result of lack of incentives, heavy 
work load and burn-out.   
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4.7.3 Health information systems 
A well-functioning health information system is one that warrants the creation, scrutiny, 
dissemination and use of high quality of information on the performance of health systems 
which is critical for decision making (WHO 2007). The study established gaps in the 
documentation of pre-ART care information for patients. In addition, service providers were 
not aware of the pre-ART monthly progress data for their facilities which are important for 
decision making and planning. 
4.7.4 Access to essential medicines 
A well-functioning health system ensures equitable access to vital medical supplies which are 
technically sound and of high quality, while maximising the use of the available resources 
(WHO 2007). Both pre-ART patients and service providers reported drug stock-outs, which 
led to patients not getting their prescribed medication or receiving less medication than they 
required. In turn, this led to multiple clinic visits. This also increased the workload of service 
providers and resulted in long waiting times for patients increasing their frustration.   
4.7.5 Financing 
A good health financing system sources sufficient funds to run the health system and ensures 
that services are affordable to those who utilise them (WHO 2007). Even though pre-ART 
services were reported to be free, people carried direct costs including transport and food and 
indirect costs associated with time spent travelling to the facilities and waiting for the 
services. This was made worse when patients had to make multiple visits to the facility, were 
reported to negatively affecting the uptake of pre-ART services. 
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4.7.6 Leadership/governance 
Good leadership and governance guarantees strategic direction of the health systems, and 
includes policies and processes that promote maximum benefits on the available resources 
(WHO 2007). One aspect of strategic direction assessed in this study was allocation and 
management of resources. For example, even though shortage of staff was reported by both 
staff and patients, the managers reported that at the time of the consultative workshop, there 
were no funds to recruit new nurses or counsellors This meant that with the limited resources, 
staff recruitment was not prioritised for resource allocation at that time despite that this was 
crucial for service delivery.  
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Chapter Five 
Discussion 
5.1 Accessibility of pre-ART services  
In line with the conceptual framework illustrated on page 69 of the thesis, many factors 
related to patients, staff and health systems emerged as preventing patients from accessing 
care, and although some remained in care. This was only for CD4 cell count checks and 
multivitamins. Others dropped out of care completely. As described above in Lusungu‟s 
pathway to care, some patients were able to endure the challenges and remain in care; others 
like Nabanda had no choice but to drop out of care.   
There was no proper follow-up system to trace pre-ART patients lost to follow-up. Of those 
people traced back for interviews in this study, none had been followed up by the service 
providers. A plausible reason for this would be the poor recording system, also established in 
this study, making it difficult for service providers to identify those defaulting from care. 
Enhancing patient and provider engagement through follow-up phone calls and in-person 
visits when a patient misses appointment has shown to improve the retention of HIV+ 
patients in care (Sendzik, 2004, Thomson et al., 2011). Similarly strengthening counselling of 
pre-ART patients, in order to provide them with accurate information about HIV and disease 
progression, has been shown to contribute to motivate patients to remain in care (Smith et al., 
2013). In our case the patients who were traced back for the study interviews after defaulting 
for > 12 months received further intensive counselling and they all later returned into care – 
implying that if patients were properly followed up in our study sites, they might have been  
retained in care. 
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The file audit for patients initiated on ART established that only 30/203 (14.7%) of people 
initiated on ART and included in the study, had participated in the pre-ART program 
beforehand. The majority did not have any pre-ART care documented in their files. This 
indicates that most people test late, i.e. when they are already eligible to start ART. This is a 
sign of delay in testing for HIV, probably due to the many documented barriers to people 
testing for HIV in the city of Johannesburg. These include younger age group and negative 
health worker attitude towards service users (Tshuma et al., 2014). In addition to these 
barriers, the other plausible reason is poor linkage to care, when patients test positive and are 
neither motivated to continue in care nor linked to care and return only when sick (Boyles et 
al., 2011; Lessells et al., 2011).  Addressing these barriers to HIV testing and guaranteeing 
appropriate linkage to care after a positive HIV test is critical to ensure timely ART initiation 
(Lessells et al., 2011, Tshuma et al., 2014). 
I have established that the majority (95%) of patients who were retained in pre-ART care 
accessed CD4 cell count check and multivitamins at least once. However, most patients did 
not take advantage of other services included in pre-ART care and likelihood is that they 
were not offered. For example, the file audits revealed that female patients included in the 
pre-ART patient file audits had neither cervical cancer (CA CX) screening nor family 
planning documented in their files. Lack of CA CX screening is a lost opportunity for pre-
ART care women who are at higher risk of developing CA CX (Batra et al., 2010, Serraino et 
al., 1999, Snyman, 2013). Yearly screening is therefore critical (SA, 2000b, SA, 2014(b)) for 
early diagnosis, management and to avert unnecessary and premature deaths among HIV+ 
women (Franceschi and Jaffe, 2007, Maiman, 1998).  
In addition, family planning is critical to be accessed by HIV+ women to prevent unplanned 
pregnancies, as part of the PMTCT strategy towards elimination of mother to child 
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transmission of HIV (WHO/UNICEF, 2007). Unintentional pregnancies among HIV+ 
women have been well documented in South Africa and elsewhere, calling for focus on 
ensuring that HIV+ women are accessing the reproductive health services, including family 
planning  (Akelo et al., 2013, Sutton et al., 2014, Schwartz et al., 2012). 
The other point is that only about a third of patients in this study had received IPT and 
adherence counselling.  This is another missed opportunity as HIV+ individuals have ten 
times higher risk of getting TB (McIlleron et al., 2007), and IPT reduces TB incidence 
(Selwyn et al., 1989). In addition, comprehensive adherence counselling before ART 
initiation is critical to enable people to understand and accept their situation and promote 
adherence on ART (Visser et al., 2009).  Adherence to ART is important for treatment 
success, as poor adherence on ART leads to viral replication and resistance mutations which 
may result in treatment failure, so requiring switching the patient to more complex and 
expensive regimens (Liu et al., 2006, Long et al., 2010).  
CD4 cell count monitoring and multivitamins are the bare minimum pre-ART services. 
Retention in care for these services does not mean access to the available prescribed 
comprehensive package of services, defeating the purpose of the establishment of the pre-
ART care program. There is considerable focus on retaining pre-ART care patients in care as 
it is low in South Africa (duToit et al., 2014)  as well as elsewhere in sub-Saharan Africa 
(Rosen and Fox, 2011), but it is also critical that those retained in care are prioritised to 
access the full comprehensive package of pre-ART services.  
In South Africa, there is no single reason to explain poor access to the prescribed 
comprehensive package of services, even when patients present at the facilities. The 
challenges affecting the health system service delivery emanate at different levels of the 
system. These challenges are pervasive. For example, Mail and Guardian reported a case of a 
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65 year old man who died at a hospital in Free State Province; his wife blamed the hospital 
for “killing her husband” (Malan, 2015). When reporters followed the story, it was 
established that there was shortages of staff, medicine and supplies to manage patients at the 
hospital and service providers were working under pressure with little support from the 
decision makers and politicians. The identified gaps in this story included poor leadership, 
poor governance, and budget constraints leading to staff shortages, coupled with high staff 
turnover, stock-outs of medicine and supplies. These multiple factors lead to patients 
presenting at the hospital where there were no resources to help them, including in this story 
no porters to carry dead bodies to the mortuary (Malan, 2015 pp 2-5). The Free State story 
cannot be generalised to CoJ facilities; circumstances vary across facilities, and so it does not 
explain directly the poor access of pre-ART services by patients who present at the facilities 
in CoJ. However, it is critical to further explore the origin of such gaps whenever they occur 
in order to address them at the right levels, to ensure that patients are able to access available 
services and that the services that are available are appropriate and affordable. 
5.2 Awareness of available pre-ART services among pre-ART patients 
While the majority (95%) of patients in this study were aware of CD4 cell count monitoring 
and multivitamin supplementation, very few knew that there were other important pre-ART 
services. For instance, only 17% and 12% were aware of the availability of nutritional 
supplements and of support group services. Access to the available services was shown to be 
associated with levels of awareness, as demonstrated in Figure 4.6. Even though no studies 
have quantified awareness and access to services, strengthening education to raise awareness 
of HIV and the disease progression has been reported to improve retention, resulting in 
access to available services (Smith et al., 2013, Nyasulu and Nyasulu, 2011).  
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Although the majority of patients reported that they were not aware of the available services, 
the interviewed staff thought that the patients were aware of all available pre-ART services. 
This discordance in knowledge meant that no efforts were made to address the gap. Without 
the identification of a gap, no quality improvements processes can be put in place (SA, 
2012b). 
5.3 CD4 cell count monitoring among patients retained in pre-ART care 
In the study site facilities at the time of the study, CD4 testing was conducted by the National 
Health Laboratory Services (NHLS) at a centralised place, and all patients, whose blood was 
collected for CD4 cell check, were asked to come back after two weeks to collect their blood 
results. Almost all interviewed patients (99%) had had their CD4 cell count checked at least 
once after they had tested HIV+, and about two thirds (68%) had had their CD4 cell count 
checked within the past six months, consistent with the WHO and RSA pre-ART guidelines 
(SA, 2014(b), WHO, 2013a). This was higher than what has been reported in Cape Town 
(duToit et al., 2014)  (46%) or in a review of studies in sub-Saharan Africa where (14/28) 
studies included in the review were from South Africa, where the six monthly CD4 cell 
check-up  was at 46-68% at different stages of pre-ART care (Rosen and Fox, 2011). Six 
monthly CD4 cell count is critical for timely ART initiation (SA, 2014b). Delays in ART 
initiation lead to an increase in the costs as a result of high morbidity and mortality of 
patients after ART initiation (Brinkhof et al., 2008, Eaton et al., 2014, Ingle et al., 2010, 
Leisegang et al., 2009, WHO, 2013b).  
Demographic characteristics did not show significant differences in 6 monthly CD4 cell 
count checking among the interviewed patients. However, those who indicated that an 
individual can get married (p=0.03) and have an HIV- baby (p=0.001) whilst HIV+ were 
more likely than others to be checked for CD4 cell count within the past 6 months. Despite 
165 
 
the fact that high knowledge levels may not necessarily lead to positive behaviour change 
(James et al., 2004, Rubin et al., 1992, Williams et al., 2003), knowledge around normalising 
HIV+ status, i.e. one can lead a normal life even though HIV+,- has been shown to positively 
affect CD4 cell count checking behaviour. A plausible reason for this would be the fact that 
the availability of ART and PMTCT has positively affected child bearing desires (Ndlovu, 
2009), hence the motivation of PLWHAs to adhere to care and access timely ART (Cooper et 
al., 2007). In addition, having a healthy baby was used as a sign for normal life (Igonya and 
Moyer, 2013, Moyer et al., 2013). This finding may mean that an understanding that one can 
lead a normal life by getting married and having an HIV- healthy baby, inspite of being 
HIV+, can positively affect retention in care, in this case as reflected by the 6 monthly CD4 
cell count monitoring among pre-ART patients. Therefore, though difficult to achieve 
(Mattes, 2014), normalisation of HIV as a disease can lead to retention in pre-ART care, as 
shown in this study.  
However, in this study, even those pre-ART care patients who were retained in pre-ART care 
delayed ART initiation.  These delays of timely ART initiation were established through both 
interviews and pre-ART file audits. The file audits showed no significant difference (p=0.6) 
in timely ART initiation between those who went through pre-ART and those who did not. In 
addition, 35% of interviewed patients were eligible to start ART and one patient had an 
extremely low CD4 cell count of 03 cells/μL.  Delays in timely ART initiations have been 
documented in other studies, primarily because of poor retention and loss to follow-up in pre-
ART care program, leading to individuals returning to care too late for effective treatment 
(Lessells et al., 2011, Fox and Rosen, 2010). Poor access to prescribed pre-ART care services 
by those retained in care has not established in other studies, but was established in this study. 
This could lead to further delays to timely ART initiation. The commonly cited 
recommendation of pre-ART care retention leading to timely ART initiation is futile if 
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retained patients are not offered and do not access the prescribed services and still delay ART 
initiation.  
5.4 First CD4 count check and collection of results  
The established average CD4 cell count levels for those with CD4 cell count above 200 
cells/μl was 464 cells/μl, with women having significantly higher CD4 cell counts than men 
(p 0.000). This finding is consistent with other findings, which illustrate that women have 
higher CD4 cell counts without HIV infection (Maini et al., 1996), and that with HIV 
infection, women reach the ART initiation point twelve months later than men and the 
differences exist even after ART initiation (Prins et al., 1999, CASCADE-Collaboration, 
2003, Loupa et al., 2006, Manolescu and Marinescu, 2013). This consistent finding raises 
questions about the need to differentiate the CD4 cell count cut-off point for ART initiation 
so that women start at a higher CD4 cell count than men (CASCADE-Collaboration, 2003, 
Kumarasamy et al., 2008). 
The pre-ART register audit indicated that women and >24 yr olds were more likely to come 
back and collect their CD4 cell count (p=0.001 and p=0.05 respectively). This finding was 
consistent with the findings from interviews with pre-ART patients where both male and 
female participants reported that women had more opportunities of visiting the clinic, 
resulting in their increased access to results of tests as well as other aspects of pre-ART care. 
Similar to other studies, men and youths were most often lost to follow-up in pre-ART 
(Mugglin et al., 2012, Rosen and Fox, 2011, Ahmed et al., 2013, Lessells et al., 2011) 
because they had no reason to visit the facility other than for pre-ART care.  
Those who had phone contacts documented in the register were more likely to come back to 
collect their first CD4 cell count results than those without recorded phone numbers. The 
main purpose for recording the patient phone numbers was to call them back into care in case 
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they miss their appointments.  However, patients were not phoned to advise them to return 
and collect their results because, although the phone number was collected for patient follow-
up purposes, there was no allocated phone to use for pre-ART patient follow up at the time of 
this study. Could it mean that in addition to being compelled to access services, leaving their 
phone contacts made them feel obliged to return to the facility? Or is having a phone or 
contact number associated with some enabling factors to retention in care like being a proxy 
for a higher economic or educational status? A PMTCT program access study conducted in 
sub-Saharan Africa within which South Africa was included, showed significantly higher 
adherence to the program among the mothers who had phone contacts (Nassali et al., 2009), 
though there is need for more research to answer these questions. Nonetheless, telephone call 
approaches have been tried and tested to minimise attrition in HIV care stages, and have 
shown to reduce attrition in HIV care with up to 64.8% of those lost to care traced back in 
care (Dalal et al., 2008).   
5.5 Categories of identified gaps through interviews with patients and 
staff 
A number of barriers to care in the current pre-ART care program have been established, 
leading to the attrition of patients from the time they test HIV+ to timely ART initiation. 
These gaps have been categorised into (1)  patient-related  gaps: including lack of time to 
attend clinic, breech of privacy and confidentiality of HIV+ status, patients not ready to test 
for HIV and HIV/AIDS knowledge gaps (2) staff-related gaps: including shortage of staff, 
staff attitude and lack of HIV knowledge among facility HIV counsellors and (3) health 
systems-related gaps: youth unfriendliness of the services, drug stock outs, poor record 
keeping to track retention, multiple clinic visits and pre-ART services not prioritized by 
service providers. Below I discuss these in detail. 
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5.6 Time related factors  
A consistent problem reported by pre-ART care patients was lack of time to attend clinic 
appointments, as many were either working or seeking some casual work to earn a living. 
This is consistent with other study findings (Nakigozi et al., 2013, Moshabela, 2012). This 
lack of time was aggravated by other related factors, as illustrated in the Figure 5.1 below. 
 
 
Figure 5.1: A synthesis of patient reported interrelated factors to pre-ART access 
Firstly patients described how attending the clinic lead to financial loss, especially in terms of 
transport costs and time spent on travelling and waiting for the services in the clinic. For 
some, it meant a deduction in their wages, while for others, this resulted in lost opportunities 
for them to look for a job. Transport costs, traveling and clinic waiting times have been well 
documented as costly for patients, negatively affecting access to services among both 
adolescents and adults (Philbin, 2014, Pinto et al., 2013). Working on ways of reducing time 
spent on seeking pre-ART services can positively affect uptake of the services.   
Lack of time to attend 
scheduled clinic times 
Shortage of staff leading to 
long waiting times coupled 
with unsystematic queuing 
Drug stock outs, loss of blood results, 
repeat visit to collect CD4 cell count 
blood results and lack of integration 
of services  leading to multiple visists 
Breech of HIV+ status confidentiality leading 
to unplanned disclosure especially for men 
and youths 
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Secondly, the long time spent in the facility by healthy pre-ART care patients had the 
potential to breech the confidentiality of their HIV+ status, especially among men and youths. 
Women have many other reasons for visiting a clinic, as I have already noted. This finding 
can be a possible reason for men and youths being most likely to be lost to follow-up in pre-
ART care, as reported from other studies in SA and elsewhere in sub-Saharan Africa (Rosen 
and Fox, 2011, Lessells et al., 2011). Therefore addressing factors that cause multiple clinic 
visits, as discussed above would also reduce unplanned disclosure of the patients‟ HIV+ 
status and reduce the stigma and discrimination that may result. Reducing time spent in the 
clinic by pre-ART patients may reduce loss to follow-up, particularly among youths and men. 
Only some of the pre-ART patients interviewed had disclosed their HIV+ status to their 
partners (74%), family (55%) or friends (33%). In this study, I established that those 
employed were more likely to disclose to partners and friends than their unemployed 
counterparts (P=0.05 and p=0.04 respectively). The plausible reason could be the fact that 
being employed indicates financial independence, hence less financial reliance on the partner 
or friend (Makin et al., 2008). Although people may be reluctant to disclose to partners and 
other community members because disclosure may lead to negative outcomes including 
gender-based violence, stigma and discrimination (Gari et al., 2010, Nyasulu and Nyasulu, 
2011, Cloete et al., 2010), it is an important component in pre-ART care programs in 
preparation for ART initiation (Worley et al., 2009). Rates of disclosure are associated with 
social support (Kalichman et al., 2003) and improved adherence to treatment (Unge et al., 
2010).  
Possible solutions through best practices to address the above identified gaps have been 
documented; these  include establishing CD4+ cell count at the point of care (Manabe et al., 
2012), reducing drug stock outs (Muhamadi et al., 2010) and reducing waiting times through 
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the improved triage of patients (Sokhela et al., 2013). However, synthesising these tried and 
tested ideas into a feasible pre-ART care guideline is still a challenge in South Africa (Boyles 
and Wilkinson, 2011, Govindasamy et al., 2014). Therefore, there is need to develop 
recommendations to assist in establishing guidelines in pre-ARTR service delivery to 
increase quality of care and hence improve retention. 
I have established a lack of integration of pre-ART services, and that this increased the 
number of clinic visits for patients, making it difficult for them to attend to all clinic 
appointments. Integration models in service delivery have been shown potentially to be more 
efficient, although there is a need for further research in the area (Siapka et al., 2014). In 
addition training and mentoring of health workers to provide integrated HIV services has 
been recommended as a solution to maximise the limited human resources and to provide a 
comprehensive package of care at PHC level (see also Nyasulu et al., 2013). 
Loss of CD4 cell count results, as reported by respondents in this study, requires that patients 
undergo a further CD4 cell count check and this increase the number of clinic visits, further 
increasing time spent in the facility by patients. In addition, not all patients come back to 
collect their CD4 cell counts, leading to poor linkage to care (Faal et al., 2011, Larson et al., 
2013, Losina et al., 2010). Loss of CD4 cell counts results for those who come back for 
results just exacerbated the existing challenges for linkage to care. For example, in an earlier 
study conducted in Johannesburg, only 50% of HIV+ pregnant women who returned within 
60 days after CD4 cell count check had their CD4 results recorded in the register (Schnippel 
et al., 2013).  
Some patients reported that they were not ready for an HIV test at the time they tested for 
HIV, and spoke of “being taken by surprise.” This unreadiness made it difficult for them to 
accept the HIV+ test results. Denial of results can be a catalyst for further transmission of 
171 
 
HIV coupled with secrecy and non-disclosure, which leads to poor access and retention in 
HIV services (Rankin et al., 2005). Denial may also be a problem among pre-ART care 
patients as they are mostly healthy and do not have any signs that they are HIV+ (Greeff et 
al., 2008). The HCT guidelines recommend the importance of pre-test counselling to ensure 
readiness of individuals before they are tested for HIV (SA, 2010b).  
5.7 Pre-ART patients’ knowledge levels around HIV/AIDS 
HIV/AIDS knowledge gaps were established in this study, especially in relation to patients‟ 
understanding of disease progression from HIV to AIDS. Only 27% stated that HIV is not the 
same as AIDS. HIV knowledge levels are still low among the general population in South 
Africa (Shisana et al., 2014). No study has established pre-ART care patient knowledge 
levels around HIV disease progression. Patients demonstrated major knowledge gaps around 
the prevention of re-infection when both partners are positive, and only 38% of interviewed 
pre-ART care patients knew that there was a need to use a condom when both partners are 
HIV+.  This is consistent with findings from a demographic health survey conducted in eight 
sub-Saharan African countries, which revealed very low use of condoms amongst HIV+ men 
and women in their last sex encounter; only 8% of HIV+ married men in Uganda reported 
that they had used condoms in their last sex (Wenjuan et al., 2012). Not knowing prevention 
of HIV transmission for pre-ART care patients is a lost opportunity for positive prevention 
(IHA, 2007). Prevention of HIV transmission from those who know their HIV+ status to 
others is amongst the objectives for positive prevention approaches, and the provision of HIV 
information, and education about risk reduction methods for PLWHAs is key to positive 
prevention of HIV (IHA, 2007). Even though HIV prevention knowledge may not necessarily 
mean positive behaviour change (Williams et al., 2003), it is important for those who are 
HIV+ engaging in HIV prevention practices (HRSC report 2013).  
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The other point of concern is the fact that even though counsellors (80%) were the main 
source of information in the facility and nurses (14%) the least, the patients reported lack of 
HIV knowledge among facility HIV counsellors and poor quality of counselling. The patients 
themselves recommended the need for training of counsellors to improve quality of 
counselling: “Counsellors should have more workshops on updated HIV/AIDS information.” 
Quality of counselling should be considered the most important factor for all counsellors, as 
this could motivate service seeking and uptake (Gatta and Thupayagale-Tshweneagae, 2012). 
Even though no study has been documented on quality of counselling given to pre-ART 
program patients, poor quality and compromised information from counsellors has been 
documented in PMTCT programs in South Africa and elsewhere, negatively affecting the 
decision making for feeding choices and utilisation of services by PMTCT patients (Chopra 
et al., 2005, Rea et al., 2007, Manuela de Paoli et al., 2002). In order to ensure good quality 
of counselling, it is critical that HIV counsellors are trained, mentored and coached in quality 
counselling. 
5.8 Negative staff attitudes 
Negative staff attitudes emerged as a barrier to retaining patients in care, consistent with 
findings in a study among ART initiated patients (Nakigozi et al., 2013) and another study 
done among service providers and patients highlighting the health services‟ affordability and 
availability barriers in the post-apartheid era (Harris et al., 2014). Some patients felt that pre-
ART service providers stigmatised them, and since the patients were in most cases healthy, 
they were never prioritised and taken seriously when they reported to the facility to access 
care. Staff attitude is a ministerial priority area in delivering health services, as already 
described above (SA, 2011b). However, negative attitudes towards HIV+ patients in South 
Africa and elsewhere are well documented (Famoroti et al., 2013, Mukora et al., 2011, 
Mulaudzi et al., 2011). For example, a study done in Kwazulu Natal, South Africa also 
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established that staff were stigmatising people who were HIV+ people by testing patients 
before surgery to avoid infection and gossiping about patients‟ HIV+ status, so breaching the 
privacy and confidentiality policy (Famoroti et al., 2013).  
One area we need to look at is how the pre-ART patients respond to negative staff attitude: 
do they hold the service providers accountable or they just feel powerless to resist?  As 
reported in this study, the stigmatisation by health workers discouraged pre-ART patients 
from continuing in care, as patients felt powerless to complain and take those involved to task 
to be accountable for their actions: “The nurse became rude to me and I felt stigmatised, hurt 
and disappointed, I decided not to come back. After all, I am not sick.” However, the South 
African government has put in place a protocol that provides information and guidance to the 
public on how to complain and how management can handle and resolve those complaints in 
a timely manner – this protocol recommends that patients not happy with the services should 
be able to lodge a complaint with an assurance that the process of resolving the complaint 
will not negatively affect the services offered to the complainant but rather well address the 
complaint for the benefit of all who access the facility (SA, 2014 August). In this study, there 
is evidence that the pre-ART care patients were not aware of this protocol and processes 
involved, resulting into them defaulting from care when unhappy with the services. It is 
therefore important to sensitise health facility service users on the complaints management 
protocol for them to maximise its benefits.  
5.9 Seeing beyond an HIV- baby  
Currently, globally and in South Africa, there is a clear acknowledgment that in addition to 
having an HIV- baby, the health of the mother is of paramount importance to the survival of 
the child (Burton, 2013).  The South African Government has emphasized this in the latest 
radical change in the PMTCT guidelines to Option B+ (SA, 2014(b)). Under the previous 
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guidelines, ART was provided to women in pregnancy, but discontinued after delivery or 
breastfeeding (Option B) (SA, 2013e). The PMTCT Option A and B regimens led to mothers 
being lost to follow up (Wettstein et al., 2012). In South Africa, Option A showed attrition 
whereby only two out of 72 (2.8%) ART eligible women were initiated on ART within 30 
days (Schnippel et al., 2015), and even in countries like Malawi where Option B+ was rolled 
out two years ago,  although there is improved retention, there is still attrition, with women 
again lost to follow-up (Tenthani et al., 2014). Under the revised guidelines, 'Option B+' 
requires that all pregnant women are initiated on lifelong ART (SA, 2014(b)). The main goal 
for Option B+ is to ensure that mothers are initiated early, without delays due to CD4 count 
checks, and retained in care to ensure there is increased maternal life expectancy, and so 
reduced mortality and morbidity (SA, 2014(b)). 
Some PMTCT mothers in this study reported that all they wanted was an HIV- baby and they 
were interested in neither pre-ART nor ART after delivery. This finding is of great concern 
because, regardless of the HIV status of the child, a child is 3.8 times more likely to die if the 
mother is terminally ill or dead than if the mother is alive and healthy (Nakiyingi et al., 
2003). Generally one might expect women to want to see their children grow, so how do we 
explain Nabanda‟s attitude, for example? After delivery, Nabanda left her child with her 
mother as the caregiver, and went back to work without continuing with pre-ART care. This 
is not uncommon in South Africa as maternal grandparents regularly help out as caregivers to 
ensure that children get optimum care, at times because of single parenthood and need for 
mother to work; mothers would not be available if the child stayed with his or her mother. 
This results in nearly eight percent of all children being cared for by grandparents (Holborn 
and Eddy, 2011). 
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The other plausible reason for Nabanda defaulting from pre-ART care is the possibility that 
she was still in denial that she was HIV+. Denial of one‟s HIV+ status has been shown to 
lead to medical pluralism and “doctor shopping” as people try to confirm and find an 
alternative to diagnosis as well as treat the symptoms (Wringe et al., 2009). The other point is 
that those who are in denial are not in a position to disclose and are particularly afraid of 
stigma and discrimination (Nakigozi et al., 2013). Therefore supporting those in denial, like 
Nabanda, with intensive counselling and education to accept their HIV+ status, to support 
them to disclose (SA, 2010b), and to emphasize the importance of pre-ART care would retain 
patients, so ensuring continuation of treatment once they commenced on ART (Smith et al., 
2013). After further counselling and education, Nabanda returned to care and resumed pre-
ART care.  
One aspect that may be relevant in understanding this was that Nabanda was South African; 
she had grown up under Apartheid and had had only limited primary school education. 
During Apartheid, black men particularly were separated from their families, as they went to 
cities or to mines or other industries where family accommodation was not possible. Wives 
and children were left at home (Holborn and Eddy, 2011). Although Apartheid came to an 
end 20 years ago, South Africa still experiences the long-term ripple effects of this extended 
period of structural violence and racist control (Harris 2014). For example, poor access to 
education under the apartheid era had a negative effect on Nabanda‟s generation, separated 
families due to migration can affect the way the generation of people who were children at 
the time relate with their own children. Lastly, the HIV prevalence is the highest among the 
blacks (15%) compared to whites (0.3%), Coloured (3.1%) and Indians/Asian (0.8%) 
(Shisana et al., 2014). The Apartheid era migration for black South African men could be one 
of the contributing factors to this high prevalence, since migration places individuals in 
situations where they are at higher risk of contracting HIV (Lurie et al., 2003). Finding 
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employment still involves family separation. Currently only 30% of black children in South 
Africa live with both their parents, compared with >80% Indian and white children who live 
with both parents (Holborn and Eddy, 2011). Indicators of dysfunction or changes in family 
structure emerge from a comparison of 1996 and 2009 data in South Africa; among black 
Africans especially, the number of registered marriages has reduced, whilst the number of 
single headed households and absent fathers has increased. The after effects of the Apartheid 
era may directly and indirectly effect the decisions made by Nabanda and other pre-ART care 
patient to access health care and to take responsibility for their own children. In South Africa, 
when reflecting on strengthening access to health systems, it is important therefore to 
consider not only proximate issues, but the continued impact of Apartheid and the structures 
of social exclusion on contemporary families and decision making regarding family 
responsibilities and care. As a result there is need for more research to better understand the 
ripple effects of to better address these health accessibility gaps (Harris, 2014) 
5.10 Service delivery costs, monitoring systems and accountability 
The latest UNAIDS progress report has recognised South Africa as taking lead in their 
commitment to mobilising resources towards meeting the global targets in HIV service 
delivery (2015). The cost of ART in public health facilities for SA is higher than other 
African countries, at an estimated average of $682/person/year (Tagar et al., 2014). This 
estimate includes personnel, laboratory and other costs (Tagar et al., 2014).  Another study 
showed that the mean monthly cost for managing an ART patient ($2415) was two times 
more than that of a pre-ART ($1207) at a referral hospital research project in Johannesburg 
this costing (Martinson et al., 2009). This costing reflects the fact that ART service delivery 
is higher than pre-ART probably due to the costs of ARVs and multiple blood tests for 
monitoring. This means that if people can use pre-ART services, the cost of care is reduced.  
These cost differences are evidence that the government invests more resources in ART 
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patients than pre-ART patients and as a result, there is the likelihood that more efforts are put 
in monitoring ART service delivery than are for pre-ART. For example, the results showed 
that better monitoring systems are in place for ART service delivery, demanding 
accountability from the facility on monthly performance. On the other hand, even though 
there are registers to record pre-ART services, there is poor recording leading to incomplete 
records and less accountability as facilities are not requested to collate and report pre-ART 
indicators on a monthly basis.  
This trend drills down to patients themselves when they referred to pre-ART as “simple 
treatment,” whilst ART was regarded as “serious treatment,” as one patient explained: “I am 
very scared, maybe my CD4 cell count has dropped further by now. Maybe I need to start 
taking the serious HIV medication (referring to ART)!” There is logic in the patients‟ 
interpretation, as ART medication (ARVs) is expensive, requiring prescription and close 
monitoring, it is a more serious treatment than pre-ART multivitamins, which need no 
prescriptions nor close monitoring. However, the patients‟ assumption that since the pre-ART 
medication is not serious then the program can be ignored is critical, and needs to be urgently 
addressed as it is important for the patients to see the link of pre-ART to ART. This 
assumption could be the plausible reason for poor retention in pre-ART compared to ART 
reflected in this study. Another study conducted in Johannesburg, that followed up a cohort 
from HIV diagnosis for one year, showed a higher attrition among pre-ART (57%) than after 
ART initiation (2.1%) (Clouse et al., 2013). Drawing on the above assumptions, evidenced by 
increasing CD4 cell count cut off point from ≤200-≤500 cells/μl within between 2012-2014 
(SA, 2014(b)), we could say that currently ART is a more serious business for government, 
service providers and patients themselves than pre-ART. The challenge is that increasing the 
ART CD4 cell count initiation cut off points without prioritising pre-ART care can only reach 
those accessing pre-ART care and will miss those not accessing the current pre-ART 
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services. Yet it is critical that pre-ART care be prioritised by the government, service 
providers and patients themselves, because poor retention leads to delays in ART and 
PLWHA missing out on all the benefits, described above. In addition, those who are on ART 
and virally suppressed reduce the risk of HIV transmission (Cohen, 2011) whilst the risk of 
HIV transmission for pre-ART patients is high, making it critical to target pre-ART care 
patients as a source of HIV infection to curb the spread of HIV. 
5.11 Incompleteness of data and monitoring of pre-ART services 
During the file and register audits, major gaps in relation to pre-ART data collection were 
established. In both study sites, the pre-ART registers were far less complete than the ART 
registers. The main reason for this was that, at the time of the study, most of the ART register 
data elements were used in monthly progress reporting of DHIS indicators whilst most data 
elements for the pre-ART register were used only for monitoring at a facility level, as 
described in Chapter four. As a result, the facility managers responsible for the compilation 
of monthly DHIS data would monitor and remind staff to ensure proper recording and timely 
reporting for the DHIS data elements but not those data elements not included on DHIS. 
Facility data can be used in monitoring the quality of services provided in the facility and 
adjustment of care through quality improvement processes which can best be achieved if data 
is of high quality (Pass, 2010). Nonetheless, the incompleteness of data found in this study is 
similar to that found in the South African public health sector (Ndabora et al., 2013, Nicol 
and Bradshaw, 2010). It compromises five components of data: accuracy, completeness, 
reliability, precision and integrity (Pass, 2010). This finding indicates that the degree of 
accountability on program areas directly affects the quality of data. This is in line with a 
quote from the latest UNAIDS report “measure what you treasure: when it comes to data, 
what gets measured gets done” (UNAIDS, 2015: 408). Unless the pre-ART indicators are 
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captured and included in the DHIS, the service implementation will neither be done nor 
documented.   
However, the interviewed staff complained that there was too much documentation required 
and spoke of completing the different registers, reducing time spent on patients and so 
potentially compromising the quality of patient care. This was triangulated in this same study 
as nurses rated the lowest as sources of HIV information for pre-ART patients. An 
assessment conducted in 2011 established that there were a minimum of 54 registers in the 
health facilities which were found to consume patient care time and took up a lot of space in 
the patient consultation rooms and other areas (Dombo et al., 2014). As a result, DoH with 
the support from HST technical advice integrated and reduced the registers from 54 to six. 
This was piloted in 2012 and currently the Rationalisation of Registers (ROR) project is 
being rolled out across all South African provinces (Dombo et al., 2014).  I envisage that this 
is a possible solution to problems in time constraint related gaps due to documentation. 
Therefore supporting the implementation of ROR in the facilities should address this gap in 
all facility service points including pre-ART.  
5.12 Referral system of complicated cases 
A referral system was in place for PHC facility staff from the study sites for complicated pre-
ART care patients to go to Hillbrow CHC clinic or Charlotte Maxeke Academic Hospital 
(CMAH). However, there was a poor feedback system from the referral sites which the staff 
felt was a “missed learning opportunity.” Communication between the referral initiation and 
receiving facilities is critical to ensure continuity of patient care (SA, 2009) and this 
established disconnection in communication of patient management at different levels of care 
can lead to discontinuity of care.  In addition, documentation on the referral of patients at 
different levels can be used by supervisors for capacity building (SA, 2009, WHO, 2015); 
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hence this finding is indeed a missed learning opportunity for service providers at both levels 
of care. To ensure continuity of patient care and monitoring of the referral system, it is 
critical to strengthen documentation and feedback at all levels of care. 
5.13 NIMART roll-out  
WRHI as a PEPFAR partner for CoJ provided technical support in rolling out NIMART. This 
was a ten step process. The first step was to conduct the third to fifth stages of this process 
focussed on NIMART roll out readiness assessment to identify gaps to be addressed in order 
to implement NIMART. Throughout the process, there was the need for a sense of ownership 
and commitment to address the gaps in order to make NIMART implementation a reality. Of 
interest was Clinic A‟s facility manager, described in the case study (4.3.1), who was 
committed to implement NIMART. Her commitment led the facility to improve from being 
least likely to participate in NIMART, to be among the first to implement NIMART. The 
case is a good example of maximising available resources to address quality gaps. The 
facility manager‟s commitment and innovative ideas enabled her to quickly address facility 
health problems in readiness for NIMART implementation. Engaging with the service 
providers themselves in quality improvement processes can enable them to find ingenious 
solutions to address gaps using available resources (Rahimza et al., 2014). 
Decentralisation of ART initiation through NIMART in Region F in the CoJ significantly 
increased uptake of ARVs by a monthly average of 99 patients immediately after rollout 
(p=0.013). This is consistent with findings from other studies, as rolling out NIMART to 
PHC facilities reduces the distance for patients to travel and requires fewer levels of referral 
for ART initiation, potentially leading to an increase in ART patient retention and access to 
services (Brinkhof et al., 2008, Zachariah et al., 2007). However, patient dissatisfaction with 
lack of trained HIV clinical staff, and negative patient-nurse interactions, compromising 
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confidentiality and stigma at lower levels of ART services has been highlighted (Decroo et 
al., 2011). Better mentoring and support for nursing staff are indicated to address these 
problems. 
I have shown how the ten-step process involved in rolling out NIMART succeeded, with 
support from partner organisations, ensuring buy-in and sustainability of the program. 
Establishing that rolling out NIMART was a priority, and engaging with service providers, 
enabled both WRHI mentors and CoJ partners to have a shared vision, which inspired and 
motivated implementers in achieving sustainable change (Hunting and Tilbury, 2006). 
The roll out of NIMART led to a steady reduction in the number of patients requiring 
initiation of treatment in the main referral health facility. This decrease allowed for the 
treatment of more complicated cases being managed at the referral site (Chan et al., 2010), 
while straight forward cases continue to be managed at a local PHC facility by nurses. The 
advantage of primary health care involvement at a local level in ART service delivery, 
especially in resource-limited settings, has been emphasised previously (Wester et al., 2005, 
Zachariah et al., 2007). However, there is a need for proper guidelines for upwards referral of 
complicated cases to prevent unnecessary delays in line with the WHO referral system 
adopted in SA (WHO, 2015). Providing ART initiation without increasing human and space 
resources resulted in an increased workload in CoJ primary health clinic levels. Staff shortage 
and lack of sufficient consulting rooms has been documented as a barrier to rolling out 
NIMART (Cameron et al., 2012, Jones et al., 2012). It is important to ensure capacity 
building, training and mentoring of nurses to integrate HIV services in order to reduce 
workload and provide a comprehensive package of care to patients. Partnership with the 
DoH/CoJ proved integral to increasing outputs as well as to sustainability of the NIMART 
program.  
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Introduction of NIMART resulted in an immediate increase in the number of ART initiations 
for Region F. The number of initiations was initially high but eventually stabilised, with 
evidence of an increasing trend in monthly initiations after NIMART. Decentralisation of 
ART through down-referral and NIMART services has also shown to be cost-effective, 
increase access and strengthen retention of patients on ART, owing to the closer proximity to 
their homes and decreased costs (Brinkhof et al., 2008, Miles et al., 2007, Sanne et al., 2010, 
Zachariah et al., 2007).  
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Chapter Six 
Conclusion and Recommendations 
6.1 Summary 
This research project was conducted to understand retention in and access to pre-ART 
services, with the goal that this information would allow me to draw recommendations to 
improve the quality of pre-ART services delivery. These research aims were achieved 
through a cross-sectional survey to establish the gaps in pre-ART service delivery, their 
causes and solutions to address the identified gaps. In addition, I documented the 
implementation of NIMART, with a focus on the effectiveness of this mode of service 
delivery and the lessons learnt that are applicable in pre-ART service delivery, as provided by 
nurses at primary health care service delivery level. In this study, I established that there was 
poor access to the available comprehensive services (described in sections 2.3-2.4) by 
patients retained in pre-ART care. The majority of the retained patients only accessed the 
minimum CD4 cell count monitoring and multivitamin tablets and not the whole prescribed 
comprehensive package of pre-ART services, although all these services were available at the 
facilities. Currently, there is evidence of high loss to care of pre-ART care patients with less 
than half retained in care (Rosen and Fox, 2011, Clouse et al., 2013, Lessells et al., 2011). 
According to these study findings, even the few patients retained in pre-ART care do not 
access the available comprehensive pre-ART care package. This is a critical new finding not 
found in other studies (Fox and Rosen, 2010, Fox et al., 2014, Lessells et al., 2011) and a 
great lost opportunity with the realisation of the importance of accessing all services (Chapter 
two).  
The results showed lack of awareness of the available comprehensive pre-ART package and 
this was directly associated with poor uptake of services (Figure 4.6). As a result, one 
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possible reason to this lack of access to pre-ART care services for patients retained in care 
would be lack of awareness of the comprehensive pre-ART package, as shown in other 
studies (Tshuma et al., 2014, Chimoyi et al., 2015, Nyasulu and Nyasulu, 2011b). This means 
that raising awareness of the available services may improve access consistent with other 
findings (Smith et al., 2013, Nyasulu and Nyasulu, 2011a). 
Stigma against patients who were HIV+ was established to still occur in pre-ART care 
services. To date, even though there are multiple advocacy efforts to fight against stigma, 
HIV has not been normalised and discriminatory attitudes continue. As a result, people with 
HIV are reluctant to present to pre-ART care services, lest others suspect that they are HIV+. 
Some patients felt stigmatised by pre-ART service providers and even though no specific 
examples for this claim were given by the patients themselves, the finding is consistent with 
other findings (Famoroti et al., 2013).  
In addition, there is a lack of normalisation of men accessing health facility care compared 
with women. Participants explained that it was normal in this society to see a healthy woman 
accessing care in a health facility, whilst it is an anomaly for men to access care with the 
same frequency. This has led to men‟s reluctance to access available pre-ART care. Pre-ART 
care patients who are healthy are able to lead a normal life, and are therefore not expected to 
visit a clinic. On the other hand, it is also important to emphasise that one‟s HIV+ status is 
expected to be treated as private and confidential, disclosed only by the HIV+ person or the 
service provider with consent from that person.  
At the time of this study, patients were not able to collect CD4 cell count blood results on the 
same day of providing blood samples; they were asked to come back to the clinic after two 
weeks. At times when they came back to collect their blood results, the results were missing, 
requiring them to be retested. Other studies have shown attrition in care between testing 
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HIV+ and linkage to care, including the collection of CD4 cell count results (Faal et al., 
2011, Larson et al., 2013, Losina et al., 2010, Schnippel et al., 2013). Loss of blood results 
established in this study appeared to be associated with attrition. Currently multiple studies in 
South Africa, of which one was conducted in the inner City of Johannesburg, have shown 
that point of care (POC) collection of CD4 cell count results increases retention in care (Faal 
et al., 2011, Jani et al., 2010, Larson et al., 2013, Wynberg et al., 2014) worth considering.  
Many times, when gender is discussed in relation to access to care, the scale tips towards men 
as the ones in control of finances and decision makers, leading to barriers for women to 
access care (Nyasulu and Nyasulu, 2011b, Nyasulu and Nyasulu, 2011a, HIarlaithe et al., 
2014). In contrast, this study has established the fact that men are most often lost to follow up 
and the contributing factors that explain why men and youths are most often lost to follow-up 
are consistent with those in other studies (Mugglin et al., 2012, Rosen and Fox, 2011). Men, 
mainly bread winners, explained that they lacked time to attend pre-ART care clinic which 
was aggravated by multiple interrelating factors (Figure 5.1), meaning they had competing 
priorities to using their time to access pre-ART care. Likewise, young people have other 
priorities in life, including socialisation, as well as education and employment - hanging out 
with friends rather than sitting in the queue at a health facility (SA, 2013c). Women were 
better able to attend the clinic as they had many other reasons, including family planning and 
infant and child health care, to visit the clinic; youths and men were seen by others as 
presenting only for pre-ART or ART. Unless efforts are made to reduce clinic time for men 
and youths, and indeed for all people, the health system is likely to continue to lose them 
from care.  
Lack of disclosure of HIV+ status by pre-ART care patients was also established in the study. 
Those who were employed were more likely to disclose than their unemployed counterparts. 
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This means that the financial gains and self-reliance that comes with employment puts an 
individual in a better position to disclose (Makin et al., 2008), as financial reliance on 
someone like a partner has been reported to be a barrier to access to services, as this risks 
unplanned disclosure (Nyasulu and Nyasulu, 2011b). Even though disclosed HIV+ status can 
lead to stigma and discrimination, disclosure is important if pre-ART patients are to access 
the comprehensive pre-ART care package; supporting adherence to care, especially through 
building up the support structure around the individual (Worley et al., 2009, Unge et al., 
2010). 
In addition to patient-related factors highlighted above, health service delivery gaps were 
identified in this study. One finding was the lack of use of facility data for planning of service 
delivery. The compilation and completeness of monthly data mainly depended on what was 
reported through the District Health Information System (DHIS). At the time of the study, 
ART indicators were included on DHIS and not pre-ART indicators. As a result, I was able to 
establish that there was poor recording and collation of pre-ART indicators, which led to 
service providers not knowing the uptake and progress of pre-ART services. This contrasted 
with ART indicators, which had well completed registers with proper monthly collation for 
DHIS monthly reporting. However, pre-ART care is equally important as ART because for 
its relevance in ensuring timely ART initiation and in preventing HIV transmission.  
Lastly but not least, the introduction of NIMART in the CoJ, through training, mentoring and 
coaching of nurses, with clear patient outcome indicators, was shown to have a positive 
impact on the uptake of ART services. However, in the case of pre-ART care roll-out with 
nurses, there was no training, mentoring and coaching of service providers, nor were there 
clear indicators to monitor progress. Therefore, although pre-ART care appeared to be 
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already in progress, there is need to put systems in place to train, mentor and coach pre-ART 
service providers and monitor pre-ART service uptake progress.  
6.2 Government’s commitment to improving access to care 
There are several efforts by the South African Government in investing resources to improve 
the quality of care and access in public health services, for example, ensuring that all 
facilities meet the minimum standards through the implementation of NCS through the 
OHSC, the NHI piloting (SA, 2011b), Rationalisation of Registers (ROR)  (Dombo et al., 
2014), implementation of ideal clinics (Zuma, 2014) and other initiatives. These efforts are 
key to improving quality of health services and access. However, there is lack of clarity on 
how these efforts are related to each other as they are mostly implemented as parallel separate 
structures, confusing the implementers at facility level.  
The latest UNAIDS report (2015) has commended the commitment shown by South African 
Government in taking lead in the African continent in expanding the ART program. For 
instance, SA increased the CD4 cell count levels for ART initiation from ≤200 cells/μl to 
≤350 cells/μl then of late to ≤500cells/μl in line with the changing body of knowledge aiming 
to attain maximum benefits of ART to South Africa as a whole (SA, 2014(b)). Currently SA 
is focusing on achieving the 90-90-90 target which is the latest UNAIDS global strategy 
towards elimination of HIV (UNAIDS, 2014a).  Even though these efforts have high 
immediate national budgetary implications (Nene, 2015, Motsoaledi, 23 July 2014), they 
have massive benefits in averting new infections, curbing morbidity and mortality, and 
improving the quality of life of all people (Granich et al., 2012).  
From the time of ART roll-out to date, the South African ART guidelines were being 
produced in four different sets which were: (1) HCT, (2) Pediatric, (3) PMTCT and (4) 
Adolescent and Adult guidelines (SA, 2013d, SA, 2013e, SA, 2010b).  This posed a 
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challenge as service providers had to consult different sources when managing different 
categories of patients, and so wasted time. On a positive note, the latest 2015 South African 
ART guidelines have been consolidated into one source document (SA, 2014b). This change 
will strengthen the integration of patient management, whereby a pregnant woman can be 
managed together with her child and spouse using one guideline reference document.  
6.3 Recommendations 
In view of the findings in this study, in order to strengthening health systems and improving 
access and retention in pre-ART care, recommendations are made. This study, although 
conducted among pre-ART and ART patients, identified many health systems gaps and the 
consequent recommendations are applicable to different service delivery points and can still 
be relevant even if the policy changes to treating all HIV+ persons regardless of their CD4 
cell count level. These recommendations are in line with the study‟s conceptual framework 
illustrated in section 2.10 of this thesis. For better understanding and application, the 
recommendations are classified according to the WHO health systems building blocks, 
already described in Chapter Four which are: Service Delivery, Health Workforce, Health 
Information Systems, Access to Essential Medicines, Financing and Leadership/Governance. 
These are outlined below. 
6.3.1 Service Delivery 
 At all levels (from strategic to service delivery levels), there is an urgent need to 
address the existing gaps in the pre-ART care service delivery and improve access by 
those already in care, even before thinking of following up on those lost from care or 
registering more in care. In addition to increasing resources to increase the numbers of 
people initiated on ART, it is critical that the South African government‟s HIV 
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policies and guidelines prioritise access to comprehensive pre-ART care by those 
retained in care, and then to address those lost from care or not linked to care.  
 Service providers should maximize the use of time patients spend at the clinic while 
waiting to be seen by raising awareness of available pre-ART services among 
patients. This can be accomplished through health talks and posters on the pre-ART 
services provided at the facility, which were not available at the time of the study. The 
content in the poster and health talk should answer the following questions: 
o What is pre-ART care? 
o Why is pre-ART care important? 
o What pre-ART care services are available in the facility? and 
o What one can do to access the available pre-ART care services? 
 Working on ways of reducing time spent on seeking pre-ART services can positively 
affect uptake of the services. This can also reduce unplanned disclosure of the 
patients‟ HIV+ status mainly among youths and men. This can be achieved through 
initiatives at different levels such as: 
o Integration of  pre-ART care by service providers with other existing services 
like family planning and cervical cancer screening, just to mention a few; this 
was recommended mainly by patients themselves in this study. Patients 
reported that parallel service structures at PHC level led to different service 
points giving different clinic appointment days, increasing the number of days 
and times that pre-ART care patients needed to spend in the facilities. 
Integration of services has always been recommended in South Africa, but was 
still not in existence at the study sites at the time of the study. The plausible 
contributing factor to lack of integration is that service providers are not multi-
skilled and so are unable to provide a one stop shop service package. Currently 
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the South African health system is rolling out the implementation of the Ideal 
Clinic concept which focuses on multi-skilling service providers, enabling 
them to provide all services in one room (Zuma, 2014). Therefore the SA 
Government – Ministry of Health (MoH) needs to prioritise incorporating Pre-
ART care services in the Ideal Clinic roll-out; after all, the integration of pre-
ART care into current primary health care services has already been shown to 
retain pre-ART patients in care (Kohler et al., 2011, Smith et al., 2013). In 
addition, it is critical that the Ministry of Health (MoH) clarifies the 
integrative efforts towards achieving the common goal of improving access 
and quality of health care inclusive of pre-ART. 
o Service providers to pre-pack pre-ART medications (multivitamins and IPT) 
to ensure that patients do not wait in the queues to collect them. 
o Currently with technical support from Health Systems Trust, the South 
African government is piloting a program that provides alternative chronic 
medicine access to public sector patients through the Central Chronic 
Medicine  Distribution and Dispensing Programme (CCMDDP) (HST, 2015 
April, Du Toit, 2014).  The first phase for this project targets HIV+ ART-
initiated individuals who are adherent and virally suppressed, with the second 
phase incorporating many other chronic diseases, such as TB continuation 
phase, hypertension treatment, Diabetes Mellitus type 2, epilepsy and 
dyslipidemia (Du Toit, 2014). More chronic conditions will be added as the 
programme matures. I recommend that the Ministry of Health adds pre-ART 
medication to this list for those patients who are stable and are not scheduled 
for blood tests.  
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o SA Government - MoH needs to consider POC CD4 cell count results in order 
to reduce the number of patient clinic visits to ensure retention among pre-
ART care patients (Larson et al., 2013, Faal et al., 2011, Jani et al., 2010, 
Wynberg et al., 2014), even though two to four times much more expensive 
(Cassim et al., 2014).   
 It is critical that South Africa explores new ways of addressing the existing stigma 
and discrimination against those who are HIV+. Focussing on normalising HIV+ 
status in the community and among service providers, as an approach to reduce 
stigma against people who are HIV+, may result in greater retention among pre-ART 
care patients. In addition, unless clinic visits by men is normalised, the public health 
system will continue to lose men from care, not just in pre-ART care but also at many 
other service points. 
 There is a need for service providers to continuously support pre-ART patients to 
disclose their HIV+ status, to ensure they have a support structure around them as 
stipulated in the pre-ART care guidelines (SA, 2013d, WHO, 2008, WHO, 2013a). 
This type of support structure has shown to improve retention in HIV care (Rankin et 
al., 2005). 
 There is need for service providers to ensure that pre-ART patients access the 
comprehensive pre-ART care package and not just CD4 cell check and multivitamin 
tablets supplies when patients present at a health facility. In order to address this, I 
have designed a checklist (Appendix 8.1) on all pre-ART services to be offered at 
each visit. If this checklist were put in the patients‟ files, it would remind service 
providers and patients themselves to discuss what services can be accessed on the day 
of their visit. 
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 Service providers must ensure that health service facility users are sensitised on the 
available complaints management protocol for them to maximise its benefits.  
 Service providers should incorporate interventions targeting men, with a focus on 
providing services that account for their mobility due to employment. This  may result 
in retention in pre-ART and improved uptake of HIV services (Marson et al., 2013). 
6.3.2 Health workforce 
 Heath service delivery management should strengthen quality and frequency 
counselling of pre-ART patients with a focus on building capacity of facility HIV 
counsellors through training, mentoring and coaching on HIV counselling to pre-ART 
care patients. This would include providing counsellors with accurate information 
about HIV prevention and the disease progress.   
 It is important that service providers are trained, mentored and coached in using the 
existing tools to identify service delivery gaps and causes in order for them to apply 
the quality improvement processes to address the existing gaps. 
 There is need for the CoJ health service delivery management to establish YFHS in all 
facilities through training mentoring and coaching service providers in YFHS as well 
as availability of youth peer educators. 
 Although pre-ART care appeared to be already in progress, there is need for CoJ 
health service delivery management to put systems in place to enable training, 
mentoring and coaching of pre-ART service providers in implementation and 
monitoring of pre-ART service uptake progress.  
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6.3.3 Health Information Systems (HIS) 
 The HIS team needs to prioritise supporting service providers in documentation, 
completeness of records and use of information for pre-ART services‟ facility 
planning. This can also be achieved by including more pre-ART care uptake progress 
data elements in monthly DHIS monitoring, as it directly calls for facilities to be 
accountable for their pre-ART services that they deliver in the facilities - “measure 
what you treasure: when it comes to data, what gets measured gets done” (UNAIDS, 
2015: 408). 
 Linkage to care from the point of testing HIV+ to joining pre-ART care program is a 
challenge. Use of e-health facilities, whereby electronic registers are used, would 
assist to link patients to care from testing to pre-ART program enrolment would 
strengthen linkage to care. 
6.3.4 Access to essential medicines 
 Pre-ART medicine stock outs have been established in this study, leading to increased 
clinic visits or the expectation that patients would buy medication that they mostly 
could not afford. Therefore there is need for facility managers to ensure timely re-
ordering of medications as well as allocation of resources by CoJ health service 
delivery management to ensure the timely procurement of the medications. 
6.3.4 Leadership, governance and financing, 
 The national as well as the CoJ health service delivery leadership and management 
should prioritise the allocation of resources for additional staff recruitment in order to 
curb the staff shortage problems in the facilities and improve supply chain 
management. 
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 A number of gaps identified are in relation to the key health ministerial six priority 
areas, described above in Chapter Two of this thesis. Long waiting times, negative 
staff attitude, and drug stock outs are an indication of how far implementation of pre-
ART care services are from meeting the six priority areas. Access to services in a 
facility can easily be achieved if the SA MoH leadership provides support and 
guidance for health service facilities to work towards meeting these key ministerial 
priority areas in all service points, including pre-ART. 
6.4 Areas for further research 
The findings presented in this thesis point to the need for more research to further explore the 
complex factors contributing to poor access to pre-ART services, especially for patients 
retained in care. In addition, more research needs to be done on testing some innovative ideas 
in addressing the identified gaps to improve access to available pre-ART services. Below are 
proposed areas for further research: 
 More research needs to be done on those patients not retained in pre-ART care, to 
explore ways of retaining them in care. These factors can be complex and much of 
the time, out of control of the service providers and patients themselves, but it is 
critical when working on the research questions to think broadly by involving 
decision makers, politicians and the community as they also influence these factors.  
 Normalising HIV+ status may enhance retention results among pre-ART care 
patients. However, more research needs to be done on defining and establishing the 
normalisation of HIV+ status, care of people with HIV, and the role of HIV+ status 
normalisation in retention of HIV+ patients in care. 
  There is need for further research on integration models in delivery of pre-ART 
services (Siapka et al., 2014). 
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 The pre-ART care checklist (Appendix 8.1) needs to be tested to determine its 
effectiveness in improving access and retention in pre-ART care.  
 Despite the many challenges in the health service delivery system, there are still 
many service providers who are committed to providing quality patient care. More 
research needs to be done to explore motivation factors for health service providers. 
 One recommendation from both service providers and patients themselves was to 
provide six monthly pre-ART medication packs to reduce patient clinic visits to twice 
a year. More research should be done to establish if reducing the number of visits for 
patients might improve retention in care for pre-ART patients.  
 Other patients felt it would be better if they could collect the pre-ART care 
medications near to their place of residence or work, rather than from the clinic. One 
example of this model would be to use community distribution agents or expert 
patient-volunteers to dispense medication at a household or community level, or for 
patients to collect their medication from a chemist near their place of residence or 
work. Others preferred to collect their medication at the facility but outside working 
hours, and proposed that facilities provide the services during the weekend or after 
working hours. This latter suggestion would allow a wide range of services consistent 
with pre-ART; the former two assume that pre-ART involves only basic medication. 
These delivery innovations need to be tested to see if they can improve retention of 
pre-ART patient in care. 
 Another option that requires testing would be fast queues for pre-ART care patients 
through the pre-packing of medication, so that patients just come and collect their 
medication without waiting in the queue, unless they are scheduled for a 6 monthly 
CD4 cell count and comprehensive services. 
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 There is need for operational research that would test the effect of some innovative 
ideas targeting men and youths to retain them in pre-ART care; for example, fast 
queues for working men and school going youths, and consulting pre-ART care 
youths separately from adults. Mainly innovations need to be developed and tested to 
reduce waiting times, and clinic visibility of pre-ART youths and men. 
 More research should be done on the importance of documentation, complete records 
and use of information for health facility planning. For example, with the current 
implementation of ROR project, it is critical to establish whether the reduction of 
registers has created time for longer consultation to allow delivery of comprehensive 
pre-ART care. 
6.5 Conclusion 
In conclusion, the study has established poor access to prescribed pre-ART care services for 
those retained in care, a gap not yet identified in other studies. Many interrelated factors have 
been established to negatively affect access to available pre-ART services, such as lack of 
awareness of the available services, negative staff attitude, and lack of time to attend the 
clinic, aggravated by poor service integration, loss of blood results and no immediate CD4 
cell count results.  Stigma and discrimination against those living with the HIV virus has also 
shown to lead to lack of normalisation of HIV as a disease, making it difficult for people to 
disclose their HIV+ status. Access to the available pre-ART services has shown to lead to 
fear of unplanned disclosure, especially among youths and men in this study. However, 
training, mentoring and coaching of service providers in NIMART has been shown to 
significantly improve ART uptake in this study, suggesting that if a similar approach were 
applied to pre-ART it may yield similar results. To improve uptake of pre-ART, care 
services, it is critical that resources are invested in addressing the above identified gaps.  In 
addition more research around the lived experiences of pre-ART care patients, their 
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challenges, causes and possible solutions to poor care address these is needed to better 
understand the Health Systems Strengthening (HSS) approaches to be used.   
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8.0: Appendices 
8.1 Pre-ART services checklist 
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Pre-ART 
services 
received 
Patients’ Name                                                                 File# 
Patients’ facility visits 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Counselling                   
TB Screening                   
Family Planning                   
CA screening                   
CD4 cell count                   
Multivitamin                   
Support group                   
Social grant                   
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8.4 City of Johannesburg research approval letter 
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8.5: Data collection tools 
8.5.1: Consent forms 
8.5.1.1 Patient Interview consent forms 
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Information Sheet and Informed Consent – Patient  
1. Introduction 
Hello, my name is _________________. I am a researcher at the Wits Reproductive Health 
Institute (WRHI) of the University of the Witwatersrand. We would like to ask you to 
participate in a research study, entitled “The effect of an appropriate wellness program in a 
PHC facility on the retention of HIV+ pre-ART individuals in the city of Johannesburg.”  
 
This consent form will give you information to help you decide whether you would like to 
participate by answering a questionnaire on client satisfaction.  
 
1. Before agreeing to participate, it is important that you read and understand the following 
explanation of the purpose of the study, the study procedures, benefits, and risks, and 
your right to withdraw from the study at any time. 
This information leaflet is to help you to decide if you would like to give your permission 
to participate. You should fully understand what is involved before you decide to take 
part in this study.  
2. If you have any questions, do not hesitate to ask me.   
3. You should not agree to take part unless you are satisfied about all the procedures 
involved.  
4. If you decide to take part in this study, you will be asked to sign this document to confirm 
that you understand the study. You will be given a copy to keep. 
2. Purpose of the study 
We have been commissioned by Wits reproductive Health Institute (WRHI) senior 
management and DASH program managers to conduct a baseline assessment now and a 
project evaluation at least a year later on the wellness programs in the PHC facilities. The 
evaluation has been endorsed by managers from the CoJ and the Gauteng DOH. The baseline 
assessment will assist in identifying gaps in how the pre-ART program services are delivered 
at PHC level. The identified gaps from the assessments will be used to inform future program 
decision and to improve the quality of the program. 
 
3. Why we would like to interview you 
Your experience in accessing services at this PHC which is one of the sites offering pre-ART 
care services is integral to us understanding the strengths and challenges facing this program. 
The purpose of the interview with you is to obtain a general impression regarding service 
delivery around the Pre-ART or wellness program and your views around access and quality 
of care being provided to you as a client.  
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4. Length of the study and participants 
The study is being performed in selected City of Johannesburg Primary Health Facilities. The 
study is running from July 2012 to July 2014. We will interview patients accessing pre-ART 
care and their health service providers in selected facilities in the city of Johannesburg. 
 
5. Procedures 
One research team member will interview you and take notes using a semi-structured 
questionnaire. The interview will take approximately 45 minutes. All findings of the study 
will be anonymous i.e. you will not be identified. Your views along with clients interviewed 
will be collated and analysed, however as mentioned, we stress confidentiality and anonymity 
of the information you provide. 
 
6. Will any of the study procedures result in any inconvenience? 
During the interview, we will ask you questions about your experience in accessing and using 
certain services at this clinic. You do not have to answer any of the questions if you do not 
feel comfortable doing so. We will maintain confidentiality of your responses, only the 
researchers will have access to any identifying information. We assure you that information 
you may share with us will remain confidential and anonymous i.e. none of the information 
will be shared with the health care workers, therefore you will not be victimized in any way. 
There are no risks to this research as it does not involve using any drugs or taking blood tests. 
There are also no discomforts. However you may be referred to facility based counsellors for 
counselling, care, support and further referral when necessary. 
7. Benefits 
There are no direct benefits to participating in the interview. However, your answer will help 
program managers to understand the issues around implementing the pre-ART program. The 
answers you provide may help to improve the quality pre-ART or wellness program in the 
future. 
 
8. Rights as a participant in the study 
Your decision to participate in this study is completely free and you can decline to be part of 
the study at any time, without stating any reason. Your decision to participate in this study 
will not affect your relationship to the WRHI or other partner organisations in any way.  
 
9. Financial arrangements 
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There is no cost to you for being in the study.  There is no cost to you for taking part in the 
interview. WRHI will cover all costs related to implementation of the study. 
 
10. Reimbursement for study participation 
You will not be paid if you decide to participate in this study. 
 
11. Ethical approval 
This study protocol has been submitted to the University of the Witwatersrand, Human 
Research Ethics Committee (HREC) and written approval has been granted by that 
committee.  
 
12. Confidentiality 
All information obtained during the course of this study, including hospital records, personal 
data and research data will be kept strictly confidential.  Data that may be reported in 
scientific journals will not include any information that identifies you as a participant in this 
study. 
The information might be inspected by the University of the Witwatersrand, Human Research 
Ethics Committee (HREC), these records will be utilised by them only in connection with 
carrying out their obligations relating to this study. 
 
13. For More Information 
The 24-hour telephone number through which you can reach Juliet Nyasulu or other 
authorized persons is: 0739735487 
If you want any information regarding your rights as a research participant, or complaints 
regarding this research study, you may contact the Chairperson of the University of the 
Witwatersrand, Human Research Ethics Committee (HREC), which is an independent 
committee established to help protect the rights of research participants at (011) 717 2301. 
 
Should you have any questions concerning this study, please contact us:  
Juliet Nyasulu   Tel: 0739735487 Email: jnyasulu@wrhi.ac.za  
Dr Vivian Black                                Tel 0113585500             Email vblack@wrhi.ac.za  
Our supervisor is Professor Eugene Sickle and he is contactable on: 
Tel: +27 11 358 5500 Email: sickle@wrhi.ac.za  
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WRITTEN PARTICIPANT INFORMED CONSENT – PI 
 
The effect of an appropriate wellness program in a PHC facility on the retention of HIV+ pre-
ART individuals in the city of Johannesburg. 
 
I hereby confirm that I have been informed by _______________________ about what my 
involvement in this in-depth interview would entail.  I have also received, read and 
understood the above written information regarding the study.    I am aware that the results of 
the study will be anonymously processed into a study report.  In view of the requirements of 
research, I agree that the data collected during this study can be processed in a computerised 
system by __________________ or on their behalf. 
 
I may, at any stage, without prejudice, withdraw my consent and participation the interview.  
I am not required to give a reason for withdrawal, and leaving the study will not affect my 
future relationships with WRHI or partner organisations.  I have had sufficient opportunity to 
ask questions and (of my own free will) declare myself prepared to participate. 
If you want a copy of this signed consent form we will provide it for you. 
1. I confirm that I have read and understood the information sheet for the above study 
and have had opportunity to ask questions. yes /No 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving reasons. yes /No 
3. I agree to take part in the study. yes /No 
4. I agree to access to my clinical records by the study team yes/No 
5. I agree to the interview being audio recorded. yes /No 
PARTICIPANT: 
I have read this consent form (or had it read and explained to me), and all of my questions 
have been answered to my satisfaction.  My signature below confirms that I agree to take part 
in the study. 
 
Printed Name     Signature     Date and Time 
INTERVIEWER: 
I, __________________, herewith confirm that the above participant has been fully informed 
about the nature, conduct and risks of the above study. 
 
Printed Name   Signature     Date and Time  
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VERBAL PARTICIPANT INFORMED CONSENT 
(Applicable only when participants cannot read or write) 
An appropriate pre-ART program at a PHC facility level that would promote retention, access 
to services and timely referral for Antiretroviral Treatment (ART) initiation of HIV+ pre-
ART individuals in the city of Johannesburg, South Africa 
 I, the undersigned, interviewer. ………..................................have read and have explained 
fully to the participant, named ........................…………………………. the participant 
information leaflet.  
 The account I have given has explained both the possible risks and benefits of the study. 
The participant understands these. 
 The participant indicated that he/she understands that the participant will be free to 
withdraw from the study at any time for any reason and without jeopardising his/her 
subsequent treatment.   
I hereby certify that, the participant: 
1. Has confirmed that he/she has understood the information sheet for the above study 
and has had opportunity to ask questions. yes /No 
2. Has understood that his/her participation is voluntary and that he/she is free to 
withdraw at any time without giving reasons. yes /No 
3. He/she agrees to take part in study. yes /No 
4. He/she agrees to access to his/her clinical records by the study team yes/No 
5. He/she agrees to the interview being audio recorded. yes /No 
 
PARTICIPANT: 
 
Printed Name  Mark or Thumbprint (if applicable)  Date and Time 
Interviewer/Fieldworker: 
 
Printed Name     Signature   Date and Time 
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8.5.1.2: Staff interview consent form 
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Information Sheet and Informed Consent – Service provider 
Introduction 
Hello, my name is _________________, a researcher at the Wits Reproductive Health 
Institute of the University of the Witwatersrand. We would like to invite you to consider 
participating in a research study, entitled; “An appropriate pre-ART program at a PHC 
facility level that would promote retention, access to services and timely referral for 
Antiretroviral Treatment (ART) initiation of HIV+ pre-ART individuals in the city of 
Johannesburg, South Africa.” 
This consent form will give you information to help you decide whether you would like to 
participate in the interviews as part of the study.  
Before agreeing to participate, it is important that you read and understand the following 
explanation of the purpose of the study, the study procedures, benefits, and risks, and your 
right to withdraw from the study at any time. This information leaflet is to help you to decide 
if you would like to give your permission to participate. You should fully understand what is 
involved before you decide to take part in this study.  
 If you have any questions, do not hesitate to ask me.   
 You should not agree to take part unless you are satisfied about all the procedures 
involved.  
 If you decide to take part in this study, you will be asked to sign this document to 
confirm that you understand the study. You will be given a copy to keep. 
Purpose of the study 
We have been commissioned by Wits Institute to conduct a baseline assessment and then a 
project evaluation of the project in the city of Johannesburg. The baseline assessment and the 
project evaluation have been endorsed by managers from the CoJ and the Gauteng DOH. The 
research will establish how an appropriate wellness program should be delivered in a PHC 
facility whilst ensuring retention of HIV+ pre-ART individuals. 
Why we would like to interview you 
You are one of the core staff responsible for implementing the pre-ART program. Your 
experience in managing the delivery of these services, and with the strengths and challenges 
of the program, will give us an understanding of how the wellness program is working on the 
ground.  
Length of the study and number of participants 
The study is being performed in selected City of Johannesburg Primary Health Facilities. The 
study is running from July 2012 to July 2014.  
Procedures 
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One of the research team members will interview you and take notes using a semi-structured 
questionnaire. The interview will take approximately 45 minutes. Your responses will be 
audio-recorded. We may also ask your assistance in gathering information on aspects such as 
staffing, drug supplies and facility statistics. The interview will take about one hour or so to 
complete. All the findings of the study will be anonymous. Your views will be combined 
with those of other health workers your name will not feature in the report.   
Will any of the study procedures result in any inconvenience? 
During the interview, we will ask you questions about your work and about your opinion on 
certain services in the clinic. You do not have to answer any of the questions if you do not 
feel comfortable doing so. We will maintain confidentiality of your responses, only the 
researchers will have access to any identifying information. 
Benefits 
There are no direct benefits to participating in the interview. However, your answer will help 
program to understand the issues around implementing the program. The answers you 
provide may help to develop an appropriate wellness program which will improve retention 
of patients in the wellness program quality of ART services in general. 
Rights as a participant in the study 
Your decision to participate in this study is completely free and you can decline to be part of 
the study at any time, without stating any reason. Your decision participate in this study will 
not affect your relationship to the WRHI or other partner organisations in any way.  
Financial arrangements 
There is no cost to you for being in the study.  There is no cost to you for taking part in 
interviews. WRHI will incur all the costs related to conducting the interviews. 
Reimbursement for study participation 
You will not be paid if you decide to participate in this study. 
Ethical approval 
This study protocol has been submitted to the University of the Witwatersrand, Human 
Research Ethics Committee (HREC) and written approval has been granted by that 
committee.  
Confidentiality 
All information obtained during the course of this study, including hospital records, personal 
data and research data will be kept strictly confidential.  Data that may be reported in 
scientific journals will not include any information that identifies neither your facility nor 
yourself as a participant in this study. 
The information might be inspected by the University of the Witwatersrand, Human Research 
Ethics Committee (HREC), these records will be utilised by them only in connection with 
carrying out their obligations relating to this clinical study. 
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For More Information 
The 24-hour telephone number through which you can reach Juliet Nyasulu or another 
authorized person, is 0739735487 
If you want any information regarding your rights as a research participant, or complaints 
regarding this research study, you may contact the Chairperson of the University of the 
Witwatersrand, Human Research Ethics Committee (HREC), which is an independent 
committee established to help protect the rights of research participants at (011) 717 2301. 
Should you have any questions concerning this study, please contact us:  
Juliet Nyasulu   Tel: 0739735487 Email: jnyasulu@wrhi.ac.za  
Dr Vivian Black                                Tel 0113585500             Email vblack@wrhi.ac.za  
Professor Eugene Sickle  Tel: +27 11 358 5500 Email: sickle@wrhi.ac.za  
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WRITTEN PARTICIPANT INFORMED CONSENT: 
The effect of an appropriate wellness program in a PHC facility on the retention of HIV+ pre-
ART individuals in Johannesburg. 
I hereby confirm that I have been informed by _______________________ about what my 
involvement in this interview would entail.  I have also received, read and understood the 
above written information regarding the study.  I understand that what I say will be audio-
recorded.  I am aware that the results of the study will be anonymously processed into a study 
report.  In view of the requirements of research, I agree that the data collected during this 
study can be processed in a computerised system by __________________ or on their behalf. 
I may, at any stage, without prejudice, withdraw my consent and participation the interview.  
I am not required to give a reason for withdrawal, and leaving the study will not affect my 
future relationships with WRHI or partner organisations.  I have had sufficient opportunity to 
ask questions and (of my own free will) declare myself prepared to participate. 
PARTICIPANT: 
If you want a copy of this signed consent form we will provide it for you. 
6. I confirm that I have read and understood the information sheet for the above study 
and have had opportunity to ask questions. yes /No 
7. I understand that my participant is voluntary and that I am free to withdraw at any 
time without giving reasons. yes /No 
8. I agree to take part in study. yes /No 
9. I agree to the interview being audio recorded. yes /No 
 
Printed Name    Signature     Date and Time 
 
INTERVIEWER: 
I, __________________, herewith confirm that the above participant has been fully informed 
about the nature, conduct and risks of the above study. 
 
Printed Name  Signature    Date 
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8.5.2: Patient interview questionnaire 
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Interview Form for Patients 
1. Interview details       
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: ________________  
1.4 Facility code: _____________ 
1.5 Data capturing:  Date_________________  By__________________  
2.  Demographic Information 
2.1 Age: _________        2.2 Gender: Male______  Female_________ 
2.3 Please state your level of education? 1. Never went to School 
2. STD 1-5 
3. Secondary school 
4. Tertiary 
 
2.4 What is your marital status 1. Married or living with a 
partner 
2. Single 
3. Divorced 
4. Windowed 
5. Others specify 
 
2.5 What is your occupation 1. Teacher 
2. Nurse 
3. Casual Labourer 
4. Not employed 
5. Others specify 
 
 
3.0 Access to care 
3.1 Why did you come for this service? I was referred from another service 
_______________ 
 I decided to come on my own? ___________________ 
3.2 Regarding the services, can you describe to me the pathway in which you accessed care 
i.e from HIV pre-test counselling to initiation date?  
[Prompt: guide me to draw the pathway of your care through the system from your first 
encounter at the facility to date] 
 
Participant 
No: 
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4.0 Basic HIV knowledge 
4.1. The following statement focus on knowledge of HIV/AIDS. After each statement, please 
tell me whether it is true or false [Interviewer, only 1 answer is applicable for each question] 
[Mark with an X where appropriate] 
Statements True False 
4.2.3 HIV is the same as 
AIDS 
  
 
4.2 The following statements focus on the perceptions and behaviour surrounding 
HIV/AIDS. After each statement, please tell me whether it is true or false [Interviewer, only 1 
answer is applicable for each question] 
[Mark with an X where appropriate] 
Statements True False 
4.2.1 If you have HIV you cannot get married   
4.2.2 If you have HIV you cannot have an HIV- baby   
4.2.3 If both partners have HIV then there is no need to use 
condoms 
  
4.2.5 I have told my parents that I have HIV   
4.2.6 I have told my family that I have HIV   
4.2.7 I have told friends that I have HIV   
4.2.8 I have told have told my partner that I have HIV    
 
4.3 In your own words, what does it mean to YOU PERSONALLY if an individual has 
HIV? ______________________________________________________________________ 
 
4.4 In your own words, what does it mean if an individual has AIDS?  
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______________________________________________________________________ 
5. CD4 Count Knowledge and Reasons for Return  
5.1  Do you know what a CD4 count is?      1=Yes____        2=No_____ 
 
[Interviewer if the answer is no, explain the answer to the patient and Skip to 5.4] 
[Interviewer continue to 5.2 below if the answer is Yes] 
 
5.2 In your own words what is a CD4 count and what does it tell you? 
___________________________________________________________________________
_________________________________________________________________ 
 
5.3 If you do know what a CD4 count is, how did you learn about it?  
(Counselling, educational material other) 
[Skip if participant doesn‟t know] 
___________________________________________________________________________
_________________________________________________________________ 
5.4 What do you think happens if your CD4 count is above 350? 
________________________ 
[Interviewer, mark an X where appropriate and fill in code above as well]:  
 
 
 
 
 
 
5.5 What happens if your CD4 count is less than 350? ___________________ 
[Interviewer, mark an X where appropriate and fill in code above as well]:  
Don‟t know 1 
Start ARVs or medication for HIV 2 
You are sick 3 
You are not sick – no need for ARVs 4 
Others 5 
Don‟t know 1 
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6. ARV Knowledge  
6.1 Do you know what antiretroviral therapy (also known as ART/ARVs) is?  
1=Yes _____ 2=No _____ 0 =Don‟t know__________ 
 
[[Interviewer if the answer is no, explain the answer to the patient and Skip to 7) 
[Interviewer continue to 6.2 below if answer is Yes] 
6.2) If you had to start ARVs do you know where you would start treatment? [Name of 
clinic] 
______________________________________________________________________ 
 
6.3)  If you know where you would start ARVs, how did you find out this information? 
______________________________________________________________________ 
6.4). the following questions focus on knowledge and perceptions of ART. Please tell me if 
you think the following statements are true, false or don‟t know, so that we can understand 
your knowledge and perceptions of ART. 
Statements True=1 False=2 Don‟t 
know=3 
6.4.1 ARVs will cure me of HIV    
6.4.2 I can stop the ARV drugs once I am feeling 
better 
   
 
6.5) For how long do you have to take ARVs once you start taking them? 
Start ARVs or medication for 
HIV 
2 
You are sick 3 
You are not sick 4 
Other 5 
3-6 months  
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Pre-ART care or wellness services 
7 What services are lendered to individuals who are not yet eligible to start ART (CD4 
count >350) in this facility.  
 Components  Tick if the respondent 
mentions the service 
1 Voluntary counselling and testing,  (HCT)  
2 Disclosure and prevention, ongoing counselling,   
3 health literacy and peer education,-   
4 PLWHA support groups  
5 TB IPT – client education, screening and administration 
of IPT 
 
6 TB IPT – client screening of IPT  
7 TB IPT – client administration of IPT  
8 Social grant acquisition support  
9 Nutrition – (food parcels and infant feeds)  
10 Multivitamin supplements  
11 adherence support,   
12 Voluntary counselling and testing,  (HCT)  
 
7   Which of the following wellness programs have you accessed at this facility? 
6-12 months  
1-3 years  
3-5 years  
5-10 years  
>10 years  
forever  
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 Wellness program components  YES/NO 
1 Voluntary counselling and testing,  (HCT)  
2 Disclosure and prevention, ongoing counselling,   
3 health literacy and peer education,-   
4 PLWHA support groups  
5 TB IPT – client education, screening and administration of IPT  
6 TB IPT – client screening of IPT  
7 TB IPT – client administration of IPT  
8 Social grant acquisition support  
9 Nutrition – (food parcels and infant feeds)  
10 Multivitamin supplements  
11 adherence support,   
12 Voluntary counselling and testing,  (HCT)  
 
8  What exact service was offered to you in relation to the services below? 
 Components  Description of exact services 
1 Voluntary counselling and testing,  (HCT)  
2 Disclosure and prevention, ongoing counselling,   
3 health literacy and peer education,-   
4 PLWHA support groups  
5 TB IPT – client education, screening and IPT 
administration 
 
6 TB IPT – client screening of IPT  
7 TB IPT – client administration of IPT  
8 Social grant acquisition support  
9 Nutrition – (food parcels and infant feeds)  
10 Multivitamin supplements  
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11 adherence support,   
12 Voluntary counselling and testing,  (HCT)  
 
10   What do you think should be done to improve the services below? 
 Components  Description on what to be 
done 
1 Voluntary counselling and testing,  (HCT)  
2 Disclosure and prevention, ongoing counselling,   
3 health literacy and peer education,-   
4 PLWHA support groups  
5 TB IPT – client education, screening and IPT 
administration 
 
6 TB IPT – client screening of IPT  
7 TB IPT – client administration of IPT  
8 Social grant acquisition support  
9 Nutrition – (food parcels and infant feeds)  
10 community- and home-based care,   
11 adherence support,   
12 Voluntary counselling and testing,  (HCT)  
13 Disclosure and prevention, ongoing counselling,   
 
11   Have you been educated on the following areas? 
 Area Content 
1 Appropriate methods for family planning for spouse and 
yourself 
 
2 What happens in case you become pregnant  
3 Counselling and appropriate referral for TOP  
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4 Counselling and information for violence abuse where 
required 
 
5 Information on pap smear how often do you need to have 
it? (if male skip the question) 
 
6 Whether spouse tested for HIV  
 
12.0 Men/Youth Friendly Health Services (YFHS) 
12.1 Do you think your facility provides YFHS? 
 
 
12.2 What do you think must be done to ensure that your facility provides YFHS? 
 
 
12.3 In your own understanding does your facility provides men friendly health services? 
 
 
12.4 Do you think your facility provides men friendly health services? 
 
 
2.5 What do you think must be done to ensure that your facility provides men friendly 
health services? 
 
13 Regarding all the services accessed by you at this facility, what are the gaps or problems 
you have personally observed in delivering HIV related service? 
___________________________________________________________________________
_______ 
14. From your own opinion how do you think these problems can be solved 
________________________________________________________________________
________________________________________________________________________
______________ 
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Do you have any questions you would like to ask me? 
 
 
[END OF INTERVIEW] 
Thank you very much for your time and participation! 
Interview stop time: ______________ 
INTERVIEWER NOTES AND COMMENTS: 
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8.5.3 Staff interview questionnaire 
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Interview Form for Service Provider 
1. Interview details       
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: ________________  
1.4 Staff category: ________________ 
1.5 Facility code: _____________ 
1.6 Data capturing:  Date_________________  By__________________  
2.  Demographic Information 
Age: __________________ 
Gender: Male____________  Female______________ 
2.0 Description of the clinic profile 
2.1 Clinic profile and staffing 
 
Can you tell me what staff you have available in this clinic and their involvement in wellness 
program? (Applicable if facility manager) 
 
Category Female Male Youths Involvement in Wellness 
program 
Partner/CoJ staff 
Doctors      
Professional 
nurses 
     
Doctors      
Professional 
nurses 
     
Enrolled nurses      
Enrolled nurse 
assistant 
     
Health promoters      
Serv provider 
No: 
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Dietician      
Social worker      
Psychologist/ 
Counsellor 
     
Clerical staff      
Others      
Others      
 
2.2  Please describe to me how the staffs are allocated to activities in this clinic? Highlight 
those involved in wellness program 
 Probe overlapping functions; rotations  
2.3 Can you tell me if each of these services is available? (Fill in second column) 
Which of the following wellness program components are offered at your facility? 
Wellness program components  YES/NO 
Voluntary counselling and testing,  (HCT)  
Disclosure and prevention, ongoing counselling,   
health literacy and peer education,-   
PLWHA support groups  
TB IPT – client education, screening and administration of IPT  
TB IPT – client screening of IPT  
Nutrition – (food parcels and infant feeds)  
TB IPT – client administration of IPT  
Social grant acquisition support  
community- and home-based care,   
adherence support,   
Voluntary counselling and testing,  (HCT)  
Disclosure and prevention, ongoing counselling,   
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Do you think you have enough staff to deliver HIV related services? If not why 
 
 
3.0 Access to care 
Regarding ART services, can you describe to me the pathway in which patients access care 
i.e from HIV pre-test counselling to initiation on ART? 
[Prompt: guide me to draw the pathway of your care through the system from your first 
encounter at the facility to date] 
 
 
 
 
 
    
 
 
 
4.0 Basic HIV knowledge 
4.1 The following statements focus on knowledge of HIV/AIDS. For the following 
statements please tell me if you strongly agree, disagree, strongly disagree, or do not know 
[Interviewer, only 1 answer is applicable for each question] 
[Mark with an X where appropriate] 
Statements Strongly 
agree=1 
Agree=2 Disagree=3 Strongly 
Disagree=
4 
Don‟t 
know=5 
4.1.1 HIV is the virus 
that causes AIDS 
     
4.1.2 If you have HIV 
you are going to die 
sooner 
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4.1.3 If you have HIV it 
means you also have 
AIDS 
     
4.1.4 Tests for HIV are 
not always correct 
     
4.2 The following statements focus on the perceptions and behaviour surrounding 
HIV/AIDS. After each statement, please tell me whether you strongly agree, agree, disagree, 
strongly disagree or don‟t know  
[Interviewer, only 1 answer is applicable for each question] 
[Mark with an X where appropriate] 
Statements Strongly 
agree=1 
Agree=2 Disagre
e=3 
Strongly 
Disagree=
4 
Don‟t 
know=
5 
4.2.1 If you have HIV you cannot get 
married 
     
4.2.2 If you have HIV you cannot have 
an HIV- baby 
     
4.2.3 If both partners have HIV then 
there is no need to use condoms 
     
4.2.4 If one partner is positive and the 
other negative the couple cannot have a 
baby? 
     
4.2.5 HIV+ patients must encourage 
their partners to test for HIV 
     
 
4.5  In your own words, what does it mean to YOU PERSONALLY if an individual has 
HIV? ______________________________________________________________________ 
 
4.6 In your own words, what does it mean if an individual has AIDS?  
______________________________________________________________________ 
 
258 
 
5. CD4 Count Knowledge and Reasons for Return  
5.1 Do you know what a CD4 count is?      1=Yes____        2=No_____ 
[Interviewer Skip to 5.4 if answer is No] 
[Interviewer continue to 5.2 below if the answer is Yes] 
5.2 In your own words what is a CD4 count and what does it tell you? 
___________________________________________________________________________
_________________________________________________________________ 
 
5.3 If you do know what a CD4 count is, how did you learn about it?  
(Counselling, educational material other) 
[Skip if participant doesn‟t know] 
___________________________________________________________________________
_________________________________________________________________ 
 
5.4 What do you think happens when an HIV+ individuals‟ CD4 count is 350? 
________________________ 
[Interviewer, mark an X where appropriate and fill in code above as well]:  
 
 
 
 
 
 
 
6 Which of the following wellness program do you have at this facility and which one 
do you have knowledge and skills to provide? (Fill in the table below)  
 
 Wellness program 
components  
Availability (Y/N) Skills & knowledge (S&K) 
Don‟t know 1 
Start ARVs or medication for 
HIV 
2 
You are sick 3 
You are not sick 4 
Other 5 
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1 Voluntary counselling and 
testing,  (HCT) 
  
2 Disclosure and prevention, 
ongoing counselling,  
  
3 health literacy and peer 
education,-  
  
4 PLWHA support groups   
5 TB IPT – client education, 
screening & administration of 
IPT 
  
6 TB IPT – client screening of 
IPT 
  
7 TB IPT – client 
administration of IPT 
  
8 Social grant acquisition 
support 
  
9 Nutrition – (food parcels and 
infant feeds) 
  
10 community- and home-based 
care,  
  
11 adherence support,    
12 Voluntary counselling and 
testing,  (HCT) 
  
13 Disclosure and prevention, 
ongoing counselling,  
  
 
7 What are the challenges for this facility in delivering the services below? 
 Components  Challenges Possible 
solutions 
1 Voluntary counselling and testing,  (HCT)   
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 Components  Challenges Possible 
solutions 
2 Disclosure and prevention, ongoing 
counselling,  
  
3 Contraception for HIV+ women   
4 Cervical cancer screening for HIV+ women   
5 health literacy and peer education,-    
6 PLWHA support groups   
7 TB IPT – client education, screening and 
administration of IPT 
  
11 Social grant acquisition support   
12 Community- and home-based care,    
13 Adherence support,    
14 Voluntary counselling and testing,  (HCT)   
15 Disclosure and prevention, ongoing 
counselling,  
  
 
8 What advice do you give to an HIV+ female patient of the reproductive age 
group? 
 
 Area Content 
1 Appropriate methods for family 
planning for spouse and yourself 
 
 
2 What happens in case female HIV 
patient becomes pregnant 
 
3 Counselling and appropriate referral 
for TOP 
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 Area Content 
4 Counselling and information for 
violence abuse where required 
 
5 Information on pap smear how often 
do you need to have it? (if male skip 
the question) 
 
 
6 Whether spouse tested for HIV  
 
 
 
9 What are the possible solutions to improving the services in the table above? (Fill in 
the table above) 
10 Referral systems 
10.1Where do you refer complicated patients who need additional Wellness program care (if 
not provided on site)? 
Name of facility  
If you refer Pre-ART cases, do you (read out each question): 
Know the name of the person in charge of the Pre- ART service where you 
refer patients? 
Y N 
Ever discuss the management of individual patients with staff in the Pre-
ART service? 
Y N 
Receive information back from the ART service on your patients you 
referred? 
Y N 
Provide transport for patients to get to the Pre-ART service? Y N 
Comments on referral system 
   
10.2 Do you have any challenges with the up-referral system? 
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11.0 Men/Youth Friendly Health Services (YFHS) 
11.1  In your own understanding what does Youth Friendly Health Services (YFHS) mean? 
(If cannot define then define the YFHS to the participant) 
 
 
11.2 Do you think your facility provides YFHS? 
 
 
11.3 What do you think must be done to ensure that your facility provides YFHS 
 
 
11.4  In your own understanding what does Male friendly health Services mean? (If cannot 
define then provide the meaning to the participant) 
 
 
11.5 Do you think your facility provides men friendly health services? 
 
11.6 What do you think must be done to ensure that your facility provides men friendly 
health services? 
12       Regarding all the services accessed by patients at this facility, what are the gaps or 
problems you have personally observed in delivering HIV related service? 
___________________________________________________________________________
___________________________________________________________________________
______________ 
13 From your own opinion how do you think these problems can be solved? 
___________________________________________________________________________
___________________________________________________________________________
______________ 
14 Information Systems 
14.1 I‟d like to know now about the collection of statistics in this clinic. Can you describe to 
me how the system of collecting statistics in this clinic works? 
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[Prompt: the RDQA will verify this, but it would be useful to know the human element face 
behind this activity] Write verbatim response 
 
What is your role in collection or generation of monthly, quarterly and annual statistics for 
this facility? Write verbatim response 
 
5.2 Do you know, more-or-less, the following statistics for your clinic? 
 [Prompt: review if facility manager and other staff members know the approximate # of 
patients entering the HIV care cascade] 
 
# of HIV tests conducted?  
# HIV +  
# get CD4 count  
# CD4> 200  
# CD4 <200  
# suspected TB cases in the last month?  
# HIV + clients screened for TB?  
# HIV +v clients registered on pre-ART 
care 
 
# HIV + clients initiating on ART  
# clients initiated on  IPT  
Write verbatim response 
 
According to your observation or experiences what have been the differences in rolling out 
and or implementation of NIMART and pre-ART? Write verbatim response; 
 
Do you have any questions you would like to ask me? [END OF INTERVIEW] 
Thank you very much for your time and participation! 
Interview stop time: ______________   INTERVIEWER NOTES AND COMMENTS: 
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8.5.4: Pre-ART register audit tool 
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Pre-ART Register tool 
Data variables Patient numbers 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Date of file was open               
Patient name               
Phone No               
Age               
Gender               
Youth or not               
TB screening               
CD41 testing               
Cd4 cell count value               
Collected results               
CD4 2 testing               
Cd4 cell count value               
Collected results               
CD4 2 testing               
Cd4 cell count value               
Collected results               
Eligible for IPT/INH               
IPT Commenced               
Eligible for CPT               
CPT commenced               
Referred to Wellness clinic               
Patient attended Wellness clinic               
Patient still at wellness               
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8.5.5: File audit tool 
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Data variables Patient numbers 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Gender               
Initiation decision month               
First CD4 cell count               
ART initiation month               
1
st
 pre-ART registration date               
TB screening               
First DC4 cell count               
Second CD4 cell count               
Third CD4 cell count               
Cervical cancer screening               
IPT               
CPT               
Family planning               
Multivitamin supply               
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8.5.6: NIMART Readiness assessment tool 
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FACILITY ART SERVICE READINESS FORM 
Note: All items marked with an asterisk (*) are regarded as minimum requirements for 
accreditation. 
Province:           GAUTENG_______________________________ 
District:       JOHANNESBURG DISTRICT_______________________________________ 
Sub-district:    REGION F________________________________ 
Facility Name: _ 
Type of facility: Clinic     CHC                        Hospital  
 
 
 
If hospital, indicate total number of beds:   
 
 
 
Facility representative:  Facility Manager 
(Phone): 011 432 3546 Fax): 011 682 1455   E-mail):_________________   
                                Other               Specify: Phase I accreditation  
If hospital, indicate the level:  N/A         II        III  
Does the hospital have a designated gateway clinic?  
If yes, name of gateway clinic:  
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Other facility representatives: ______________________Tel: _______________Cell____________, 
Fax: _______________ 
1.1 Recording and reporting of facility. 
1.1.1 
A print out or softcopy of the DHIS PHC data elements / hospital data set 
of the facility available containing monthly data for the past 12 months 
   
1.1.2 
If yes in 1.1.1, what is the last reporting month according to the said data 
set? 
 
1.1.3 The DHIS PHC data set complete for every month over the past 12 months    
1.1.4 
A data set available for the VCT monitoring form for every month over 
the past 12 months 
 
 
 
1.1.5 
A data set available for the PMTCT monitoring form for every month over 
the past 12 months 
 
 
 
1.1.6 A data set available for TB for every quarter in the past 12 months    
1.1.7 A data set available for nutritional services over the past 12 months    
1.1.9 A data set available for STI services over the past 12 months    
1.1.10 
A data set available for PEP services over the past 12 months 
(Occupational Exposure)  
 
 
 
Sexual Assault    
24hr s Comments: PEP: Sexual assault clients are referred to Hillbrow CHC where the 
service is available for 24 hrs.Starter pack is available on site for occupational exposure. 
 
 
 
1.     GENERAL  
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1.2 Projected HIV & AIDS patient load during the first 6 months (please apply formula). 
Month 
 May June July Aug Sept Oct Total 
1.2.1 
Number of patients in ARV assessment 
period:  
Adults        
Children        
1.2.2 
Number of patients ready and waiting 
for treatment:  
Comment: All Children are referred to 
Referral Hospitals 
Adults        
TB        
PMTCT        
Children 
 
       
1.2.3 
Number of patients already on ARV          
treatment:  
Adults        
Children        
          
 
1.3 Physical space, communication and medical waste management. 
Intent: Sufficient space is required for consultation and treatment considering 
confidentiality, and for counselling and for storage in order to accommodate projected 
patient case-load, communication and waste management.  
1.3.1 The facility has the following number of consultation/ treatment rooms*  
1.3.2 The facility has the following number of counselling rooms*  
1.3.3 The facility has sufficient storage space for nutritional supplements   
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1.3.4 
The facility has the following number of consultation and counselling rooms for 
children* 
 
1.3.5 The facility has a Medical Waste Management System in place*? Yes  
 Name Medical Waste Management System: PICK IT UP 
1.3.5 The facility has a dedicated cell or land line for patient communication* Yes  
1.3.6 Patients/ Clients‟ complaints and compliments are recorded and settled Yes  
 
Other additional comments noteworthy: Operational Manager is allocated a Council cell-
phone. The clinic has one landline and a separate phone-fax line, two extension lines. 
2.     BASIC HIV & AIDS SERVICES – CURRENTLY AVAILABLE 
Services currently available 
Available 
On-site 
Referr
al 
Off-
site 
Not 
Availabl
e 
Comments 
2.1 Family Planning* Yes    
2.2 Antenatal services* Yes    
2.3 VCT* 
(Include Self & Med ref.ANC 
,PCR &TB Clients) 
 
Yes    
 2.3.1 Number of VCT clients currently seen for 6 months  776  
2.3.2 Would facility be able to manage more VCT clients 
per month? 
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2.4 IMCI / EPI*  Yes    
 
2.5 PMTCT*  Yes   
 2.5.1 Number of enrolled PMTCT patients over past 6 
months  
114 
2.5.2 Number of children followed up over the past 6 
months  
18 
2.6 TB Management* Yes    
 2.6.1 What is the current TB cure 
rate?                 
  Region F              =   
 (Site)                   = 
2.6.2 What is the current TB 
Defaulter rate?            
 Region F              =  
(Site)                    = 
2.6.3 What is the current TB Sputum 
turnaround time?    Days 
 Region F              < 
48 HRS 
(Site)                    < 
48 HRS 
2.6.4. Dots coverage  Region F             =   
(Site)                   = 
2.7 STI*  2.7.1 1
st
 line management Yes 277   
 2.7.2 2
nd
 line management  No   
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2.8 PEP [Occupational exp: 24h 
access]* 
 
 No   
2.9 PEP [Sexual assault victims: 24h]* 
 
Yes    
2.10 Nutritional Support* 
 
 No   
 2.10.1 
 Nutritional 
Supplement  
 
 No   
2.11 Social Worker Support* Yes    
Additional Basic HIV and AIDS Services Comments: DOTS Supporters from nearby NGO‟s 
are involved in treatment supervision, support and patient tracing. Sexual assault clients are 
referred to Hillbrow CHC where the service is available for 24 hrs.Starter packs is available 
on site for stat doses. 
3.     POLICIES AND NATIONAL TREATMENT GUIDELINES/ PROTOCOLS 
3.1 The facility has a written Confidentiality Policy*   
3.2 The facility has written Universal Infection Precaution Policies*   
3.3 National ARV treatment guidelines are adhered to*   
3.4 
National guidelines for management of HIV infected children are adhered 
to* 
  
3.5 Contraceptive service delivery guidelines are adhered to*   
3.6 National Antenatal Services guidelines are adhered to*   
275 
 
3.7 National VCT guidelines are adhered to*   
3.8 National PMTCT guidelines are adhered to*   
3.9 National TB Management guidelines are adhered to*   
3.10 National STI Treatment guidelines are adhered to*   
3.11 National Post Exposure Prophylaxis guidelines are adhered to*   
3.12 
National Nutritional guidelines for people living with TB, HIV & AIDS are 
adhered to* 
  
4. LABORATORY CAPACITY  
     
4.1 Is there a laboratory in the facility?     
 
4.1.1      
4.1.2      
4.2 
If there is no laboratory in the facility, is 
there a laboratory depot? 
 
   
 
4.2.1 If yes, is there a centrifuge in depot?     
4.2.2 
If yes, is there cool storage for 
specimens [2 - 8
o
C] 
 
  
 
4.2.3 
If yes, is specimen details recorded 
electronically? 
 
  
 
4.3 Facility utilizes the NHLS     
4.4 Utilizes other outside/ private lab services     
4.5 System to transport specimens to lab     
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4.6 System in place to receive results from lab      
4.7 
Is there a Laboratory Information System 
currently in use?  If yes, which system? 
 
  
 
4.8 Phlebotomist or trained nurse on lab staff*     
4.9 Specimen preparation protocols available*     
4.10 
Standard operating procedures are available 
for all laboratory tests 
    
4.11 CD4 testing capacity available     
4.12 HIV viral load capacity available     
4.13 Full blood count capacity available     
4.14 Liver function test capacity available     
4.15 HIV DNA PCR capacity available     
4.16 TB testing capacity available     
4.17 Lipid profile testing capacity available     
4.18 Viral hepatitis testing capacity available     
4.19 An equipment maintenance plan in place     
4.20 
All equipment is calibrated to a national 
standard 
    
4.21 
A copy of the NHLS Safety Manual signed 
by all lab staff is available 
    
4.22 
The laboratory participates in a Quality 
Assurance accreditation scheme/ program 
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 4.22.1 If yes, what scheme/ program?   
4.23 Biohazard & chemical waste are disposed      
 If yes, how is it done? : PHAMBILI Waste Management 
 
4.24 Current staffing of laboratory                                                     N/A 
  Rank Number in rank 
4.24.1 Supported by NHLS  
4.24.2   
4.24.3   
4.24.4   
4.24.5   
4.24.6   
Additional Laboratory Comments:  
5.     PHARMACY CAPACITY 
Please indicate how the drug capacity indicators are performing against current volumes and 
anticipated increases (refer back to 1.2). 
 Drug capacity Indicators Yes No N/a Response/ Comments 
5.1 The facility has its own pharmacy     
5.2 
Standard operating procedures (SOPs) 
for drug dispensing are followed 
    
5.3 A computerised medicine inventory     
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system is in place 
 
 Drug capacity Indicators     
5.4 
A computerised drug ordering system 
is in place ( Langlaagte Pharmacy) 
 
    
 Storage space sufficient     
 
5.5.1 Against current volumes     
5.5.2 Against anticipated increases     
5.6 
Security adequate [according to 
minimum certification requirements]  
    
5.7 Dispensing „Schedule 5‟ drugs     
5.8 Cold storage for drugs     
 
5.8.1 Against current volumes     
5.8.2 Against anticipated increases     
5.9 
At least one Full Time Equivalent 
pharmacist/ pharmacist assistant 
    
5.10 
Professional nurse licensed to 
dispense, on site* 
    
5.11 Currently stocking ARV medication     
5.12 Fluconazole/ Diflucan available     
5.13 
Pharmacy meets minimum 
certification requirements 
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5.13.1 
Implementation of SOPs for 
receiving, storing and 
dispensing Schedule 5 drugs 
    
5.13.2 
Four weeks of supply of 
buffer stock 
    
5.13.3 Registered pharmacist on site     
Additional Pharmacy Comments: Site will be supported by Hillbrow ARV Pharmacist  
6.     HIV AND AIDS SERVICE POINT    
6.1 Access to care, treatment and support.  
Intent: Care; treatment and support to HIV patients are available 24 hours per day at, (a) the 
facility, and/or (b) on referral. 
 Days/week Hours/day 
At facility On referral At facility On referral 
6.1.1 Casualty/ Emergency 
Room[s] 
    
6.1.2 High care unit     
6.1.3 Intensive care unit     
6.1.4 Nursing care*     
6.1.5 Clinician care*     
6.1.6 Outpatients Department     
Comments: Referral Hospitals are: Hillbrow CHC, Charlotte Maxeke Johannesburg Hospital, 
South Rand Hospital and Germiston Hospital 
6.2 Access to expert consultation. 
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Intent: Access to specialist and sub-specialist services does exist or is being planned. 
Speciality 
Available                       
on site 
Available                                    
off-site 
If off-site, is                                                         
transport available? Comments 
and/or plans 
Yes No 
6.2.1 HIV Clinical expertise*      
6.2.2 Gastro-enterology*      
6.2.3 Paediatrics*      
6.2.4 Internal medicine*      
6.2.5 Dermatology*      
6.2.6 Gynaecology & Obstetrics      
6.2.7 Surgery*      
6.2.8 Neurology*      
6.2.9 ENT*      
6.2.10 Oncology*      
6.2.11 Ophthalmology*      
6.2.12 Pulmonary medicine*      
6.2.13 Oral health services*      
6.2.14 Infectious diseases*      
6.2.15 Antenatal services*      
6.2.16 Cardiology*      
6.2.17 TB services*      
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6.2.18 X-ray/ Ultrasound*      
6.2.19 STI services*      
6.3 Appropriately trained staff managing HIV and AIDS services at service point. 
Intent: Current number of trained staff members managing HIV and AIDS Services at 
facility and additional numbers needed to meet projected patient load for ARV 
treatment. 
 
Current status 
Additional 
requirements 
How determined? 
  Trained 
Not 
trained 
  
6.3.1 Medical officer     
6.3.2 Professional Nurse *     
6.3.3 Staff Nurse*     
6.3.4 Enrolled nurse assistant      
6.3.5 Dietician/ Assistant *      
6.3.6 Pharmacist      
6.3.7 Pharmacist Assistant *     
6.3.8 Social Worker *     
6.3.9 Lay counsellor *     
6.3.10 Administrative Clerk *     
6.3.11 Data capturer *     
 EPW 
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6.4 Project Management 
Intent: A dedicated person is required to supervise the treatment component of the 
Comprehensive Plan implementation and expansion.  This person may provide a service to 
more than one service point. 
 Yes No N/a Comments 
6.4.1 A project manager has been appointed     
6.4.2 The terms of reference for the project manager is 
available 
    
6.5 Access to home/ community based services. 
Intent: Home/ community based services are utilised by service points to ensure a 
continuum of care. Facilities refer patients to or receive patients from these 
services [Provide numbers for the past 12 months] 
Patients referred to and from home/ community 
based services 
Yes No 
Number of 
patients 
Name services 
6.5.1 NGOs  6.5.1.1 Referred to  No   
 6.5.1.2  Received from     
6.5.2 CBOs 6.5.2.1  Referred to     
 6.5.2.2  Received from     
6.5.3 FBOs 6.5.3.1  Referred to     
 6.5.3.2  Received from     
6.5.4 
Other patient 
support groups 
6.5.4.1  Referred to 
    
 6.5.4.2  Received from     
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6.5.5 
Traditional 
healers 
6.5.5.1  Referred to 
    
 6.5.5.2  Received from     
Comments: Most of the clients are TB patients. Meeting with DOT supporters are held 
monthly. DOT Supporters visit the clinic daily. Support group meetings are held every 
Friday. 
6.6 Patient Management Systems at the service point. 
Intent: Systems are in place to, (i) identify, contact, schedule and locate patients, (ii) 
capture patient information and maintain medical records, (iii) transmit core data to a 
central data collection point, and (iv) refer patients successfully. 
 Yes No Comments 
6.6.1 Standard patient referral and reporting letter used     
6.6.2 Appointment system for patients in place    
6.6.3 Patient identification system in place [name system]    
6.6.4 Patient tracking system in place [name system]     
6.6.5 
Patient ID & tracking systems can identify defaults 
and reschedule  
   
6.6.6 
The specific content of clinical records in line with 
the National requirement is available  
   
6.6.7 Standardised diagnosis & procedural codes are used    
6.6.8 
Clinical records contain adequate information to 
support the diagnosis 
   
6.6.9 
Clinical records contain adequate information to 
justify the care and treatment 
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6.6.10 
Clinical records contain adequate information on the 
course and results of treatment 
   
6.6.11 
The author can be identified for each patient record 
entry 
   
6.6.12 
Clinical records of patients include information on the 
organisation that referred 
   
6.6.13 
Data or information is contributed to a central 
collection point 
   
6.6.14 
The facility compares its performance using the 
central data collection point‟s data 
   
6.6.15 
Core data is transmitted without compromising 
security 
   
6.6.16 
Core data is transmitted without compromising 
confidentiality and correctness 
   
6.6.17 The facility uses a patient-kept patient record    
6.6.18 The facility uses a facility-kept patient record    
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6.7 Governance and management. 
Intent: The facility (service point) assures that the community actively participates in 
the planning and monitoring processes of the facility.  The facility also builds 
formal relationships with the relevant official structures of government at local 
and provincial level.    
 Yes No Comments 
6.7.1 
The service point closely interacts with the District 
Management Team 
   
6.7.2 
The service point closely interacts with the HIV and 
AIDS Unit in the provincial office 
   
6.7.3 
Agendas and minutes of a functioning hospital board 
are available 
   
6.7.4 
Agendas and minutes of a well-functioning clinic / 
CHC committee are available 
 
  
 
6.8 Information, Education and Communication (IEC). 
Intent: Initial and ongoing HIV education is provided to patients, family members and 
the community. 
 Yes No Comments 
6.8.1 An IEC plan is in place    
6.8.2 A Communication Strategy is in place    
6.8.3 HIV & AIDS educational material is available    
    
6.8.4 Mind-set Health Channel is available    
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6.9 Equipment and building maintenance. 
Intent: The building and equipment is viewed as a major asset and thus managed 
accordingly.   
  Yes No Comments 
6.9.1 A procurement system is in place    
6.9.2 The facility has a maintenance plan for the building    
6.9.3 The facility has a maintenance plan for equipment    
6.9.4 
An inventory for equipment is kept & regularly 
updated 
   
 
Comments: Inventory list in each room and file are available and updated. Invoices file has 
been created. 
7.     ACCREDITATION TEAM MEMBERS 
  
         
NAME 
POSITION E-MAIL TEL NO 
    
    
    
    
    
                                           
Date of amendment  
 
 
Date of planned follow-up visit:
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ANNEXURE A 
a) Please list all the facilities that are referring to you and indicate the type of facility, e.g. 
clinic, CHC, hospital, FBO, CBO (hospices), NGO, and THP: 
1. Type:  
2. Type:  
3. Type:  
4. Type:  
5. Type:  
6. Type:   
(b) Over the past 12 months:   
1. From public health facilities as listed in (a) above ---  
2. From NGOs, CBOs and & FBOs    ---  
3. From the private sector     --- 
4. From traditional health practitioners   ---   
ANNEXURE B 
a) Please list all the facilities to which your facility is referring to and indicate the type of 
facility, e.g. clinic, CHC, hospital, FBO, CBO (hospices), NGO, and TH: 
1.       Type:  
2.       Type:  
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3.       Type:  
4.       Type:   
5.       Type:  
b) Provide accurate numbers of patients/ clients that over the past 12 months have been 
referred by your facility to the following:   
Facilities listed in (a) above [added totals for 1.1 to 1.6]  
1. Family planning services (off-site)   __ 
2. Antenatal services (off-site)    __ 
3. VCT services (off-site)    __ 
4. PMTCT services (off-site)    __ 
5. TB Management services (off-site)   __  
6. STI services ( off-site)    __ 
7. NGOs, CBOs and & FBOs    __ 
8. The private sector     __ 
9. Traditional health practitioners   __ 
ANNEXURE C 
Terms of Reference of the Project Manager 
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8.6 Training program for data collectors 
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Date:  4
th
-7
th
 -July 2012; Venue: 3
rd
 Floor boardroom – Esselte clinic 
Training content FACILITATOR 
Pre-ART project and research study summery  Juliet  
Overview of the questionnaires Patients‟ /YFHS/MFHS 
Discussion of emerging issues and feedback 
Petronella 
Conducting interviews 
Introduction 
Characteristics of a good interviewer 
behavioural techniques for building rapport in interviews 
Unbiased versus leading questions 
Examples of effective probes (direct and indirect probes) 
Other check points after the in-depth interviews 
What to take to an interview (preparation for an interview 
Discussion of emerging and feedback 
Juliet  
Data quality checks -Discussion of emerging and feedback Juliet 
Debriefing sessions -Discussion of emerging and feedback Juliet 
Practical on conducting interviews using the questionnaires- 
Discussion of emerging and feedback 
Petronella/Juliet 
Role-play on conducting interviews 
Discussion of emerging and feedback 
Petronella/Juliet 
Feedback sessions 
Discussion of emerging and feedback 
Petronella/Juliet 
More practice on conducting interviews 
Discussion of emerging and feedback 
Petronella/Juliet 
Way forward and planning for the data collection week Petronella/Juliet 
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8.7: NIMART training content 
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NIMART Capacity building programme 
 
Date: 
Sessions for the 5 day training 
Welcome, introduction, learning objectives and pre training assessment 
HIV basic science refresher including diagnosis 
Staging and opportunistic infections 
PMTCT refresher including infant feeding 
Case finding/diagnosis cases 
Staging and OI cases 
Participant reflections and action plans 
Adult ARV initiation and management: Regimens, when to start, how to start, 
monitoring and side effects 
Adherence 
Adult ARV initiation and management cases 
Participant reflections and action plans 
TB/HIV co-infection 
TB infection control 
Quality improvement 
TB/HIV cases 
Way forward: mentoring visits, assessment process, participant case 
documentation tools 
Participant reflections and action plans 
NIMART post-training assessments 
NIMART course evaluation 
Close 
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8.8: CoJ Referral Form 
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8.9: Publications and conference outputs 
  8.9.1: NIMART Roll out publication 
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8.9.2   Factors contributing to pre-ART care access- 2013 PHASA 
conference 
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 Title: Factors contributing to retention and timely ART referral for pre-ART patients 
in the city of Johannesburg - A pre-ART care program baseline assessment.  
 
Nyasulu J C Y., Muchiri E., Fonn S.  
 
Corresponding author: Nyasulu J C Y:  
Telephone: +2779735487; Fax: +27865213132 Email: Juliet.nyasulu@hst.org.za or 
julietnyasulu@gmail.com 
Introduction: Delays in timely treatment of known HIV+ patients leads to patients 
presenting sick and increased mortality. How pre-ART care is best set up and managed 
within the general health system is currently unknown and requires operational research. The 
study aim is to identify gaps in implementing Pre-ART program in order to develop and test 
the impact of an appropriate per-ART program that increases timely ART referral in PHC 
facilities in the city of Johannesburg.  
Methods: This is a baseline assessment for an intervention study in two primary PHC 
facilities from the city of Johannesburg. Data was collected through interviews with pre-ART 
care service providers and patients and document review. STATA version 12.0.1 was used to 
analyse quantitative data.  
Findings: A total of 12 service providers and 73 pre-ART care patients (24 males & 48 
females) of whom 9 were youths were interviewed. Seventy one percent of the pre-ART 
patients had their CD4 count checked within the past 6 months. Gaps established were: long 
waiting times, staff shortage and negative staff attitudes, lack of monitoring systems, lack of 
acceptance of one‟s HIV+ status, drug stock outs, lost CD4 count and other blood results, 
youth and male unfriendliness. In addition, lack of knowledge about HIV/AIDS, CD4 cell 
count, pre-ART and ART care was also established.  
Conclusion: There are major gaps in the pre-ART care services leading to poor patient 
retention and delays in ART initiation. Therefore, to ensure timely ART referral and access to 
pre-ART care, there is urgent need to design an appropriate pre-ART care program that 
would address the existing gaps targeting patients, staff and health systems in PHC facilities.  
 
Key words: Pre-ART care, CD4 count, Timely ART referral, ART initiation 
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8.9.3   Pre-ART care access register audit- 2015 SAAIDS conference 
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Title: Retaining people in pre-ART care in Johannesburg PHC facilities 
Nyasulu J C Y
1,2,
, Fonn S
1
 and Manderson, L
1
. 
Affiliations 
1
 University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, 7 
York Road, Park Town, Johannesburg, South Africa. 
2
Health Systems Trust (HST), 1
st
 Floor, 
Block J, Central Park. 400 16
th
 Road, Midrand 
Background and Objectives: Pre-ART is believed to be critical for timely ART initiation. 
Many studies have documented poor retention in pre-ART, but there has been little research 
on access to care by pre-ART patients retained in care.  The aim of this study was to establish 
factors influencing access to pre-ART care services by pre-ART care patients in the City of 
Johannesburg (COJ). 
 
Methods: Two COJ facilities were randomly selected for file audits on patients initiated on 
ART between February 2012 – August 2012. Patient files were audited on the pre-ART care 
services accessed during their pre-ART care period.  
Results: A total of 203 patients were initiated on ART during the study period. Of these, 7% 
had >350 CD4 cell count. Women were more likely to initiate on ART timely than male 
(P=0.04). Only 30 of the 203 patients initiated on ART had gone through pre-ART care. 
Being on pre-ART was not associated with timely ART referral (p=0.6). Out of the 30 
patients, 16 were screened for TB, 10 were initiated on IPT, and all received multivitamins 
and checked their CD4 count at least once. Family planning and cervical cancer screening 
were not documented in their files. 
Conclusion: Most patients initiated on ART do not go through the pre-ART care program as 
documented by other studies. Poor access to prescribed pre-ART care services by those 
retained in care, not found in other studies, indicates the urgent need to prioritise access to 
services for patients still in care. Raising awareness of available pre-ART care services and 
priotising pre-ART care access by those retained in care is critical for pre-ART care service 
delivery.  
 
Key words: Access, Pre-ART, Care, Services, retention  
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8.9.4   Mentoring and coaching in pre-ART register documentation – 2014 PHASA Conference 
(Award winning: Best oral presentation – PHASA 2014) 
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Title: Mentoring and coaching: Improving documentation gaps in pre-ART register at 
Roedtan Clinic, Waterberg District, Limpopo Province 
M Selepe
1
, K Setsiba
2
, M Ledwaba
2
, K Mathekga
2
, J Nyasulu
1
 
1
Health System Trust; 
2
Limpopo Department of Health 
BACKGROUND 
Pre-ART care for HIV-positive individuals with high CD4 cell counts is critical to strengthen 
monitoring and ensure timely referral for ART. However, poor documentation in pre-ART 
care is reported in South Africa and elsewhere. Significant gaps in documentation were 
identified at Roedtan Clinic. 
OBJECTIVE: To improve service providers‟ information recording in the pre-ART care 
register in Roedtan Clinic, Waterberg District. 
METHODS: The Clinic‟s pre-ART register was audited to identify documentation gaps and 
their causes. A quality improvement plan was developed in collaboration with the facility and 
district staff. The clinic‟s pre-ART care service providers were trained, mentored and 
coached by the HST facility mentor in completing the pre-ART register and managing pre-
ART clients according to national guidelines. A routine process was established for 
reviewing register completeness.  
RESULTS: Pre-intervention baseline figures in April 2013 reflected a total of 17 HIV-
positive clients in the HCT register, with only six in the pre-ART register, and with 16 
incomplete fields (e.g. no CD4 results). With training, mentoring and monthly register 
review, by April 2014 the HCT register recorded 12 HIV-positive clients and all were linked 
to pre-ART, with 100% of data fields completed. 
CONCLUSION: The project identified major documentation gaps in the pre-ART register, 
which could lead to poor monitoring and management of patients in the pre-ART care 
programme. Training, mentoring and coaching of service providers on the importance of pre-
ART care data led to improved documentation and strengthened lines of care from HCT to 
pre-ART. 
Key words: Pre-ART, Pre-ART register, Documentation, Mentoring and coaching 
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8.9.5   NIMART roll out – 2011 PHASA Conference 
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P 104 - NiMART roll-out to Primary Health Care (PHC) facilities a tool to increasing 
access to care and reduce workload for referral facilities in Region F – Johannesburg 
J Nyasulu, S Mazwi, M Kgopa 
Wits Reproductive Health and HI Institute (WRHI); Faculty of Health Sciences, University of 
the Witwatersrand, Hugh Solomon Building, Hillbrow, Johannesburg 
INTRODUCTION 
South Africa has made remarkable progress in rolling out antiretroviral treatment, with the 
largest number of people enrolled on ARVs in the world UNAIDS (2008). Since the roll-out 
of ART services, decentralisation of ART services has also proved to strengthen retention of 
patients on ART and reduce burden of managing uncomplicated cases at referral hospitals. 
By October 2010, only one out of the 17 PHC facilities in the region F of City of 
Johannesburg (CoJ) was initiating patients on ART. This lead to loss of patients who were 
being referred to hospitals for initiation and referral hospitals being overburdened with non-
complicated cases 
AIM: The aim of the intervention was to reduce work overload of non-complicated cases at 
referral hospitals and increase access to ART services. 
METHODS: This was a NIMART roll-out intervention whereby nurses from 17 PHC 
facilities of Region F city of Johannesburg were trained and mentored In NIMART by WRHI 
to start initiating patients on ART in their PHCs. Number of patients initiated on ARVs PHCs 
and referral hospitals were monitored.  
FINDINGS: 100 Professional nurses were trained and mentored in NIMART by WRHI. By 
the end of August 2011, 16 out of 17 PHC facilities were initiating patients on ART and 
1,400 Patients were initiated through NIMART. Monthly initiation coverage for Region F 
increased from 642 to 746 per month and initiations at the referral CHC facility significantly 
(p=0.04) reduced. 
CONCLUSION: In order to promote accessibility of ART services, there is need to 
decentralise services to PHC facilities through training and mentoring professional nurses in 
ART initiation. ARV initiation of non-complicated cases at PHC facilities will reduce the 
workload at referral hospitals enabling them to concentrate on complicated cases. 
 
Key words: NIMART roll-out, PHC facilities, Time series analysis and ART uptake   
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8.9.6 Pre-ART Linkage to care abstract – 2015 PHASA conference 
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Title: Linkages to care for ineligible newly diagnosed HIV+ individuals – A register 
audit in the City of Johannesburg (CoJ), South Africa 
Nyasulu J C Y
1,2 ,
and Manderson, L
1
. 
Background: Linkages to care for those diagnosed with HIV is critical for monitoring to 
ensure timely ART initiation. However, delays in ART initiation have been established in 
South Africa and elsewhere, with poor linkages to care the main contributing factor. The aim 
of the study was to establish factors contributing to poor linkage of newly diagnosed HIV+s 
in the City of Johannesburg. 
Methodology: A pre-ART register file audit was conducted in two facilities in the inner city 
of Johannesburg. Patients who tested HIV+ with CD4 cell count of >200 cells/μl from May 
2011 to April 2012 in these facilities were included. Data were analysed using STATA 12.0 
to establish these factors. 
Results: A total of 1705 patients were included and major gaps around incomplete registers 
were established. The average CD4 cell count for ART ineligible patients was 464 cells/μl.  
Women were more likely to have higher CD4 cell count levels (p=0.000) and collect CD4 
cell results (p=0.001) than males (p=0.000). Those aged >24yrs (p=0.05), and those who had 
phone contact numbers (p=0.021) were more likely to collect their CD4 cell count results 
than those < 24 years and those without phone numbers.   
Discussion/Conclusion: Consistent with other findings, poor linkages to care was coupled 
with poor documentation from testing HIV+. Being a man and young (<24yrs) has shown to 
negatively affect collection of CD4 cell count results which is important for clinical decision 
making and linkage to care. In addition those who had phone contacts, even though the phone 
numbers were not used to follow then up, were more likely to come back for CD4 cell count 
results than those without phone numbers. Therefore, strengthening documentation and 
prioritising men and young people may strengthen linkage to care for people still not yet 
eligible for ART.  
Key words: Linkage to care, CD4 cell count, ART ineligible and HIV+ 
